WO2023031032A1 - Appareil et procédé permettant d'obtenir un contrôle urinaire - Google Patents

Appareil et procédé permettant d'obtenir un contrôle urinaire Download PDF

Info

Publication number
WO2023031032A1
WO2023031032A1 PCT/EP2022/073763 EP2022073763W WO2023031032A1 WO 2023031032 A1 WO2023031032 A1 WO 2023031032A1 EP 2022073763 W EP2022073763 W EP 2022073763W WO 2023031032 A1 WO2023031032 A1 WO 2023031032A1
Authority
WO
WIPO (PCT)
Prior art keywords
patient
implantable
constriction
urinary bladder
urine
Prior art date
Application number
PCT/EP2022/073763
Other languages
English (en)
Inventor
Peter Forsell
Original Assignee
Implantica Patent Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2021/073893 external-priority patent/WO2022043555A1/fr
Application filed by Implantica Patent Ltd filed Critical Implantica Patent Ltd
Priority to EP22772432.5A priority Critical patent/EP4395704A1/fr
Priority to JP2024513471A priority patent/JP2024536982A/ja
Priority to CA3230660A priority patent/CA3230660A1/fr
Priority to AU2022336957A priority patent/AU2022336957A1/en
Priority to AU2023221544A priority patent/AU2023221544A1/en
Priority to PCT/EP2023/053988 priority patent/WO2023156574A1/fr
Publication of WO2023031032A1 publication Critical patent/WO2023031032A1/fr
Priority to PCT/EP2024/054071 priority patent/WO2024170775A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0004—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
    • A61F2/0031—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra
    • A61F2/0036—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra implantable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/042—Urinary bladders

Definitions

  • the present invention relates to an implantable apparatus for obtaining urinary control and emptying of the urinary bladder, thereby preventing or treating involuntary urinary retention. More particularly, the invention relates to an implantable apparatus for discharging urine from the urinary bladder with a powered member operating from the outside of the urinary bladder assisted by a support structure.
  • Urinary dysfunction is commonly caused by spinal cord injuries which involve involuntary urinary retention. This condition is associated with urinary infections, renal damages, or damages to the urinary tract. A common treatment of urinary retention is continuous or intermittent catherization. Besides the inconvenience for the patient, catheters always represent a risk of acquiring infections. Summary
  • an implantable pumping device for evacuating urine from the urinary bladder of a patient.
  • the implantable pumping device comprises a first constriction device configured to constrict a portion of the urinary bladder for closing a first portion of the urinary bladder.
  • the implantable pumping device further comprises a second constriction device configured to constrict a second portion of the urinary bladder, downstream the first portion, for evacuating urine from the urinary bladder when the first portion of the urinary bladder is closed.
  • the implantable pumping device further comprises a controller configured to control the first and second constriction device.
  • an implantable pumping device for evacuating urine from the urinary bladder (U) of a patient.
  • the implantable pumping device comprises a rotor carrying a constriction device.
  • the constriction device comprises a first constriction element, a second constriction element and a third constriction element.
  • the constriction elements are position equidistantly from an axis of rotation of the rotor.
  • the implantable pumping device further comprises a support element spaced from the rotor.
  • the implantable pumping device is applied on the urinary bladder so that the urinary bladder extends between the support element and the rotor.
  • the implantable pumping device further comprises a controller configured to control the rotor so that the constriction elements successively constrict a series of selected portions of the urinary bladder in order to evacuate urine from the urinary bladder.
  • an implantable pumping device for evacuating urine from the urinary bladder of a patient.
  • the implantable pumping device comprises a first operably hydraulic constriction element configured to be inflated to constrict the urinary bladder for restricting the flow of fluid therethrough.
  • the implantable pumping device further comprises a second operable hydraulic constriction element configured to be inflated to constrict the urinary bladder for restricting the flow of fluid therethrough and for evacuating urine from the urinary bladder.
  • the implantable pumping device further comprises an interconnecting fluid conduit fluidly connecting the first operable hydraulic constriction element to the second operable hydraulic constriction element.
  • ISA/EP hydraulic constriction element is configured to be placed at a first portion of the urinary bladder for constricting the first portion of the luminary organ for restricting the flow of fluid therethrough
  • the second operable hydraulic constriction element is configured to be placed at a second portion of the urinary bladder, downstream the first portion, for constricting the second portion of the urinary bladder for restricting the flow of fluid therethrough and for evacuating urine from the urinary bladder
  • the interconnecting fluid conduit is configured to conduct fluid from the first operable hydraulic constriction element to the second operable hydraulic constriction element when the pressure increases in the first operable hydraulic constriction element, such that second operable hydraulic constriction element constricts the second portion of the urinary bladder further.
  • an implantable pumping device for evacuating urine from a urinary bladder of a patient.
  • the implantable pumping device comprises a first implantable constriction device for constricting the urinary bladder.
  • the first implantable constriction device comprises a first operable hydraulic constriction element configured to be inflated and thereby expand in a first direction towards the urinary bladder to constrict a first portion of the urinary bladder for restricting the flow of fluid therethrough.
  • the first implantable constriction device further comprises a supporting operable hydraulic constriction element configured to be inflated and thereby expand in the first direction towards the urinary bladder to support the first operable hydraulic constriction element in constricting the first portion of the urinary bladder for restricting the flow of fluid therethrough.
  • the implantable pumping device further comprises a second implantable constriction device similar to the first implantable constriction device.
  • the second implantable constriction device is configured to constrict a second portion of the urinary bladder downstream the first portion in order to evacuate urine from the urinary bladder.
  • the second portion extends a longer distance along an axial direction than the first portion.
  • an implantable pumping device for evacuating urine from a urinary bladder of a patient.
  • the implantable pumping device comprises a first constriction device for constricting the urinary bladder.
  • the first constriction device comprises a first operable hydraulic constriction element configured to be inflated to exert a pressure on the urinary bladder in a first direction to constrict a first portion of the urinary bladder for restricting the flow of fluid therethrough.
  • the first constriction device further comprises a second operable hydraulic constriction element configured to be inflated to exert a pressure on the urinary bladder in a second direction to constrict the first portion of the urinary bladder for restricting the flow of fluid therethrough.
  • the first constriction device further comprises a first hydraulic system in fluid connection with the first operable hydraulic constriction element.
  • the first constriction device further comprises a second hydraulic system in fluid connection with the second operable hydraulic constriction element.
  • the first and second operable hydraulic constriction elements are adjustable independently from each other.
  • the implantable pumping device further comprises a second constriction device for constricting the urinary bladder and for evacuating urine from the urinary bladder.
  • the second constriction device comprises a third operable hydraulic constriction element configured to be inflated to exert a pressure on the urinary bladder in a first direction to constrict a second portion of the urinary bladder for restricting the flow of
  • the second constriction device further comprises a fourth operable hydraulic constriction element configured to be inflated to exert a pressure on the urinary bladder in a second direction to constrict the second portion of the urinary bladder for restricting the flow of fluid therethrough and for evacuating urine from the urinary bladder.
  • the second constriction device further comprises a third hydraulic system in fluid connection with the third operable hydraulic constriction element.
  • the second constriction device further comprises a fourth hydraulic system in fluid connection with the fourth operable hydraulic constriction element.
  • the third and fourth operable hydraulic constriction elements are adjustable independently from each other.
  • an implantable pumping device for evacuating urine from the urinary bladder of a patient.
  • the implantable pumping device comprises a first constriction device for constricting the urinary bladder.
  • the first constriction device comprises an operable hydraulic constriction element configured to be inflated to exert a pressure on the urinary bladder.
  • the first constriction device further comprises a first hydraulic reservoir for holding a hydraulic fluid.
  • the first constriction device further comprises a first hydraulic pump for pumping fluid from the first hydraulic reservoir to the first operable hydraulic constriction element.
  • the first constriction device further comprises a first fluid conduit creating a fluid connection between the first hydraulic reservoir and the first hydraulic pump.
  • the implantable pumping device further comprises a second constriction device for constricting the urinary bladder downstream the first constriction device for evacuating urine from the urinary bladder.
  • the second constriction device comprises a second operable hydraulic constriction element configured to be inflated to exert a pressure on the urinary bladder.
  • the second constriction device further comprises a second hydraulic reservoir for holding a hydraulic fluid.
  • the second constriction device further comprises a second hydraulic pump for pumping fluid from the second hydraulic reservoir to the second operable hydraulic constriction element.
  • the second constriction device further comprises a second fluid conduit creating a fluid connection between the second hydraulic reservoir and the second hydraulic pump.
  • the implantable pumping device further comprises an electrode arrangement configured to be arranged between at least one of the first constriction device, the second constriction device and the urinary bladder.
  • the electrode arrangement is configured to engage and electrically stimulate muscle tissue of the urinary bladder to exercise the muscle tissue to improve the conditions for long term implantation of the implantable pumping device.
  • an implantable pumping device for evacuating urine from the urinary bladder of a patient comprises a first constriction device for constricting the urinary bladder for restricting the flow of fluid therethrough.
  • the first constriction device comprises a first operable hydraulic constriction element configured to be inflated to exert a pressure on the urinary bladder.
  • the first constriction device further comprises a second operable hydraulic constriction element configured to be inflated to exert a pressure on the urinary bladder.
  • the first constriction device further comprises a first hydraulic pump for pumping fluid to the operable hydraulic constriction element.
  • the first constriction device further comprises a second hydraulic pump for pumping fluid to the operable hydraulic constriction element.
  • the first constriction device further comprises a motor. The motor is mechanically connected to the first and second
  • the implantable pumping device further comprises a second constriction device for constricting the urinary bladder, downstream the first constriction device.
  • the second constriction device is configured for evacuating urine from the urinary bladder.
  • the second constriction device is similar to the first constriction device.
  • an implantable pumping device for evacuating urine from the urinary bladder of a patient.
  • the implantable pumping device comprises a first constriction device for constricting a urinary bladder for restricting the flow of fluid therethrough.
  • the first constriction device comprises a first operable hydraulic constriction element configured to be inflated to exert a pressure on the urinary bladder.
  • the first constriction device further comprises a first hydraulic pump for pumping a hydraulic fluid to the first operable hydraulic constriction element.
  • the implantable pumping device further comprises a second constriction device for constricting a urinary bladder, downstream the first constriction device, for evacuating urine from the urinary bladder.
  • the second constriction device comprises a second operable hydraulic constriction element configured to be inflated to exert a pressure on the urinary bladder.
  • the second constriction device further comprises a second hydraulic pump for pumping a hydraulic fluid to the second operable hydraulic constriction element.
  • the implantable pumping device further comprises an implantable energy storage unit.
  • the implantable pumping device further comprises a capacitor connected to the implantable energy storage unit and connected to at least one of the first and second hydraulic pump. The capacitor is configured to be charged by the implantable energy storage unit and to provide at least one of the first and second hydraulic pump with electrical power.
  • an implantable pumping device for evacuating urine from a urinary bladder of a patient.
  • the implantable pumping device comprises a first constriction device for constricting the urinary bladder for restricting the flow of fluid therethrough.
  • the implantable constriction device comprises a first operable hydraulic constriction element configured to be inflated to exert a pressure on the urinary bladder.
  • the first constriction device further comprises a first hydraulic pump for pumping a hydraulic fluid to the first operable hydraulic constriction element.
  • the implantable pumping device comprises a second constriction device configured to constrict the urinary bladder, downstream the first constriction device, for evacuating urine from the urinary bladder.
  • the second constriction device comprises a second operable hydraulic constriction element configured to be inflated to exert a pressure on the urinary bladder.
  • the second constriction device comprises a second hydraulic pump for pumping a hydraulic fluid to the second operable hydraulic constriction element.
  • the implantable pumping device further comprises a controller configured to control the first and second hydraulic pump.
  • the controller comprises a sensor adapted to detect a magnetic field and a processing unit having a sleep mode and an active mode.
  • the implantable pumping device further comprises an external control unit adapted to be arranged outside of the patient’s body.
  • the external control unit comprising a first coil adapted to create a magnetic field detectable by the internal sensor.
  • the controller is further configured to, in response to a detected magnetic field exceeding a predetermined value, setting the processing unit in an active mode.
  • a method of implanting an implantable pumping device comprises the steps of making an incision in the body of the patient, for accessing the urinary bladder. Dissecting a portion of the urinary bladder. Inserting an implantable pumping device into the body of the patient. Placing the implantable pumping device in connection with the urinary bladder, such that the implantable pumping device can constrict the urinary bladder to restrict the flow of fluid therethrough and to evacuate urine from the urinary bladder.
  • a method in an implantable controller for controlling an implantable pumping device for constricting the urinary bladder and for evacuating urine from the urinary bladder.
  • the method comprises releasing the pressure in a first and a second implantable hydraulic constriction element such that substantially no pressure is exerted on the urinary bladder.
  • the method further comprises measuring the pressure in the first and/or the second implantable hydraulic constriction elements, when substantially no pressure is exerted on the urinary bladder.
  • the method further comprises increasing the pressure in the first implantable hydraulic constriction element to a defined level.
  • the method further comprises increasing the pressure in the second implantable hydraulic constriction element to a second defined level.
  • a controller for controlling the pressure in an implantable pumping device for constricting the urinary bladder and for evacuating urine from the urinary bladder.
  • the controller comprises a pressure sensor for measuring the pressure in a first and/or second implantable hydraulic constriction element.
  • the controller further comprises a computing unit.
  • the computing unit is configured to create an absolute pressure by subtracting the pressure in the first and/or second implantable hydraulic constriction element, when substantially no pressure is exerted on the urinary bladder, from the pressure in the hydraulic constriction element, when the pressure in the first and/or second implantable hydraulic constriction element has been increased.
  • an implantable pumping device for evacuating urine from the urinary bladder of a patient.
  • the implantable pumping device comprises a first constriction device configured to constrict a portion of the urinary bladder for closing a first portion of the urinary bladder.
  • the implantable pumping device further comprises a second constriction device configured to constrict a second portion of the urinary bladder, downstream the first portion, for evacuating urine from the urinary bladder when the first portion of the urinary bladder is closed.
  • the implantable pumping device further comprises a controller configured to control the first and second constriction device.
  • the implantable pumping device further comprises a coating arranged on at least one surface of at least one of said first or second constriction device.
  • a medical device for evacuating urine from the urinary bladder of a patient and configured to be held in position by a tissue portion of a patient.
  • the medical device comprises an implantable pumping device for evacuating urine from the urinary bladder of a patient.
  • the implantable pumping device comprises a first constriction device configured to constrict a portion of the urinary bladder for closing a first portion of the urinary bladder.
  • the implantable pumping device further comprises a second constriction device configured to constrict a second portion of the urinary bladder, downstream the first portion, for evacuating urine from the
  • the medical device further comprises an implantable energized medical device configured to be held in position by a tissue portion of a patient.
  • the implantable energized medical device comprises a first portion configured to be placed on a first side of the tissue portion, the first portion having a first cross-sectional area in a first plane and comprising a first surface configured to face a first tissue surface of the first side of the tissue portion.
  • the implantable energized medical device further comprises a second portion configured to be placed on a second side of the tissue portion, the second side opposing the first side, the second portion having a second cross-sectional area in a second plane and comprising a second surface configured to engage a second tissue surface of the second side of the tissue portion.
  • the implantable energized medical device further comprises a connecting portion configured to be placed through a hole in the tissue portion extending between the first and second sides of the tissue portion, the connecting portion having a third cross-sectional area in a third plane and a fourth cross-sectional area in a fourth plane and a third surface configured to engage the first tissue surface of the first side of the tissue portion.
  • the connecting portion is configured to connect the first portion to the second portion.
  • the first, second, third and fourth planes are parallel to each other.
  • the third cross-sectional area is smaller than the first, second and fourth cross-sectional areas, such that the first portion, second portion and connecting portion are prevented from travelling through the hole in the tissue portion in a direction perpendicular to the first, second and third planes.
  • the first portion is detachably connected to at least one of the connecting portion and the second portion.
  • the second portion is configured to connect to the implantable pumping device in a cadial direction.
  • An implantable energized medical device configured to be held in position by a tissue portion of a patient
  • the medical device comprising: a first portion configured to be placed on a first side of the tissue portion, the first portion having a first cross-sectional area in a first plane and comprising a first surface configured to face a first tissue surface of the first side of the tissue portion, a second portion configured to be placed on a second side of the tissue portion, the second side opposing the first side, the second portion having a second cross-sectional area in a second plane and comprising a second surface configured to engage a second tissue surface of the second side of the tissue portion, and a connecting portion configured to be placed through a hole in the tissue portion extending between the first and second sides of the tissue portion, the connecting portion having a third cross-sectional area in a third plane and a third surface configured to engage the first tissue surface of the first side of the tissue portion, wherein the connecting portion is configured to connect the first portion to the second portion, wherein: the first, second portion having a
  • the first portion is configured to transmit electromagnetic waves at the frequency below the frequency level to the second portion.
  • the first portion is configured to transmit electromagnetic waves at the frequency above the frequency level to an external device.
  • the frequency level is 40 kHz or 20 kHz.
  • the electromagnetic waves comprise wireless energy and/or wireless communication.
  • the first portion comprises a first wireless energy receiver for receiving energy transmitted wirelessly by an external wireless energy transmitter above the frequency level, and an internal wireless energy transmitter configured to transmit energy wirelessly to the second portion below the frequency level
  • the second portion comprises a second wireless energy receiver configured to receive energy transmitted wirelessly by the internal wireless energy transmitter below the frequency level.
  • the first portion comprises a first controller comprising at least one processing unit.
  • the second portion comprises a second controller comprising at least one processing unit.
  • the first controller is connected to a first wireless communication receiver in the first portion for receiving wireless communication from an external device above the frequency level, the first controller is connected to a first wireless communication transmitter in the first portion for transmitting wireless communication to a second wireless communication receiver in the second portion below the frequency level.
  • the second controller is connected to the second wireless communication receiver for receiving wireless communication from the first portion below the frequency level.
  • the first portion comprises an outer casing made from a polymer material.
  • the outer casing forms a complete enclosure, such that electromagnetic waves received and transmitted by the first portion must travel through the casing.
  • the second portion comprises an outer casing made from titanium.
  • the outer casing forms a complete enclosure, such that electromagnetic waves received and transmitted by the second portion must travel through the casing.
  • An implantable energized medical device configured to be held in position by a tissue portion of a patient is provided, the medical device comprising: a first portion configured to be placed on a first side of the tissue portion, the first portion having a first cross-sectional area in a first plane and comprising a first surface configured to face a first tissue surface of the first side of the tissue portion, a second portion configured to be placed on a second side of the tissue portion, the second side opposing the first side, the second portion having a second cross-sectional area in a second plane and comprising a second surface configured to engage a second tissue surface of the second side of the
  • RECTIFIED SHEET (RULE 91) ISA/EP tissue portion, and a connecting portion configured to be placed through a hole in the tissue portion extending between the first and second sides of the tissue portion, the connecting portion having a third cross-sectional area in a third plane and a third surface configured to engage the first tissue surface of the first side of the tissue portion, wherein the connecting portion is configured to connect the first portion to the second portion, wherein: the first, second, and third planes are parallel to each other, the third cross-sectional area is smaller than the second cross-sectional area, such that the first portion, second portion and connecting portion are prevented from travelling through the hole in the tissue portion in a direction perpendicular to the first, second and third planes, the first portion is configured to receive and/or transmit electromagnetic waves at a frequency below the frequency level, and wherein the frequency level is 100 kHz.
  • the second portion is configured to receive and/or transmit electromagnetic waves at a frequency below the frequency level.
  • the first portion is configured to transmit electromagnetic waves at the frequency below the frequency level to the second portion.
  • the first portion is configured to transmit electromagnetic waves at the frequency below the frequency level to an external device.
  • the frequency level is 40 kHz or 20 kHz.
  • the electromagnetic waves comprise wireless energy and/or wireless communication.
  • the first portion comprises a first wireless energy receiver for receiving energy transmitted wirelessly by an external wireless energy transmitter below the frequency level, and an internal wireless energy transmitter configured to transmit energy wirelessly to the second portion below the frequency level
  • the second portion comprises a second wireless energy receiver configured to receive energy transmitted wirelessly by the internal wireless energy transmitter below the frequency level.
  • the first portion comprises a first controller comprising at least one processing unit.
  • the second portion comprises a second controller comprising at least one processing unit.
  • the first controller is connected to a first wireless communication receiver in the first portion for receiving wireless communication from an external device below the frequency level, the first controller is connected to a first wireless communication transmitter in the first portion for transmitting wireless communication to a second wireless communication receiver in the second portion below the frequency level.
  • the second controller is connected to the second wireless communication receiver for receiving wireless communication from the first portion below the frequency level.
  • the first portion comprises an outer casing made from a polymer material.
  • the first portion comprises an outer casing made from titanium.
  • the outer casing forms a complete enclosure, such that electromagnetic waves received and transmitted by the first portion must travel through the casing.
  • the second portion comprises an outer casing made from titanium.
  • the outer casing forms a complete enclosure, such that electromagnetic waves received and transmitted by the second portion must travel through the casing.
  • An implantable energized medical device configured to be held in position by a tissue portion of a patient is provided, the medical device comprising: a first portion configured to be placed on a first side of the tissue portion, the first portion having a first cross-sectional area in a first plane and comprising a first surface configured to face a first tissue surface of the first side of the tissue portion, a second portion configured to be placed on a second side of the tissue portion, the second side opposing the first side, the second portion having a second cross-sectional area in a second plane and comprising a second surface configured to engage a second tissue surface of the second side of the tissue portion, and a connecting portion configured to be placed through a hole in the tissue portion extending between the first and second sides of the tissue portion, the connecting portion having a third cross-sectional area in a third plane and a third surface configured to engage
  • the casing of the second portion forms a complete enclosure such that the entirety of the outer surface of the second portion is covered by the casing, when the second portion is connected to the connecting portion.
  • the first portion comprises a casing made from the polymer material.
  • the casing of the first portion forms a complete enclosure such that the entirety of the outer surface of the first portion is covered by the casing.
  • the connecting portion comprises a connection arranged to connect to the first and second portion respectively and carry electrical signals and/or energy.
  • the connection is arranged in a core of the connecting portion such that it is encapsulated by outer material of the connecting portion.
  • the connecting portion comprises a ceramic material.
  • connection is encapsulated within the ceramic material.
  • the first portion comprises a first connection configured to connect to the connection of the connecting portion.
  • the second portion comprises a second connection configured to connect to the connection of the connection portion.
  • the casing of the second portion is hermetically sealed.
  • the second connection is arranged such that the hermetical seal of the second portion is kept intact.
  • the casing of the first portion is hermetically sealed.
  • An implantable energized medical device configured to be held in position by a tissue portion of a patient
  • the medical device comprising: a first portion configured to be placed on a first side of the tissue portion, the first portion having a first cross-sectional area in a first plane and comprising a first surface configured to face a first tissue surface of the first side of the tissue portion, a second portion configured to be placed on a second side of the tissue portion, the second side opposing the first side, the second portion having a second cross-sectional area in a second plane and comprising a second surface configured to engage a second tissue surface of the second side of the tissue portion, and a connecting portion configured to be placed through a hole in the tissue portion extending between the first and second sides of the tissue portion, the connecting portion having a third cross-sectional area in a third plane and a third surface configured to engage the first tissue surface of the first side of the tissue portion, wherein the connecting portion is configured to connect the first portion to the second portion, wherein: the first, second portion having a
  • the third cross-sectional area is smaller than the first cross- sectional area.
  • the connecting portion is tapered in the direction from the first portion towards the second portion along the central extension axis.
  • the connecting portion has a circular or oval cross-section along the central extension axis with a decreasing diameter in the direction from the first portion towards the second portion.
  • the second portion is tapered in the length direction.
  • the connecting portion has a circular or oval cross-section in the length direction with a decreasing diameter in the length direction.
  • the length direction extends from an interface between the connecting portion and the second portion towards an end of the second portion.
  • the length direction extends in a direction substantially perpendicular to the central extension axis.
  • a method of implanting a powered medical device comprises placing a second portion of an implantable energized medical device between a peritoneum and a layer of muscular tissue of the abdominal wall.
  • the method further comprises placing a first portion of the implantable energized medical device between the skin of the patient and a layer of muscular tissue of the abdominal wall.
  • the first and second portions are configured to be connected by a connecting portion extending through at least one layer of muscular tissue of the abdominal wall.
  • the method further comprises placing a body engaging portion of the powered medical device in connection with a tissue or an organ of the patient which is to be affected by the powered medical device.
  • the method further comprises placing a transferring member, configured to transfer at least one of energy and force from the second portion to the body engaging portion, at least partially between a peritoneum and a layer of muscular tissue of the abdominal wall, such that at least 1/3 of the length of the transferring member is placed on the outside of the peritoneum.
  • an external device configured for communication with an implantable medical device, when implanted in a patient.
  • the external device comprises at least one first wireless transceiver configured for communication with the implantable medical device using a first network protocol, for determining a distance between the external device and the implantable medical device, and at least one second wireless transceiver configured for communication with the implantable medical device using a second network protocol, for transferring data between the external device and the implantable medical device.
  • an implantable medical device configured for communication with an external device.
  • the implantable medical device comprises at least one first wireless transceiver configured for communication with the external device using a first network protocol, for determining a distance between the external device and the implantable medical device, and at least one second wireless transceiver configured for communication with the external device using a second network protocol, for transferring data between the external device and the implantable medical device.
  • a patient external device configured for communication with an implantable medical device, when implanted in a patient, is provided.
  • the patient external device comprises a wireless communication unit configured for wireless transmission of control commands to the implantable medical device and configured for wireless communication with a patient display device, and a computing unit configured for running a control software for creating the control commands for the operation of the implantable medical device.
  • the computing unit is configured to transmit a control interface as a remote display portal to a patient display device configured to display the control interface to a user, receive user input from the patient display device, and transform the user input into the control commands for wireless transmission to the implantable medical device.
  • a patient display device for communication with a patient remote external device for communication with an implantable medical device.
  • the patient display device comprises a wireless communication unit configured for wirelessly receiving an implant control interface as a remote display portal from the patient remote external device and configured for wirelessly transmitting implant control user input to the patient remote external device, a display for displaying the received implant control interface, and an input device for receiving implant control input from the user.
  • a communication system for enabling communication between a patient display device and an implantable medical device, when implanted, is provided.
  • the communication system comprises: a patient display device, a server, and a patient remote external device.
  • the patient display device comprises a wireless communication unit configured for wirelessly receiving an implant control interface as a remote display portal being provided by the patient remote external device.
  • the wireless communication unit is further configured for wirelessly transmitting implant control user input to the server, destined for the patient remote external device.
  • the system further comprises a display for displaying the received remote display portal, and an input device for receiving implant control input from the user, wherein the patient remote external device comprises a wireless communication unit configured for wireless transmission of control commands to the implantable medical device, and a computing unit.
  • the computing unit is configured for running a control software for creating the control commands for the operation of the implantable medical device, transmitting a control interface to the patient display device, receiving implant control user input generated at the patient display device, from the server, and transforming the user input into the control commands for wireless transmission to the implantable medical device.
  • a patient display device for communication with a patient external device for communication with an implantable medical device, when implanted.
  • the patient display device comprises a wireless communication unit, a display, and an input device for receiving implant control input from the user.
  • the patient display device is configured to run a first application for wireless communication with a server and/or DDI, and run a second application for wireless communication with the patient external device for transmission of the implant control input to a remote display portal of the patient external device for the communication with the implantable medical device, wherein the second application is configured to be accessed through the first application.
  • the patient display device comprises a first log-in function and a second log-in function, wherein the first log-in function gives the user access to the first application and wherein the first and second log-in function in combination gives the user access to the second application.
  • the first log-in function may be configured to use at least one of a password, pin code, fingerprint, voice and face recognition.
  • a second log-in function within the first application may be configured to use a private key from the user to authenticate, for a defined time period, a second hardware key of the patient external device.
  • a communication system for enabling communication between a patient display device and an implantable medical device, when implanted, is provided.
  • the patient display device comprises a wireless communication unit configured for wirelessly receiving an implant control interface as a remote display portal from the patient remote external device, the wireless communication unit further being configured for wirelessly transmitting implant control user input to the patient remote external device, a display for displaying the received implant control interface as a remote display portal, and an input device for receiving implant control input from the user.
  • the patient display device is configured to run a first application for wireless communication with the server, and to run a second application for wireless communication with the patient remote external device for transmission of the implant control input to the remote display portal of the patient remote external device for the communication with the implantable medical device.
  • the patient remote external device comprises a wireless communication unit configured for wireless transmission of control commands based on the implant control input to the implantable medical device and configured for wireless communication with the patient display device.
  • a computer program product configured to run in a patient display device comprising a wireless communication unit, a display for displaying the received implant control interface as a remote display portal, and an input device for receiving implant control input from a user.
  • the computer program product comprises: a first application for communication with a server or DDI, a second application for communication with an patient remote external device for transmission of the implant control input via the remote display portal of the patient remote external device for the communication with an implantable medical device, wherein the second application is configured to be accessed through the first application, a first log-in function using at least one of a password, pincode, fingerprint, or face recognition, and a second log-in function within the first application, using a private key from the user to authenticate for a defined time period a second hardware key of the patient remote external device.
  • the first log-in function gives the user access to the first application and the first and second log-in function in combination gives the user access to the second application.
  • a communication system for enabling communication between a patient display device, a patient external device, a server and an implantable medical device.
  • the communication system comprises a server, a patient display device, a patient external device, and an implantable medical device.
  • the patient display device comprises a wireless communication unit for wirelessly communicating with at least one of the patient external device and the server, a display, and an input device for receiving input from the user.
  • the patient external device comprises a wireless communication unit configured for wireless transmission of control commands to the implantable medical device and configured for wireless communication with at least one of the patient display device and the server.
  • the server comprises a wireless communication unit configured for wireless communication with at least one of the patient display device and the patient external device
  • the implantable medical device comprises a wireless communication unit configured for wireless communication with the patient external device.
  • the implantable medical device further comprises an encryption unit and is configured to: encrypt data destined for the server,
  • the implantable medical device comprises an encryption unit and is configured to: encrypt data destined for the patient display device, transmit the data to the patient display device via the patient external device, wherein the patient external device acts as a router transferring the data without full decryption.
  • the server comprises an encryption unit and is configured to: encrypt data destined for the implantable medical device, transmit the data to the implantable medical device via the patient external device, wherein the patient external device acts as a router transferring the data without full decryption
  • the server comprises an encryption unit and is configured to: encrypt data destined for the implantable medical device, transmit the data to the implantable medical device via the patient display device and the patient external device, wherein the patient display device and the patient external device acts as a router transferring the data without full decryption.
  • the patient display device comprises an encryption unit and is configured to: encrypt data destined for the implantable medical device, transmit the data to the implantable medical device via the patient external device, wherein the patient external device acts as a router transferring the data without full decryption.
  • the patient display device comprises an encryption unit and is configured to: encrypt data destined for the implantable medical device, transmit the data to the implantable medical device via the server and the patient external device, wherein the server and the patient external device acts as a router transferring the data without full decryption.
  • a server for use in the communication system according to any one of the above aspects or below embodiments is provided.
  • a patient display device for use in the communication system according to any one of the above aspects or below embodiments is provided.
  • a patient external device for use in the communication system according to any one of the above aspects or below embodiments is provided.
  • an implantable medical device for use in the communication system according to any one of the above aspects or below embodiments is provided.
  • a system configured for changing pre-programmed treatment settings of an implantable medical device, when implanted in a patient, from a distant remote location in relation to the patient, is provided.
  • the system comprises at least one health care provider, HCP, EID external device, and a HCP private key device.
  • HCP EID external device is adapted to receive a command from the HCP to change said pre-programmed treatment settings of an implanted medical device, and further adapted to be activated and authenticated and allowed to perform said command by the HCP providing the HCP private key device, wherein the HCP private key device is adapted to be provided to the HCP EID external device via at least one of: a reading slot or comparable for the HCP private key device, and a RFID communication or other close distance wireless activation communication.
  • the HCP EID external device comprises at least one of: a reading slot or comparable for the HCP private key device, a RFID communication, and other close distance wireless activation communication or electrical direct contact.
  • the HCP EID external device further comprises at least one
  • RECTIFIED SHEET (RULE 91) ISA/EP wireless transceiver configured for communication with a data infrastructure server, DDI, through a first network protocol.
  • the system comprises a data infrastructure server, DDI, adapted to receive command from said HCP EID external device and to relay the received command without modifying said command to a patient EID external device
  • the DDI comprises one wireless transceiver configured for communication with said patient external device, and a patient EID external device adapted to receive the command relayed by the DDI, further adapted to send this command to the implanted medical device, further adapted to receive a command from the HCP EID external device via the DDI to change said pre-programmed treatment settings of the implanted medical device, and further adapted to be activated and authenticated and allowed to perform said command by the patient providing a patient private key device adapted to be provided to the patient EID external device by the patient via at least one of: a reading slot or comparable for the patient private key device, a RFID communication
  • the patient EID external device comprises at least one of a reading slot or comparable for the HCP private key device, a RFID communication, and other close distance wireless activation communication or electrical direct contact.
  • the patient EID external device further comprises at least one wireless transceiver configured for communication with the implanted medical device through a second network protocol. Further, the implanted medical device is configured to treat the patient or perform a bodily function.
  • a system configured for changing pre-programmed treatment settings of an implantable medical device, when implanted in a patient, by a health care provider, HCP, in the physical presence of the patient.
  • the system comprises at least one HCP EID external device adapted to receive a command from the HCP, directly or indirectly, to change said preprogrammed treatment settings in steps of an implantable medical device, when implanted, wherein the HCP EID external device is further adapted to be activated, authenticated, and allowed to perform said command by the HCP providing an HCP private key device comprising a HCP private key.
  • the HCP private key device comprises at least one of: a smart card, a keyring device, a watch, a arm or wrist band, a necklace, and any shaped device.
  • the HCP EID external device is adapted to be involved in at least one of: receiving information from the implant, receiving information from a patient remote external device, actuating the implanted medical device, changing pre-programmed settings, and updating software of the implantable medical device, when implanted.
  • the HCP EID external device is further adapted to be activated, authenticated, and allowed to perform said command also by the patient.
  • the system further comprises a patient private key device comprising a patient private key, wherein the patient private key device comprising at least one of: a smart card, a keyring device, a watch, a arm or wrist band, a necklace, and any shaped device.
  • the HCP private key and the patient private key are required for performing said actions by the HCP EID external device to at least one of: receive information from the implant, to receive information from a patient remote external device, to actuate the implanted medical device, to change pre-programmed settings, and to update software of the implantable medical device, when the implantable medical device is implanted.
  • a system configured to change pre-programmed and pre-selected treatment actions of an implantable medical device, when implanted in a patient, by command from the patient.
  • the system comprises an implantable medical device, a patient remote external device, a wireless transceiver configured for communication with the implantable medical device, when the medical device is implanted, through a second network protocol, and a remote display portal.
  • the remote display portal is configured to receive content delivered from the patient remote external device to expose buttons to express the will to actuate the functions of the implanted medical device by the patient through the patient remote external device, and further configured to present the display portal remotely on a patient display device allowing the patient to actuate the functions of the implanted medical device through the display portal of the patient remote external device visualised on the patient display device.
  • a system configured for providing information from an implantable medical device, when implanted in a patient, from a distant remote location in relation to the patient.
  • the system comprises at least one patient EID external device adapted to receive information from the implant, adapted to send such information further on to a server or dedicated data infrastructure, DDI, further adapted to be activated and authenticated and allowed to receive said information by the implanted medical device by the patient providing a private key.
  • the system comprises a patient private key device comprising the private key adapted to be provided to the patient EID external device via at least one of: a reading slot or comparable for the patient private key device, a RFID communication or other close distance wireless activation communication or direct electrical connection.
  • the patient EID external device comprises at least one of: a reading slot or comparable for the patient private key device, an RFID communication, and other close distance wireless activation communication or direct electrical contact. Further, the patient EID external device comprises at least one wireless transceiver configured for communication with the DDI, through a first network protocol.
  • a system comprising, an implantable medical device adapted to, when implanted in a patient, to communicate with an external device, the external device comprising at least one of a patient remote external device or a patient EID external device.
  • the system further comprises the patient EID external device adapted to communicate with and send commands to the implantable medical device when implanted, to change pre-programmed settings, and a patient private key device comprising a patient private key, adapted to activate and authenticate and allow to perform said command by the patient EID external device, wherein said private key is adapted to be provided to the external device via at least one of: a reading slot or comparable for the HCP private key device, an RFID communication or other close distance wireless activation communication, or direct electrical contact.
  • the system comprises a data infrastructure server, DDI, adapted to send commands to the patient EID external device for further transport to the implanted medical device, to inactivate the authority and authenticating function of the patient private key.
  • a system configured for changing pre-programmed treatment settings in steps of an implantable medical device, when implanted in a patient, by a health care provider, HCP, either in the physical presence of the patient or remotely with the patient on
  • the system comprises at least one HCP EID external device adapted to receive a command directly or indirectly from the HCP to change said pre-programmed treatment settings in steps of the implantable medical device, when implanted.
  • the HCP EID external device is further adapted to be activated, authenticated, and allowed to perform said command by the HCP providing a HCP private key device comprising a HCP private key.
  • the HCP private key comprises at least one of: a smart card, a keyring device, a watch, an arm or wrist band, a necklace, and any shaped device.
  • the system further comprises a patient private key device comprising a patient private key, comprising at least one of: a smart card, a keyring device, a watch, an arm or wrist band, a necklace, and any shaped device.
  • a patient private key device comprising a patient private key, comprising at least one of: a smart card, a keyring device, a watch, an arm or wrist band, a necklace, and any shaped device.
  • Both the HCP and patient private key is required for performing said action by the HCP EID external device to change the pre-programmed settings in the implant and to update software of the implantable medical device, when the implantable medical device is implanted.
  • the patient private key is adapted to activate, be authenticated, and allowed to perform said command provided by the HCP, either via the HCP EID external device or when the action is performed remotely via a patient EID external device.
  • a system configured for changing pre-programmed treatment settings in steps of an implantable medical device, when implanted in a patient, by a health care provider, HCP, with the patient on remote on distance.
  • the system comprises at least one HCP EID external device adapted to receive a command from the HCP direct or indirect, to change said preprogrammed treatment settings in steps of an implantable medical device, when implanted, wherein the HCP EID external device is further adapted to be activated, authenticated, and allowed to perform said command by the HCP.
  • the action by the HCP EID external device to change pre-programmed settings in the implant and to update software of the implantable medical device, when the implantable medical device is implanted, is adapted to be authenticated by a HCP private key device and a patient private key device.
  • a system configured for changing preprogrammed treatment settings of an implantable medical device, when implanted in a patient, from a distant remote location in relation to the patient.
  • the system comprises at least one health care provider, HCP, external device adapted to receive a command from the HCP to change said pre-programmed treatment settings of an implanted medical device.
  • the HCP external device is further adapted to be activated and authenticated and allowed to perform said command by the HCP providing a HCP private key device adapted to be provided to an HCP EID external device via at least one of; a reading slot or comparable for the HCP private key device, a RFID communication or other close distance wireless activation communication.
  • the HCP EID external device comprises at least one of: a reading slot or comparable for the HCP private key device, a RFID communication, and other close distance wireless activation communication or electrical direct contact.
  • the HCP EID external device further comprises at least one wireless transceiver configured for communication with a patient EID external device, through a first network protocol.
  • the system comprises the patient EID external device, the patient EID external device being adapted to receive command from said HCP external device, and to relay the received command without modifying said command to the implanted medical device.
  • the patient EID external device comprises one wireless transceiver configured for communication with said patient
  • the controller is configured to control the first and second constriction device such that the first constriction device closes the first portion of the urinary bladder. And such that the second constriction device constricts the second portion of the urinary bladder for evacuating urine from the urinary bladder when the first portion of the urinary bladder is closed.
  • the controller is configured to receive a pressure signal from a pressure sensor configured to measure the pressure in or exerted by at least one of the first and second constriction devices.
  • At least one of the first and second constriction device is a hydraulic constriction device.
  • At least one of the first and second constriction device is a constriction device configured to constrict by electrically stimulating at least one tissue wall of the urinary bladder.
  • the second constriction device is configured to constrict the second portion of the urinary bladder using electrical stimulation.
  • the implantable pumping device further comprises a cancellation unit configured to be placed downstream the second portion.
  • the cancellation unit being configured to cancel the electrical stimulation such that the urinary sphincter remains substantially unaffected by the electrical stimulation.
  • the first constriction device is configured to constrict the first portion of the urinary bladder extending a first distance axially in the direction of the flow of urine.
  • the second constriction device is configured to constrict the second portion of the urinary bladder extending a second distance axially in the direction of the flow of urine.
  • the second distance is at least two times as long as the first distance.
  • At least one of the first and second constriction device comprises at least one constriction element configured to contact a first portion of the urinary bladder. And at least one abutment configured to contact a second portion of the urinary bladder and for withholding the force from the at least one constriction element, such that the urinary bladder is constricted between the at least one constriction element and the abutment.
  • At least one of the first and second constriction device comprises at least a first and a second constriction element.
  • the first constriction element is configured to contact a first portion of the urinary bladder and the second constriction element is configured to contact a second portion of the urinary bladder. This such that the urinary bladder is constricted between the first and second constriction elements.
  • the implantable pumping device further comprises a support element. And the at least one of the at least one constriction element and the at least one abutment is connected to the support element.
  • the support element is configured to form at least a portion of a surrounding structure configured to surround the urinary bladder.
  • the support element comprises at least one fluid conduit at least partially integrated in the support element.
  • the support element comprises a connection portion for connecting the support element to another support element for at least partially forming the surrounding structure.
  • the support element comprises a portion of a hinge for hingedly connecting the support element to other support element for at least partially forming the surrounding structure.
  • the at least one of the support elements, the at least one abutment and the at least one constriction element comprises at least one curvature adapted for the curvature of the urinary bladder.
  • the implantable pumping device further comprises an electrode arrangement configured to engage and electrically stimulate muscle tissue of the urinary bladder to exercise the muscle tissue to improve the conditions for long term implantation of the implantable pumping device.
  • the abutment comprises at least one cushioning element configured to contact the urinary bladder, wherein the cushioning element is more resilient than the support element.
  • the first constriction device comprises a first curvature having a first radius adapted for a curvature of the urinary bladder.
  • the second constriction device comprises a second curvature having a second radius adapted for a curvature of the urinary bladder.
  • the first radius may be larger than the second radius.
  • the second constriction device comprises a plurality of constriction elements configured to sequentially constrict the urinary bladder for evacuating urine from the urinary bladder.
  • the mechanical construction device comprises at least one mechanical constriction element comprising an electric motor, a screw and a plate.
  • the electric motor is configured to turn the screw in order to push the plate toward the urinary bladder in order to constrict the urinary bladder.
  • the implantable pumping device further comprises electric stimulation device comprising electrodes provided on the constriction elements and configured to electrically stimulate the constricted portions with electric pulses.
  • the electrodes are configured to stimulate the tissue of the urinary bladder in order to avoid damage to the tissue from the pressure of the constriction elements. [000111] According to an embodiment, the electrodes are configured to stimulate the tissue of the urinary bladder in order to thicken the tissue of the constricted portion in order to close the passageway of the urinary bladder.
  • the implantable pumping device further comprises a cancellation unit configured to be placed downstream the rotor and the constriction elements, the cancellation unit being configured to cancel the electrical stimulation such that the urinary sphincter remains substantially unaffected by the electrical stimulation.
  • a lumen of the first operable hydraulic constriction element has a larger volume than a lumen of the second operable hydraulic constriction element.
  • the lumen of the first operable hydraulic constriction element has a volume which is more than 1,5 times larger than the volume of the lumen of the second operable hydraulic constriction element.
  • the first interconnecting fluid conduit comprises a first electrically operable valve, such that a flow of fluid between the first operable hydraulic constriction element and the second operable hydraulic constriction element can be controlled.
  • the electrically operable valve is a solenoid valve.
  • the first interconnecting fluid conduit comprises a check valve, such that fluid can flow in a direction from the first operable hydraulic constriction element to the second operable hydraulic constriction element but not in a direction from the second operable hydraulic constriction element to the first operable hydraulic constriction element.
  • the implantable pumping device further comprises a second interconnecting fluid conduit fluidly connecting the first operable hydraulic constriction element to the second operable hydraulic constriction element, wherein a cross section of a tubular lumen of the second interconnecting fluid conduit has an area which is less than 0,5 times a cross section area of a tubular lumen of the first interconnecting fluid conduit.
  • the implantable pumping device further comprises a hydraulic pump, a reservoir for holding hydraulic fluid, and a first reservoir conduit, fluidly connecting the reservoir to the first operable hydraulic constriction element.
  • the hydraulic pump is configured to pump fluid from the reservoir to the first operable hydraulic constriction element through the first reservoir conduit, for constricting the first portion of the urinary bladder for restricting the flow of fluid therethrough.
  • the first reservoir conduit comprises a second electrically operable valve, such that a flow of fluid between the reservoir and the first operable hydraulic constriction element can be controlled.
  • the implantable pumping device further comprises a second reservoir conduit fluidly connecting the reservoir to the second operable hydraulic constriction element.
  • the second reservoir conduit comprises a check valve such that fluid can flow in a direction from the reservoir to the second operable hydraulic constriction element but not in a direction from the second operable hydraulic constriction element to the reservoir.
  • the implantable pumping device further comprises an injection port in fluid connection with the reservoir, for injecting fluid into the reservoir when the reservoir is implanted.
  • the injection port is configured to be placed subcutaneously, and wherein the implantable pumping device further comprises an injection port conduit fluidly connecting the injection port to the reservoir.
  • the implantable pumping device further comprising at least one of: a first pressure sensor configured to sense the pressure in the first operable hydraulic constriction element, and a second pressure sensor configured to sense the pressure in the second operable hydraulic constriction element.
  • the implantable pumping device further comprises a controller configured to receive a pressure sensor signal from at least one of the first and second pressure sensor, and control at least one of: the first electrically operable valve, the second operable valve and the hydraulic pump, on the basis of the received pressure sensor signal
  • the controller comprises a pressure threshold value, and wherein the controller is configured to open the first electrically operable valve if the received pressure sensor signal from the second pressure sensor exceeds the pressure threshold value.
  • the implantable pumping device further comprising further a supporting operable hydraulic constriction element.
  • the supporting operable hydraulic constriction element is configured to be placed along at least a portion of the first portion of the luminary organ and along at least a portion of the second portion of the luminary organ.
  • the supporting operable hydraulic constriction element is configured to assist in the constriction of the first and second portions of the urinary bladder.
  • the supporting operable hydraulic constriction element is connected to the first and second operable hydraulic constriction elements.
  • the supporting operable hydraulic constriction element is less resilient than at least one of the first and second operable hydraulic constriction element.
  • each of the first, second and supporting operable hydraulic constriction element comprises a lumen surrounded by a resilient wall.
  • the resilient wall of the supporting operable hydraulic constriction element is thicker than the wall of at least one of the first and second operable hydraulic constriction element.
  • the implantable pumping device further comprises a second hydraulic pump, a second reservoir for holding hydraulic fluid, and a supporting reservoir conduit, fluidly connecting the second reservoir to the supporting operable hydraulic constriction element.
  • the second hydraulic pump is configured to pump fluid from the second reservoir to the supporting operable hydraulic constriction element through the supporting reservoir conduit, for assisting in the constriction of the luminary organ.
  • the implantable pumping device further comprises a third pressure sensor configured to sense the pressure in the supporting operable hydraulic constriction element.
  • the implantable pumping device further comprises a second injection port in fluid connection with the second reservoir, for injecting fluid into the second reservoir when the second reservoir is implanted.
  • the second injection port is configured to be placed subcutaneously.
  • the implantable pumping device further comprises a second injection port conduit fluidly connecting the second injection port to the second reservoir.
  • the supporting operable hydraulic constriction element has a length in the axial direction of the urinary bladder, when implanted.
  • the first and second operable hydraulic constriction element has a combined length in the axial direction AD of the urinary bladder, and wherein the combined length is longer than the length of the supporting operable hydraulic constriction element.
  • the implantable pumping device further comprises a surrounding structure having a periphery surrounding the urinary bladder when implanted.
  • the surrounding structure is substantially rigid.
  • a major portion of the surrounding structure is made from a material having a modulus of elasticity in the range 0,2 GPa - 1000 GPa or in the range 1 GPa - 400 GPa.
  • the surrounding structure has a modulus of elasticity, radially, in the range 0,2 GPa - 1000 GPa or in the range 1 GPa - 400 GPa.
  • the surrounding structure comprises an inner surface configured to face the urinary bladder, when implanted, and wherein the supporting operable hydraulic constriction device is fixated to the inner surface of the surrounding structure, such that the supporting operable hydraulic constriction device can use the surrounding structure as support for constricting the urinary bladder.
  • the implantable pumping device further comprises at least one cushioning element configured to contact the urinary bladder, wherein the cushioning element is fixated to the inner surface of the surrounding structure and is more resilient than the surrounding structure.
  • the surrounding structure is comprised of at least a first and a second supporting element configured to be connected to each other for forming at least a portion of the periphery of the surrounding structure.
  • the supporting operable hydraulic constriction device is fixated to the first supporting element, and the at least one cushioning element is fixated to the second supporting element.
  • At least one of the first and second supporting elements have a curvature adapted for the curvature of the urinary bladder.
  • the curvature has a radius in the range 15mm - 60mm. [000147] According to an embodiment, the curvature has a radius in the range 20mm - 50mm. [000148] According to an embodiment, the supporting operable hydraulic constriction element is connected to the first operable hydraulic constriction element.
  • the supporting operable hydraulic constriction element is less resilient than the first operable hydraulic constriction element.
  • the first operable hydraulic constriction element comprises a lumen surrounded by a resilient wall and the supporting operable hydraulic constriction element comprises a lumen surrounded by a resilient wall, and wherein a portion of the resilient wall of the supporting operable hydraulic constriction element is thicker than a portion of the resilient wall of the first operable hydraulic constriction element.
  • a portion of the resilient wall of the supporting operable hydraulic constriction element is more than 1,5 times thicker than a portion of the resilient wall of the first operable hydraulic constriction element.
  • a portion of the resilient wall of the supporting operable hydraulic constriction element is more than 2 times thicker than a portion of the resilient wall of the first operable hydraulic constriction element.
  • the first operable hydraulic constriction element comprises a lumen surrounded by a resilient wall.
  • the supporting operable hydraulic constriction element comprises a lumen surrounded by a resilient wall.
  • a portion of the resilient wall of the first operable hydraulic constriction element comprises a first material.
  • a portion of the resilient wall of the supporting operable hydraulic constriction element comprises a second material.
  • the second material has a modulus of elasticity which is higher than a modulus of elasticity of the first material [000154]
  • the modulus of elasticity of the second material is more than 1,5 times higher than the modulus of elasticity of the first material.
  • the modulus of elasticity of the second material is more than 2 times higher than the modulus of elasticity of the first material.
  • the implantable pumping device further comprises a first hydraulic pump.
  • the implantable pumping device further comprises a second hydraulic pump.
  • the implantable pumping device further comprises a first reservoir for holding hydraulic fluid.
  • the implantable pumping device further comprises a second reservoir for holding hydraulic fluid.
  • the implantable pumping device further comprises a first reservoir conduit, fluidly connecting the first reservoir to the first operable hydraulic constriction element.
  • the implantable pumping device further comprises a supporting reservoir conduit, fluidly connecting the second reservoir to the supporting operable hydraulic constriction element.
  • the first hydraulic pump is configured to pump fluid from the first reservoir to the first operable hydraulic constriction element through the first reservoir conduit, for constricting the urinary bladder.
  • the second hydraulic pump is configured to pump fluid from the second reservoir to the supporting operable hydraulic constriction element through the supporting reservoir conduit, for assisting in the constriction of the urinary bladder.
  • the implantable pumping device further comprises a second pressure sensor configured to sense the pressure in the supporting operable hydraulic constriction element.
  • the implantable pumping device further comprises an implantable controller.
  • the implantable controller is configured to control at least one of the first hydraulic pump on the basis of input from the first pressure sensor, and the second hydraulic pump on the basis of input from the second pressure sensor.
  • At least one of the first reservoir conduit comprises an electrically operable valve
  • the second reservoir conduit comprises an electrically operable valve
  • the controller is configured to control at least one of the electrically operable valve on the first reservoir conduit, on the basis of input from the first pressure sensor, and the electrically operable valve on the second reservoir conduit, on the basis of input from the second pressure sensor.
  • At least one of: the first reservoir conduit comprises a check valve, and the second reservoir conduit comprises a check valve.
  • the implantable pumping device further comprises a first injection port in fluid connection with the first reservoir, for injecting fluid into the first reservoir when the first reservoir is implanted.
  • the implantable pumping device further comprises a second injection port in fluid connection with the second reservoir, for injecting fluid into the second reservoir when the second reservoir is implanted.
  • the implantable constriction device further comprises a first injection port conduit fluidly connecting the first injection port to the first reservoir
  • the second injection port is configured to be placed subcutaneously
  • the implantable constriction device further comprises a second injection port conduit fluidly connecting the second injection port to the second reservoir.
  • the supporting operable hydraulic constriction element has a length in the axial direction of the urinary bladder, when implanted, and wherein the first operable hydraulic constriction element has a length in the axial direction of the urinary bladder, and wherein the length of the first operable hydraulic constriction element is longer than the length of the supporting operable hydraulic constriction element.
  • the supporting operable hydraulic constriction device is fixated to the first supporting element, and the at least one cushioning element is fixated to the second supporting element.
  • At least one of the first and second supporting element have a curvature adapted for the curvature of the urinary bladder.
  • the second distance is substantially opposite to the first direction.
  • the first hydraulic system comprises a first hydraulic pump.
  • the second hydraulic system comprises a second hydraulic pump.
  • the third hydraulic system comprises a third hydraulic pump.
  • the fourth hydraulic system comprises a fourth hydraulic pump.
  • each of the first, second, third and fourth hydraulic systems comprises a reservoir for holding hydraulic fluid.
  • the first, second, third and fourth hydraulic systems are connected to a reservoir for holding hydraulic fluid.
  • each of the first, second, third and fourth hydraulic systems comprises an injection port for injecting hydraulic fluid into the respective first and second hydraulic systems.
  • the injection ports is configured to be placed subcutaneously, and wherein the implantable pumping device further comprises an injection port conduit fluidly connecting the injection ports (108) to the first, second, third and fourth hydraulic systems.
  • the first operable hydraulic constriction element lacks a fluid connection to the second operable hydraulic constriction element, and wherein the third operable hydraulic constriction element lacks a fluid connection to the fourth operable hydraulic constriction element.
  • the implantable pumping device comprises at least one of: a first pressure sensor configured to sense the pressure in the first operable hydraulic constriction element, a second pressure sensor configured to sense the pressure in the second operable hydraulic constriction element, a third pressure sensor configured to sense the pressure in the third operable hydraulic constriction element, a fourth pressure sensor configured to sense the pressure in the fourth operable hydraulic constriction element.
  • the implantable pumping device comprises a controller configured to receive a pressure sensor signal from at least one of the first, second, third and fourth pressure sensor.
  • the control unit is configured to control at least one of: the first hydraulic pump, the second hydraulic pump, the third hydraulic pump and the fourth hydraulic pump on the basis of the received pressure sensor signal.
  • the surrounding structure comprises an inner surface configured to face the urinary bladder, when implanted, and wherein the first, second, third and fourth operable hydraulic constriction element are fixated to the inner surface of the surrounding structure.
  • the surrounding structure is comprised of at least a first and a second support element configured to be connected to each other for forming at least a portion of the periphery of the surrounding structure.
  • the first and third operable hydraulic constriction elements are fixated to the first support element.
  • the second and fourth operable hydraulic constriction elements are fixated to the second support element.
  • the electrode arrangement is arranged on an outer surface of at least one of the first operable hydraulic constriction element and the second operable hydraulic constriction element.
  • the electrode arrangement comprises a plurality of electrode elements, each of which being configured to engage and electrically stimulate tissue of the urinary bladder.
  • the electrode arrangement comprises a coiled wire for increasing a contact surface between the electrode arrangement and the tissue of the urinary bladder and for allowing the electrode arrangement to follow contraction and relaxation of the tissue of the urinary bladder.
  • the electrode arrangement comprises a bare electrode portion configured to form a metal-tissue interface with the tissue of the urinary bladder, thereby allowing faradaic charge transfer to the be predominant charge transfer mechanism over the interface.
  • the electrode arrangement comprises an electrode portion at least partly covered by a dielectric material configured to form a dielectric-tissue interface with the tissue of the urinary bladder, thereby allowing for a faradaic portion of the charge transfer mechanism over said interface to be reduced.
  • the electrode arrangement comprises at least two electrode elements configured to be arranged on opposing sides of the urinary bladder.
  • the implantable pumping device further comprises a stimulation controller configured to be operably connected to the electrode arrangement for controlling the electrical stimulation of the tissue of the urinary bladder.
  • the stimulation controller is configured to control the electrical stimulation such that the tissue of the urinary bladder is stimulated by a series of electrical pulses.
  • the stimulation controller is configured to control the electrical stimulation such that a pulse of a first polarity is followed by a pulse of a second, reversed polarity.
  • the stimulation controller is configured to generate a pulsed electrical stimulation signal comprising a pulse frequency of 0.01-150 Hz.
  • the electrical stimulation signal comprises a pulse duration of 0.01-100 ms.
  • the electrical stimulation signal comprises a pulse amplitude of 1-15 mA.
  • the electrical stimulation signal comprises a pulse frequency of 0. 15-0.25 Hz, a pulse duration of 20-30 ms and a pulse amplitude of 3-10 mA.
  • the electrical stimulation signal comprises a build-up period of 0.01-2 s in which the amplitude is gradually increasing, a stimulation period of 1-60 s, and a stimulation pause of 0.01-60 s, wherein the electrical signal comprises a pulse frequency of 1-50 Hz and a pulse duration of 0.1-10 ms.
  • the stimulation controller is configured to receive input from a wireless remote control.
  • the implantable pumping device further comprises an implantable sensor configured to sense actions potentials generated by pacemaker cells of the tissue of the urinary bladder, and wherein the stimulation controller is configured to control the electrical simulation based at least partly on the sensed action potentials.
  • the stimulation controller is configured to generate electrical pulses amplifying the sensed action potentials.
  • the surrounding structure comprises at least one cushioning element. At least one electrode element of the electrode arrangement is placed on the surface of the cushioning element.
  • the motor of the first and/or second constriction device is an electrical motor.
  • the motor is a brushless implantable DC motor.
  • the implantable pumping device further comprises a gear system placed between the motor and the first and second hydraulic pump, and wherein the gear system is configured to reduce the velocity and increase the force of the movement generated by the motor for propelling the first and second hydraulic pump with a mechanical force with a lower velocity and a greater force
  • the motor is configured to generate a rotating force and propel the first and second hydraulic pump with a rotating mechanical force.
  • a rotating force output of the motor is connected to a force input of the gear system.
  • a rotating force output of the gear system is connected to the first and second hydraulic pump.
  • At least one of the first and second hydraulic pump of the first constriction device and/or the second constriction device comprises a gear pump.
  • At least one of the first and second hydraulic pump of the first constriction device and/or the second constriction device comprises a peristaltic pump.
  • At least one of the first and second hydraulic pump of the first constriction device and/or the second constriction device comprises a pump comprising at least one compressible hydraulic reservoir.
  • At least one of the first and second hydraulic pump of the first constriction device and/or the second constriction device comprises a gerotor pump.
  • the first hydraulic pump comprises a first gerotor pump.
  • the second hydraulic pump comprises a second gerotor pump.
  • the first constriction device and/or the second constriction device further comprises a common rotating shaft mechanically connected to the motor.
  • An inner rotor of the first gerotor pump is mechanically connected to the common rotating shaft.
  • An inner rotor of the second gerotor pump is mechanically connected to the common rotating shaft, such that the motor propels the first and second gerotor pump.
  • the implantable pumping device further comprises an implantable reservoir. At least one of the first and second hydraulic pump of the first constriction device and/or the second constriction device is connected to the implantable reservoir.
  • the first constriction device and/or the second constriction device further comprises a first implantable reservoir (107) and a second implantable reservoir.
  • the first hydraulic pump is connected to the first implantable reservoir.
  • the second hydraulic pump is connected to the second implantable reservoir.
  • the first constriction device and/or the second constriction device further comprises an implantable reservoir.
  • the first and second hydraulic pump is connected to the implantable reservoir, for pumping hydraulic fluid from the first reservoir to the first operable hydraulic constriction element and from the second reservoir to the second operable hydraulic constriction elements
  • the first operable hydraulic constriction element of the first constriction device is configured to be inflated and thereby expand in a first direction towards the urinary bladder to constrict a first portion of the luminary organ for restricting the flow of fluid therethrough.
  • the second operable hydraulic constriction element of the first constriction device is a supporting operable hydraulic constriction element configured to be inflated and thereby expand in the first direction towards the urinary bladder to support the first operable hydraulic constriction element in constricting the first portion of the urinary bladder for restricting the flow of fluid therethrough.
  • the first operable hydraulic constriction element of the second constriction device is configured to be inflated and thereby expand in a first direction towards the urinary bladder to constrict a second portion of the luminary organ for restricting the flow of fluid therethrough and for evacuating urine from the urinary bladder.
  • the second operable hydraulic constriction element of the second constriction device is a supporting operable hydraulic constriction element configured to be inflated and thereby expand in the first direction towards the urinary bladder to support the first operable hydraulic constriction element in constricting the first portion of the urinary bladder for restricting the flow of fluid therethrough and for evacuating urine from the urinary bladder.
  • the supporting operable hydraulic constriction element is connected to the first operable hydraulic constriction element.
  • the supporting operable hydraulic constriction element is less resilient than the first operable hydraulic constriction element.
  • the first operable hydraulic constriction element of the first constriction device and/or the second constriction device comprises a lumen surrounded by a resilient wall.
  • the supporting operable hydraulic constriction element comprises a lumen surrounded by a resilient wall. A portion of the resilient wall of the supporting operable hydraulic constriction element is thicker than a portion of the resilient wall of the first operable hydraulic constriction element
  • first constriction device and/or the second constriction device further comprises a first pressure sensor configured to sense the pressure in the first operable hydraulic constriction element.
  • the first constriction device and/or the second constriction device further comprises a second pressure sensor configured to sense the pressure in the second operable hydraulic constriction element.
  • the implantable pumping device further comprises an implantable controller.
  • the implantable controller is configured to control at least one of the: first hydraulic pump of the first constriction device and/or the second constriction device on the basis of input from the first pressure sensor.
  • the second hydraulic pump of the first constriction device and/or the second constriction device on the basis of input from the second pressure sensor
  • the first constriction device and/or the second constriction device further comprises a first implantable injection port in fluid connection with the first operable hydraulic constriction element.
  • the first constriction device and/or the second constriction device further comprises a second implantable injection port in fluid connection with the second operable hydraulic constriction element.
  • the implantable energy storage unit is a re-chargeable battery.
  • the implantable energy storage unit is a solid-state battery.
  • the battery is a tionyl-chlorid battery.
  • the implantable energy storage unit is connected to at least one of the first and second hydraulic pump and configured to power the first and/or second hydraulic pump after it has been started using the capacitor.
  • the capacitor is configured to store energy to provide a burst of energy to at least one of the first and second hydraulic pump.
  • the capacitor is a start capacitor.
  • the capacitor is a run capacitor.
  • the capacitor is a dual run capacitor.
  • the implantable pumping device further comprises a second capacitor configured to be charged by the implantable energy storage unit and to provide at least one of the first and second hydraulic pump with electrical power.
  • the capacitor is a supercapacitor.
  • At least one of the first and second hydraulic pump comprises an electrical motor (M) for operating the hydraulic pump.
  • M electrical motor
  • the capacitor is further configured to provide electrical power to at least one of: a device for providing electrical stimulation to a tissue portion of the body of the patient, a CPU for encrypting information, a transmitting and/or receiving unit for communication with an external unit, a measurement unit or a sensor, a data collection unit, a solenoid, a piezo-electrical element, a memory metal unit.
  • the capacitor is further configured to provide electrical power to a valve.
  • the capacitor is further configured to provide electrical power to a controller for controlling at least a part of the implantable pumping device.
  • the implantable pumping device further comprises an external energy storage unit configured be arranged outside of the patient’s body and configured to provide energy to the implantable energy storage unit.
  • the implantable pumping device further comprises an implantable energy receiver configured to be electrically connected to the implantable energy storage unit and enable charging of the implantable energy storage unit by the external energy storage unit.
  • the implantable pumping device further comprises a temperature sensor for sensing a temperature of the implantable energy storage unit.
  • the implantable pumping device further comprises a temperature sensor for sensing a temperature of the capacitor
  • the senor is at least one of: a hall effect sensor, a fluxgate sensor, an ultra-sensitive magnetic field sensor or a magneto-resistive sensor.
  • the frequency of the magnetic field generated by the coil is 9- 315 kHz.
  • the frequency of the magnetic field generated by the coil is less than or equal to 125kHz, preferably less than 58kHz.
  • the controller comprises a receiver unit.
  • the controller and the external control unit are configured to transmit and/or receive data via the receiver unit and the first coil via magnetic induction.
  • the receiver unit comprises a high-sensitivity magnetic field detector.
  • the receiver unit comprises a second coil.
  • the implantable pumping device further comprises comprising an implantable energy storage unit electrically connected to the receiver unit, wherein the implantable energy storage unit is adapted to be charged by the external control unit via the receiver unit.
  • the implantable energy storage unit is configured to be charged via magnetic induction between the first and the second coils.
  • the receiver unit is configured to control the charging of the implantable energy storage unit by controlling a receipt of electrical power from the external control unit at the receiver unit.
  • the internal receiver unit is configured to control the charging of the implantable energy storage unit by controlling a transmission of electrical power from the external control unit to the receiver unit.
  • the implantable pumping device further comprises a sensation generator adapted to generate a sensation detectable by a sense of the patient, the sensation generator
  • RECTIFIED SHEET (RULE 91) ISA/EP being connected to the controller or the external control unit, and being configured to, upon request, generate the sensation when implanted in a patient.
  • the sensation generator is configured to receive the request from the controller or the implantable pumping device.
  • the sensation generator is configured to receive the request from an external device.
  • the sensation generator is configured to create the sensation comprising a plurality of sensation components.
  • the sensation generator (381) is configured to create the sensation or sensation components by at least one of: a vibration of the sensation generator, producing a sound, providing a photonic signal, providing a light signal, providing an electric signal, a heat signal.
  • the sensation generator is adapted to be implanted in the patient.
  • the sensation generator is configured to be worn in contact with the skin of the patient
  • the sensation generator is configured generate the sensation without being in physical contact with the patient.
  • the external control unit comprises a wireless remote control.
  • the wireless remote control comprises an external signal transmitter.
  • the internal receiver is further configured to receive a signal transmitted by the external signal transmitter and to control an operation of the apparatus based on said signal, when the processing unit is in the active state.
  • the signal is selected from the group consisting of: a sound signal, an ultrasound signal, an electromagnetic signal, and infrared signal, a visible light signal, an ultraviolet light signal, a laser signal, a microwave signal, a radio wave signal, an X-ray radiation signal and a gamma radiation signal.
  • the step of inserting an implantable pumping device into the body of the patient comprises inserting an implantable pumping device comprising a first, second and third luminary organ contacting element.
  • the first luminary organ contacting element comprises a first operable hydraulic constriction element configured to be inflated to constrict the urinary bladder for restricting the flow of fluid therethrough.
  • the second luminary organ contacting element comprises a second operable hydraulic constriction element configured to be inflated to assist in releasing the constriction of the urinary bladder for restoring the flow of fluid therethrough.
  • the third luminary organ contacting element comprises at least one cushioning element configured to contact the urinary bladder.
  • the step of inserting an implantable pumping device into the body of the patient comprises inserting an implantable pumping device comprising a first operable hydraulic constriction element configured to be inflated to constrict the urinary bladder for restricting the flow of fluid therethrough.
  • the implantable pumping device further comprises a second operable hydraulic constriction element configured to be inflated to constrict the urinary bladder for restricting
  • the implantable pumping device further comprises an interconnecting fluid conduit fluidly connecting the first operable hydraulic constriction element to the second operable hydraulic constriction element.
  • the first operable hydraulic constriction element is configured to be placed at a first portion of the urinary bladder for constricting the first portion of the urinary bladder for restricting the flow of fluid therethrough.
  • the second operable hydraulic constriction element is configured to be placed at a second portion of the luminary organ, downstream the first portion, for constricting the second portion of the urinary bladder for restricting the flow of fluid therethrough and for evacuating urine from the urinary bladder.
  • the interconnecting fluid conduit is configured to conduct fluid from the first operable hydraulic constriction element to the second operable hydraulic constriction element when the pressure increases in the first operable hydraulic constriction element, such that second operable hydraulic constriction element constricts the second portion of the urinary bladder further.
  • the step of inserting an implantable pumping device into the body of the patient comprises inserting an implantable pumping device comprising a first operable hydraulic constriction element configured to be inflated and thereby expand in a first direction towards the urinary bladder to constrict a first portion of the urinary bladder for restricting the flow of fluid therethrough.
  • the implantable pumping device further comprises a supporting operable hydraulic constriction element configured to be inflated and thereby expand in the first direction towards the urinary bladder to support the first operable hydraulic constriction element in constricting the first portion of the urinary bladder for restricting the flow of fluid therethrough.
  • the step of inserting an implantable pumping device into the body of the patient comprises inserting an implantable pumping device comprising at least two implantable constriction devices each comprising a first operable hydraulic constriction element configured to be inflated to exert a pressure on the urinary bladder in a first direction to constrict a first portion of the urinary bladder for restricting the flow of fluid therethrough.
  • the implantable constriction devices further comprise a second operable hydraulic constriction element configured to be inflated to exert a pressure on the urinary bladder in a second direction to constrict the first portion of the urinary bladder for restricting the flow of fluid therethrough.
  • the implantable constriction devices further comprise a first hydraulic system in fluid connection with the first operable hydraulic constriction element, and a second hydraulic system in fluid connection with the second operable hydraulic constriction element.
  • the first and second operable hydraulic constriction elements are adjustable independently from each other.
  • the step of inserting an implantable pumping device into the body of the patient comprises inserting an implantable pumping device comprising at least two implantable constriction devices.
  • Each implantable constriction device comprises an operable hydraulic constriction element configured to be inflated to exert a pressure on the urinary bladder.
  • Each implantable constriction device further comprises a hydraulic reservoir for holding a hydraulic fluid.
  • Each implantable constriction device further comprises a hydraulic pump for pumping fluid from the hydraulic reservoir to the operable hydraulic constriction element.
  • ISA/EP further comprises a first fluid conduit creating a fluid connection between the hydraulic reservoir and the hydraulic pump.
  • Each implantable constriction device further comprises a second fluid conduit creating a fluid connection between the hydraulic pump and the operable hydraulic constriction element.
  • Each implantable constriction device further comprises an injection port for injecting and removing hydraulic fluid from the implantable constriction device when implanted.
  • Each implantable constriction device further comprises a third fluid conduit creating a fluid connection between the injection port and at least one of the second fluid conduit and the operable hydraulic constriction element, such that hydraulic fluid can be removed from the operable hydraulic constriction element through the injection port.
  • each implantable constriction device comprises an operable hydraulic constriction element configured to be inflated to exert a pressure on the urinary bladder.
  • Each implantable constriction device further comprises a hydraulic reservoir for holding a hydraulic fluid.
  • Each implantable constriction device further comprises a hydraulic pump for pumping fluid from the hydraulic reservoir to the operable hydraulic constriction element.
  • Each implantable constriction device further comprises a first fluid conduit creating a fluid connection between the hydraulic reservoir and the hydraulic pump.
  • Each implantable constriction device further comprises an electrode arrangement configured to be arranged between the implantable constriction device and the urinary bladder and to engage and electrically stimulate muscle tissue of the urinary bladder to exercise the muscle tissue to improve the conditions for long term implantation of the implantable constriction device.
  • the step of inserting an implantable pumping device into the body of the patient comprises inserting an implantable pumping device comprising at least two implantable constriction devices.
  • Each implantable constriction device comprises a first operable hydraulic constriction element configured to be inflated to exert a pressure on the urinary bladder.
  • Each implantable constriction device further comprises a second operable hydraulic constriction element configured to be inflated to exert a pressure on the urinary bladder.
  • Each implantable constriction device further comprises a first hydraulic pump for pumping fluid to the operable hydraulic constriction element.
  • Each implantable constriction device further comprises a second hydraulic pump for pumping fluid to the operable hydraulic constriction element.
  • Each implantable constriction device further comprises a motor. The motor is mechanically connected to the first and second hydraulic pump for propelling the first and second hydraulic pump.
  • the step of inserting an implantable pumping device into the body of the patient comprises inserting an implantable pumping device comprising at least two implantable constriction devices.
  • Each implantable constriction device comprises an operable hydraulic constriction element configured to be inflated to exert a pressure on the urinary bladder.
  • Each implantable constriction device further comprises a pressure sensor configured to sense the pressure in the operable hydraulic constriction element.
  • Each implantable constriction device further comprises a hydraulic pump for pumping a hydraulic fluid to the operable hydraulic constriction element.
  • ISA/EP implantable constriction device further comprises a controller configured to receive pressure sensor input from the pressure sensor and control the hydraulic pump on the basis of the received pressure sensor input.
  • the pressure sensor comprises a diaphragm, and wherein the diaphragm is in fluid connection with the hydraulic fluid in the operable hydraulic constriction element.
  • the diaphragm is further connected to a pressure sensing element of the pressure sensor, such that the pressure sensing element is separated from the hydraulic fluid in the operable hydraulic constriction element by the diaphragm
  • the step of inserting an implantable pumping device into the body of the patient comprises inserting an implantable pumping device comprising at least two implantable constriction devices.
  • Each implantable constriction device comprises an operable hydraulic constriction element configured to be inflated to exert a pressure on the urinary bladder.
  • Each implantable constriction device further comprises a hydraulic pump for pumping a hydraulic fluid to the operable hydraulic constriction element.
  • the hydraulic pump comprises a compressible reservoir configured to hold a hydraulic fluid to be moved to the operable hydraulic constriction element.
  • Each implantable constriction device further comprises a motor comprising a shaft. The motor is configured to generate force in a radial direction by rotation of the shaft.
  • Each implantable constriction device further comprises a transmission configured to transfer the force in the radial direction to a force substantially in an axial direction of the shaft for compressing the compressible reservoir.
  • Each implantable constriction device further comprises at least one bearing for the shaft. The bearing is configured to withhold at least half of the force in the axial direction, for reducing the axial load on at least one of the motor and a gear system, caused by the compression of the reservoir.
  • the step of inserting an implantable pumping device into the body of the patient comprises inserting an implantable pumping device comprising at least two implantable constriction devices.
  • Each implantable constriction device comprises at least one implantable operable hydraulic constriction element.
  • Each implantable operable hydraulic constriction element comprises a contacting wall portion configured to engage the urinary bladder for exerting force thereon.
  • Each implantable operable hydraulic constriction element further comprises a withholding wall portion configured to be connected to a withholding structure for withholding the force exerted on the urinary bladder, such that the urinary bladder is constricted.
  • Each implantable operable hydraulic constriction element further comprises a connecting wall portion, connecting the contacting wall portion to the withholding wall portion.
  • a first portion of the connecting wall portion is connected to the contacting wall portion.
  • a second portion of the connecting wall portion is connected to the withholding wall portion. The first portion of the connecting wall portion is more resilient than the second portion of the connecting wall portion.
  • the step of inserting an implantable pumping device into the body of the patient comprises inserting an implantable pumping device comprising at least two implantable constriction devices.
  • Each implantable constriction device comprises an operable hydraulic constriction element configured to be inflated to exert a pressure on the urinary bladder.
  • Each implantable constriction device further comprises a hydraulic pump for pumping a hydraulic fluid to
  • Each implantable constriction device comprises an implantable energy storage unit.
  • Each implantable constriction device comprises a capacitor connected to the implantable energy storage unit and connected to the hydraulic pump. The capacitor is configured to be charged by the implantable energy storage unit and to provide the hydraulic pump with electrical power.
  • the step of inserting an implantable pumping device into the body of the patient comprises inserting an implantable pumping device comprising at least two implantable constriction devices.
  • Each implantable constriction device comprises an operable hydraulic constriction element configured to be inflated to exert a pressure on the urinary bladder.
  • Each implantable constriction device comprises a hydraulic pump for pumping a hydraulic fluid to the operable hydraulic constriction element.
  • Each implantable constriction device comprises a controller configured to control the hydraulic pump.
  • the controller comprises a sensor adapted to detect a magnetic field and a processing unit having a sleep mode and an active mode.
  • Each implantable constriction device comprises an external control unit adapted to be arranged outside of the patient’s body, the external control unit comprising a first coil adapted to create a magnetic field detectable by the internal sensor.
  • the controller is further configured to, in response to a detected magnetic field exceeding a predetermined value, setting the processing unit in an active mode.
  • the step of placing the implantable pumping device in connection with the urinary bladder comprises placing the implantable pumping device around the urinary bladder of the patient.
  • the step of placing the implantable pumping device in connection with the urinary bladder comprises closing a locking or fixation device of the implantable pumping device around the urinary bladder to fixate the implantable pumping device to the urinary bladder of the patient.
  • the step of placing the implantable pumping device in connection with the urinary bladder comprises securing the implantable pumping device by means of at least one of sutures, staples and tissue growth promoting structure.
  • the step of inserting an implantable pumping device into the body of the patient comprises inserting an implantable controller into the body of the patient and fixating the implantable controller to tissue or bone in the body of the patient.
  • the step of inserting an implantable pumping device into the body of the patient comprises inserting an operation device comprising at least one of: an implantable hydraulic pump and an implantable valve and fixating the implantable operation device to tissue or bone in the body of the patient.
  • the method further comprises the step of implanting and fixating at least one injection port in fluid connection with the operation device.
  • the step of fixating the at least one injection port comprises the step of fixating the injection port subcutaneously.
  • the method further comprises the step of calibrating the fluid level in the implantable pumping device.
  • the method further comprises calibrating at least one of: the pressure exerted by the implantable pumping device on the urinary bladder, the time during which implantable pumping device is to remain closed after activation, the speed with which the implantable pumping device should constrict the urinary bladder, the pressure exerted on the urinary bladder relative to the blood pressure of the patient, the pressure exerted on the urinary bladder by the implantable pumping device by means of a pressure sensitive catheter, the electrical stimulation of the tissue of the urinary bladder.
  • the method further comprises testing at least one of: a fully open catheter mode, a feedback function by providing sensory feedback to the patient, a post-operative mode for enabling healing, a post-operative mode for enabling growth of fibrotic tissue, electrical stimulation of the tissue of the urinary bladder.
  • the method further comprises placing a second portion of an implantable energized medical device between a peritoneum and a layer of muscular tissue of the abdominal wall.
  • the method further comprises placing a first portion of the implantable energized medical device between the skin of the patient and a layer of muscular tissue of the abdominal wall, wherein the first and second portions are configured to be connected by a connecting portion extending through at least one layer of muscular tissue of the abdominal wall.
  • the method further comprises placing a transferring member, configured to transfer at least one of energy and force from the second portion to the implantable pumping device, at least partially between a peritoneum and a layer of muscular tissue of the abdominal wall, such that at least 1/3 of the length of the transferring member is placed on the outside of the peritoneum.
  • the step of measuring the pressure in the first and/or second implantable hydraulic constriction element, when substantially no pressure is exerted on the urinary bladder further comprises comparing the measured pressure with the atmospheric pressure.
  • the step of comparing the measured pressure with the atmospheric pressure comprises measuring the atmospheric pressure using a pressure sensor connected to a signal transmitter located outside the body of the patient.
  • the step of increasing the pressure in the first and second implantable hydraulic constriction element to a defined level comprises inflating the first and/or second implantable hydraulic constriction element to a defined cross-sectional distance.
  • the method further comprises measuring the pressure in the first and/or second implantable hydraulic constriction element when the pressure in the implantable hydraulic constriction element has been increased.
  • the method further comprises the step of creating, in the controller, an absolute pressure by subtracting the pressure in the first and/or second implantable hydraulic constriction element, when substantially no pressure is exerted on the urinary bladder, from the pressure in the hydraulic constriction element, when the pressure in the implantable hydraulic constriction element has been increased.
  • the step of controlling the operation device comprises controlling the operation device on the basis of the absolute pressure.
  • the computing unit is further configured to compare the measured pressure with the atmospheric pressure.
  • the controller is further configured to receive a pressure signal from a pressure sensor located outside of the body of the patient and compare the measured pressure with a pressure received in the pressure signal.
  • controller is configured to increase the pressure in the first and/or second implantable hydraulic constriction element on the basis of the measured pressure.
  • the controller is configured to increase the pressure in the first and/or second implantable hydraulic constriction element to a defined cross-sectional distance.
  • the coating comprises at least one layer of a biomaterial.
  • the biomaterial comprises at least one drug or substance with antithrombotic and/or antibacterial and/or antiplatelet characteristics.
  • the biomaterial is fibrin-based.
  • the implantable pumping device further comprises a second coating arranged on the first coating.
  • the second coating is a different biomaterial than said first coating.
  • the first coating comprises a layer of perfluorocarbon chemically attached to the surface.
  • the second coating comprises a liquid perfluorocarbon layer.
  • the coating comprises a drug encapsulated in a porous material.
  • the surface comprises a metal.
  • the metal comprises at least one of the following, titanium, cobalt, nickel, copper, zinc, zirconium, molybdenum, tin or lead.
  • the surface comprises a micropattem.
  • the micropattem is etched into the surface prior to insertion into the body.
  • the implantable pumping device further comprises a layer of a biomaterial coated on the micropattem.
  • the connecting portion comprises a flange comprising the fourth cross-sectional area, such that the flange is prevented from travelling through the hole in the tissue portion in a direction perpendicular to the first, second and third planes.
  • the flange protrudes in a direction parallel to the first, second, third and fourth planes, and perpendicular to a central extension of the connecting portion.
  • the flange comprises the third surface configured to engage the first tissue surface of the first side of the tissue portion.
  • the connecting portion comprises at least one protruding element comprising the fourth cross-sectional area, such that the at least one protruding element is prevented from travelling through the hole in the tissue portion, such that the second portion and the connecting portion can be held in position by the tissue portion of the patient also when the first portion is disconnected from the connecting portion.
  • the at least one protruding element protrudes in a direction parallel to the first, second, third and fourth planes, and perpendicular to a central extension of the connecting portion.
  • the at least one protruding element comprises the third surface configured to engage the first tissue surface of the first side of the tissue portion.
  • the connecting portion comprises at least two protruding elements comprising the fourth cross-sectional area.
  • the at least two protruding elements are symmetrically arranged about a central axis of the connecting portion.
  • the at least two protruding elements are asymmetrically arranged about a central axis of the connecting portion.
  • At least one of the first, second and third surfaces comprises at least one of ribs, barbs, hooks, a friction enhancing surface treatment, and a friction enhancing material, to facilitate the implantable energized medical device being held in position by the tissue portion.
  • the connecting portion comprises a hollow portion.
  • the hollow portion provides a passage between the first and second portions.
  • the first portion is detachably connected to the connecting portion by at least one of a mechanical connection and a magnetic connection.
  • the first portion is detachably connected to the connecting portion by at least one of threads and corresponding grooves, a screw, a self-locking element, a twist and lock fitting, and a spring -loaded locking mechanism.
  • the at least one protruding element has a height in a direction perpendicular to the fourth plane being less than a height of the first portion in said direction.
  • the at least one protruding element has a height in said direction perpendicular to the fourth plane being less than half of said height of the first portion in said direction.
  • the at least one protruding element has a height in said direction perpendicular to the fourth plane being less than a quarter of said height of the first portion in said direction.
  • the at least one protruding element has a height in said direction perpendicular to the fourth plane being less than a tenth of said height of the first portion in said direction.
  • the at least one protruding element has a diameter in the fourth plane being one of: less than a diameter of the first portion in the first plane, equal to a diameter of the first portion in the first plane, and larger than a diameter of the first portion in the first plane.
  • the at least one protruding element has a cross-sectional area in the fourth plane being one of: less than a cross-sectional area of the first portion in the first plane, equal to a cross-sectional area of the first portion in the first plane, and larger than a cross- sectional area of the first portion in the first plane.
  • the at least one protruding element has a height in said direction perpendicular to the fourth plane being less than half of a height of the connecting portion in said direction.
  • the at least one protruding element has a height in said direction perpendicular to the fourth plane being less than a quarter of said height of the connecting portion in said direction.
  • the at least one protruding element has a height in said direction perpendicular to the fourth plane being less than a tenth of said height of the connecting portion in said direction.
  • the first portion comprises a first wireless energy receiver configured to receive energy transmitted wirelessly from an external wireless energy transmitter.
  • the first portion comprises an internal wireless energy transmitter.
  • the second portion comprises a second wireless energy receiver.
  • the first portion comprises a first energy storage unit.
  • the second portion comprises a second energy storage unit.
  • at least one of the first and second energy storage unit is a solid-state battery.
  • the solid-state battery is a thionyl-chloride battery.
  • the first wireless energy receiver is configured to receive energy transmitted wirelessly by the external wireless energy transmitter, and store the received energy in the first energy storage unit.
  • the internal wireless energy transmitter is configured to wirelessly transmit energy stored in the first energy storage unit to the second wireless energy receiver.
  • the second wireless energy receiver is configured to receive energy transmitted wirelessly by the internal wireless energy transmitter and store the received energy in the second energy storage unit.
  • the first portion comprises a first controller comprising at least one processing unit.
  • the second portion comprises a second controller comprising at least one processing unit.
  • At least one of the first and second controller is connected to a wireless transceiver for communicating wirelessly with an external device.
  • the first controller is connected to a first wireless communication receiver in the first portion for receiving wireless communication from an external device.
  • the first controller is connected to a first wireless communication transmitter in the first portion for transmitting wireless communication to a second wireless communication receiver in the second portion.
  • the second controller is connected to the second wireless communication receiver for receiving wireless communication from the first portion.
  • the first wireless energy receiver comprises a first coil and the internal wireless energy transmitter comprises a second coil.
  • the first portion comprises a combined coil, wherein the combined coil is configured to receive energy wirelessly from an external wireless energy transmitter, and transmit energy wirelessly to the second wireless receiver of the second portion.
  • the medical device further comprises a housing configured to enclose at least the first portion.
  • a first portion of the housing is made from titanium and a second portion of the housing is made from a ceramic material.
  • the portion of the housing made from a ceramic material comprises at least one coil embedded in the ceramic material.
  • the medical device further comprises a housing configured to enclose at least the second portion.
  • a first portion of the housing is made from titanium and a second portion of the housing is made from a ceramic material.
  • the medical device further comprises at least one sensor for providing input to at least one of the first and second controller.
  • the senor is a sensor configured to sense a physical parameter of the implantable energized medical device.
  • the senor is a sensor configured to sense at least one of: a temperature of the implantable energized medical device or of a body engaging portion, a parameter related to the power consumption of the implantable energized medical device or of a body engaging portion, a parameter related to a status of at least one of the first and second energy storage unit, a parameter related to the wireless transfer of energy from a source external to the body of the patient, and a hydraulic pressure.
  • the senor is a sensor configured to sense a physiological parameter of the patient.
  • the senor is a sensor configured to sense at least one of: a parameter related to the patient swallowing, a local temperature, a systemic temperature, blood saturation, blood oxygenation, blood pressure, a parameter related to an ischemia marker, and pH.
  • the sensor configured to sense a parameter related to the patient swallowing comprises at least one of: a motility sensor, a sonic sensor, an optical sensor, and a strain sensor.
  • the sensor configured to sense pH is configured to sense the acidity in the stomach.
  • the controller is configured to transmit information based on sensor input to a device external to the body of the patient.
  • the second portion comprises at least a portion of an operation device for operating an implantable body engaging portion.
  • the second portion comprises at least one electrical motor.
  • the second portion comprises a transmission configured to reduce the velocity and increase the force of the movement generated by the electrical motor.
  • the transmission is configured to transfer a week force with a high velocity into a stronger force with lower velocity.
  • the transmission is configured to transfer a rotating force into a linear force.
  • the transmission comprises a gear system.
  • the second portion comprises a magnetic coupling for transferring mechanical work from the electrical motor through one of: a barrier separating a first chamber of the second portion from a second chamber of the second portion, a housing enclosing at least the second portion.
  • the second portion comprises at least one hydraulic pump.
  • the hydraulic pump comprises a pump comprising at least one compressible hydraulic reservoir.
  • the medical device further comprises a capacitor connected to at least one of the first and second energy storage unit and connected to the electrical motor.
  • the capacitor is configured to: be charged by at least one of the first and second energy storage units, and provide the electrical motor with electrical power.
  • At least one of the first and second portion comprises a sensation generator adapted to generate a sensation detectable by a sense of the patient.
  • the second portion comprises a force transferring element configured to mechanically transfer force from the second portion to an implanted body engaging portion.
  • the second portion comprises a force transferring element configured to hydraulically transfer force from the second portion to an implanted body engaging portion.
  • the second portion comprises at least one lead for transferring electrical energy and/or information from the second portion to an implanted body engaging portion.
  • the first portion comprises an injection port for injecting fluid into the first portion.
  • the connecting portion comprises a conduit for transferring a fluid from the first portion to the second portion.
  • the conduit is arranged to extend through the hollow portion of the connecting portion.
  • the second portion comprises a first and a second chamber separated from each other.
  • the first chamber comprises a first liquid and the second chamber comprises a second liquid.
  • the second liquid is a hydraulic liquid configured to transfer force to an implantable element configured to exert force on the body portion of the patient.
  • a wall portion of the first chamber is resilient to allow an expansion of the first chamber.
  • the second portion comprises a first hydraulic system in fluid connection with a first hydraulically operable implantable element configured to exert force on the body portion of the patient, and a second hydraulic system in fluid connection with a second hydraulically operable implantable element configured to exert force on the body portion of the patient, wherein the first and second hydraulically operable implantable elements are adjustable independently from each other.
  • the first hydraulic system comprises a first hydraulic pump and the second hydraulic systems comprises a second hydraulic pump.
  • each of the first and second hydraulic systems comprises a reservoir for holding hydraulic fluid
  • the medical device further comprises a first pressure sensor configured to sense a pressure in the first hydraulic system, and a second pressure sensor configured to sense a pressure in the second hydraulic system
  • the first surface is configured to engage the first tissue surface of the first side of the tissue portion.
  • the first, second and third planes are parallel to a major extension plane of the tissue.
  • the fourth plane is parallel to a major extension plane of the tissue.
  • the transferring member is configured to transfer mechanical force from the second portion to the body engaging portion.
  • the transferring member is configured to transfer hydraulic force from the second portion to the body engaging portion.
  • the transferring member is configured to transfer electrical energy force from the second portion to the body engaging portion.
  • the transferring member is configured to transfer data between the second portion and the body engaging portion.
  • the step of placing the transferring member comprises placing the transferring member at least partially between the peritoneum and the layer of muscular tissue of the abdominal wall, such that at least 1/2 of the length of the transferring member is placed on the outside of the peritoneum of the patient.
  • the step of placing the transferring member comprises placing the transferring member at least partially between the peritoneum and the layer of muscular tissue of the abdominal wall, such that at least 2/3 of the length of the transferring member is placed on the outside of the peritoneum of the patient.
  • the step of placing the transferring member comprises placing the transferring member entirely outside of the peritoneum of the patient.
  • the step of placing the transferring member comprises placing the transferring member such that it extends from the second portion to an area between the rib cage and the peritoneum of the patient, outside of the peritoneum.
  • the step of placing the transferring member comprises placing the transferring member such that it extends from the second portion to the subperitoneal space, outside of the peritoneum.
  • the step of placing the transferring member comprises placing the transferring member such that it extends from the second portion to the urinary bladder, outside of the peritoneum.
  • the step of placing the transferring member comprises placing the transferring member such that it extends from the second portion to the urethra, outside of the peritoneum.
  • the step of placing the second portion of the implantable energized medical device between the peritoneum and the layer of muscular tissue of the abdominal wall comprises placing the second portion between a first and second layer of muscular tissue of the abdominal wall.
  • the step of placing the second portion comprises placing a second portion comprising an electrical motor.
  • the step of placing the second portion comprises placing a second portion comprising a hydraulic pump.
  • the step of placing the second portion comprises placing a second portion comprising an energy storage unit.
  • the step of placing the second portion comprises placing a second portion comprising a receiver for receiving at least one of: energy and communication, wirelessly.
  • the step of placing the first portion comprises placing a first portion comprising a transmitter for transmitting at least one of: energy and communication, wirelessly.
  • the step of placing the second portion comprises placing a second portion comprising a controller involved in the control of the powered medical device.
  • the second portion is elongated and has a length axis extending substantially in the direction of the elongation of the second portion.
  • the step of placing the second portion comprises placing the second portion such that the length axis is substantially parallel with the cranial -caudal axis of the patient.
  • the second portion is elongated and has a length axis extending substantially in the direction of the elongation of the second portion.
  • the step of placing the second portion comprises placing the second portion such that the length axis is substantially perpendicular with the cranial -caudal axis of the patient.
  • the second portion is elongated and has a length axis extending substantially in the direction of the elongation of the second portion.
  • the step of placing the second portion comprises entering a hole in a layer of muscular tissue of the stomach wall in the direction of the length axis of the second portion and pivoting or angling the second portion after the hole has been entered.
  • the step of placing the first portion of the implantable energized medical device between the skin of the patient and a layer of muscular tissue of the abdominal wall comprises placing the first portion in the subcutaneous tissue.
  • the step of placing the first portion of the implantable energized medical device between the skin of the patient and a layer of muscular tissue of the abdominal wall comprises placing the first portion between a first and second layer of muscular tissue of the abdominal wall.
  • the step of placing the first portion comprises placing a first portion comprising an energy storage unit.
  • the step of placing the first portion comprises placing a first portion comprising a receiver for receiving at least one of: energy and communication, wirelessly.
  • the step of placing the first portion comprises placing a first portion comprising a transmitter for transmitting at least one of: energy and communication, wirelessly.
  • the step of placing the first portion comprises placing a first portion comprising a controller involved in the control of the powered medical device.
  • the first portion is elongated and has a length axis extending substantially in the direction of the elongation of the first portion.
  • the step of placing the first portion comprises placing the first portion such that the length axis is substantially parallel with the cranial- caudal axis of the patient.
  • the first portion is elongated and has a length axis extending substantially in the direction of the elongation of the first portion.
  • the step of placing the first portion comprises placing the first portion such that the length axis is substantially perpendicular with the cranial -caudal axis of the patient.
  • the first portion is elongated and has a first portion length axis extending substantially in the direction of the elongation of the first portion.
  • the second portion is elongated and has a second portion length axis extending substantially in the direction of the elongation of the second portion.
  • the step of placing the first and second portions comprises placing the first and second portions such that the first portion length axis and the second portion length axis are placed at an angle in relation to each other exceeding 30°.
  • the step of placing the first and second portions comprises placing the first and second portions such that the first portion length axis and the second portion length axis are placed at an angle in relation to each other exceeding 45°.
  • the method of implanting powered medical device further comprises the step of placing the connecting portion through at least one layer of muscular tissue of the abdominal wall.
  • the first portion, the second portion and the connecting portion are portions of a single unit.
  • the method of implanting powered medical device further comprises the step of connecting the first portion to the connecting portion, in situ.
  • the method of implanting powered medical device further comprises the step of connecting the second portion to the connecting portion, in situ.
  • the method of implanting powered medical device further comprises the step of connecting the transferring member to the first portion.
  • the method of implanting powered medical device further comprises the step of connecting the transferring member to the body engaging portion.
  • the body engaging portion comprises a medical device for stretching the stomach wall such that a sensation of satiety is created.
  • the body engaging portion comprises a constriction device configured to constrict a luminary organ of a patient.
  • the body engaging portion comprises an implantable constriction device.
  • the implantable constriction device comprises an implantable constriction device for constricting a luminary organ of the patient.
  • the body engaging portion comprises an implantable element for actively emptying the urinary bladder of the patient.
  • the implantable element for actively emptying the urinary bladder of the patient is configured to empty the bladder of the patient by compressing the urinary bladder from the outside thereof.
  • the body engaging comprises an element for electrically stimulating a tissue portion of a patient.
  • the first wireless transceiver comprises an UWB transceiver.
  • the first wireless transceiver is configured for transcutaneous energy transfer for at least one of powering an energy consuming component of the implantable medical device and charging an implantable energy storage unit.
  • the second network protocol is a standard network protocol.
  • the standard network protocol may be one from the list of: Radio Frequency type protocol, RFID type protocol, WLAN type protocol, Bluetooth type protocol, BLE type protocol, NFC type protocol, 3G/4G/5G type protocol, and GSM type protocol.
  • the second wireless transceiver comprises a Bluetooth transceiver.
  • the external device is further configured to communicate with a second external device using said at least one wireless transceiver.
  • the external device is configured for determining a distance between the external device and the implantable medical device by determining the RSSI.
  • a communication range of the first network protocol is less than a communication range of the second network protocol.
  • a frequency band of the first network protocol differs from a frequency band of the second network protocol.
  • the external device is configured to authenticate the implantable medical device if the determined distance between the external device and the implantable medical device is less than a predetermined threshold value.
  • the external device is configured to allow the transfer of data between the external device and the implantable medical device after the implantable medical device has been authenticated.
  • the external device is one from the list of: a wearable external device, and a handset.
  • the first wireless transceiver comprises an UWB transceiver.
  • the first wireless transceiver is configured for transcutaneous energy transfer for at least one of: powering an energy consuming component of the implantable medical device, and charging an implantable energy storage unit.
  • the second network protocol is a standard network protocol, such as selected from the list of Radio Frequency type protocol, RFID type protocol, WLAN type protocol, Bluetooth type protocol, BLE type protocol, NFC type protocol, 3G/4G/5G type protocol, and GSM type protocol.
  • the second wireless transceiver comprises a Bluetooth transceiver.
  • the implantable medical device is further configured to communicate with a second external device using said at least one wireless transceiver.
  • the implantable medical device is configured for determining a distance between the external device and the implantable medical device by determining the RSSI.
  • a communication range of the first network protocol is less than a communication range of the second network protocol.
  • a frequency band of the first network protocol differs from a frequency band of the second network protocol.
  • the implantable medical device is configured to authenticate the external device if the determined distance between the external device and the implantable medical device is less than a predetermined threshold value.
  • the implantable medical device is configured to allow the transfer of data between the implantable medical device and the external device after the external device has been authenticated.
  • the implantable medical device comprises at least one of: an external heart compression device, an apparatus assisting the pump function of a heart of the patient, an apparatus assisting the pump function comprising a turbine bump placed within a patient’s blood vessel for assisting the pump function of the heart, an operable artificial heart valve, an operable artificial heart valve for increasing the blood flow to the coronary arteries, an implantable drug delivery device, an implantable drug delivery device for injecting directly into a blood vessel and change the position of the injection site, all from within the patient’s body, an implantable drug delivery device for injecting potency enhancing drugs into an erectile tissue of the patient, a hydraulic, mechanic, and/or electric constriction implant, an operable volume filling device, an operable gastric band, an operable implant for stretching the stomach wall of the patient for creating satiety, an implant configured to sense the frequency of the patient ingesting food, an operable cosmetic implant, an operable cosmetic implant for adjust the shape and/or size in the breast region of a
  • RECTIFIED SHEET (RULE 91) ISA/EP affecting the dilatation of the renal artery, an implant controlling a drug treatment parameter, an implant controlling a parameter in the blood, an implant for adjusting or replacing any bone part of a body of the patient, an implant replacing an organ of the patient or part of an organ of the patient or the function thereof, a vascular treatment device, an implant adapted to move fluid inside the body of the patient, an implant configured to sense a parameter related to the patient swallowing, an implant configured to exercise a muscle with electrical or mechanical stimulation, an implant configured for emptying an intestine portion on command, an operable implant configured to be invaginated in the stomach of the patient to reduce the volume of the stomach substantially more than the volume of the device, an implant configured for emptying the urinary bladder from within the patient’s body by compressing the bladder, an implant configured for draining fluid from within the patient’s body, an implant configured for the active lubrication of a joint with an added lubrication fluid, an implant configured for removing clot
  • the system comprises a master private key device configured to allow issuance of a new private key device, wherein the HCP or HCP admin have such master private key device adapted to able to replace and pair a new patient private key device or HCP private key device into the system, through the HCP EID external device.
  • the patient remote external device and the patient EID external device are an integrated unit.
  • the HCP dedicated device and the HCP EID external device are an integrated unit.
  • the system comprises a measurement device or sensor adapted to deliver a measurement to at least one of the DDI, patent EID external device and a patient display device.
  • the system comprises a food sensor, adapted to measure at least if the patient swallows solid food or is drinking fluid, wherein said food sensor is connected to the control unit of a medical device to cause an action to stretch the stomach after a determined amount of food intake.
  • the wireless communication unit comprises a wireless transceiver for wireless transmission of control commands to the implantable medical device, and wireless transmission of the control interface as the remote display portal to the patient display device.
  • the wireless communication unit comprises a first wireless transceiver for wireless transmission of control commands to the implantable medical device, and a second wireless transceiver for wireless transmission of the control interface to the patient display device.
  • the wireless communication unit is configured for wireless communication with the patient display device using a standard network protocol.
  • the wireless communication unit is configured for wireless communication with the implantable medical device using a proprietary network protocol.
  • the wireless communication unit comprises a Bluetooth transceiver.
  • At least one of the first and second wireless transceiver comprises a Bluetooth transceiver.
  • the wireless communication unit comprises a UWB transceiver.
  • At least one of the first and second wireless transceiver comprises a UWB transceiver.
  • the wireless communication unit comprises at least one first wireless transceiver configured for communication with the implantable medical device using a first network protocol, for determining a distance between the patient external device and the implantable medical device, and at least one second wireless transceiver configured for communication with the implantable medical device using a second network protocol, for transferring data between the patient external device and the implantable medical device.
  • the first wireless transceiver is configured for transcutaneous energy transfer for at least one of: powering an energy consuming component of the implantable medical device and charging an implantable energy storage unit.
  • the standard network protocol is one from the list of: Radio Frequency type protocol, RFID type protocol, WLAN type protocol, Bluetooth type protocol, BLE type protocol, NFC type protocol, 3G/4G/5G type protocol, and GSM type protocol.
  • a communication range of the first wireless transceiver is less than a communication range of the second wireless transceiver.
  • the patient external device is configured to authenticate the implantable medical device if a distance between the patient external device and the implantable medical device is less than a predetermined threshold value
  • the patient external device is configured to be authenticated by the implantable medical device if a distance between the patient external device and the implantable medical device is less than a predetermined threshold value
  • the patient external device is configured to authenticate the patient display device if a distance between the patient external device and the patient display device is less than a predetermined threshold value
  • the patient external device is configured to be authenticated by the implantable medical device if a distance between the patient external device and the patient display device is less than a predetermined threshold value.
  • the patient external device is configured to allow the transfer of data between at least one of: the patient external device and the implantable medical device, and the patient external device and the patient display device, on the basis of the authentication.
  • the computing unit is configured to encrypt at least one of the control interface and the control commands.
  • the implantable medical device comprises at least one of: an external heart compression device, an apparatus assisting the pump function of a heart of the patient, an apparatus assisting the pump function comprising a turbine bump placed within a patient’s blood vessel for assisting the pump function of the heart, an operable artificial heart valve, an operable artificial heart valve for increasing the blood flow to the coronary arteries, an implantable drug delivery device, an implantable drug delivery device for injecting directly into a blood vessel and change the position of the injection site, all from within the patient’s body, an implantable drug delivery device for injecting potency enhancing drugs into an erectile tissue of the patient, a hydraulic, mechanic, and/or electric constriction implant, an operable volume filling device, an operable gastric band, an operable implant for stretching the stomach wall of the patient for creating satiety, an implant configured to sense the frequency of the patient ingesting food, an operable cosmetic implant, an operable cosmetic implant for adjust the shape and/or size in the breast region of a
  • RECTIFIED SHEET (RULE 91) ISA/EP patient’s blood stream, an implant configured for elongating or straightening a bone in the patient, to reduce scoliosis, a device to stimulate the brain for a several position to a focused point, an artificial stomach replacing the function of the natural stomach, an implant configured for adjusting the position of a female’s urinary tract or bladder neck, an implant configured for stimulating the ampulla vas deference and creating temporary constriction.
  • the system comprises a master private key device configured to allow issuance of a new private key device, wherein the HCP or HCP admin have such master private key device adapted to able to replace and pair a new patient private key device or HCP private key device into the system, through the HCP EID external device.
  • the patient remote external device and the patient EID external device are an integrated unit.
  • the HCP dedicated device and the HCP EID external device are an integrated unit.
  • the system comprises a measurement device or sensor adapted to deliver a measurement to at least one of the DDI, patent EID external device and a patient display device.
  • the system comprises a food sensor, adapted to measure at least if the patient swallows solid food or is drinking fluid, wherein said food sensor is connected to the control unit of a medical device to cause an action to stretch the stomach after a determined amount of food intake.
  • the patient display device further comprises an auxiliary wireless communication unit.
  • the auxiliary wireless communication unit is configured to be disabled to enable at least one of: wirelessly receiving the implant control interface as the remote display portal from the patient remote external device, and wirelessly transmitting implant control user input to the patient remote external device.
  • the wireless communication unit is configured for wireless communication with the patient remote external device using a standard network protocol.
  • the standard network protocol may be one from the list of: Radio Frequency type protocol, RFID type protocol, WLAN type protocol, Bluetooth type protocol, BLE type protocol, NFC type protocol, 3G/4G/5Gtype protocol, and GSM type protocol.
  • the wireless communication unit is configured for wireless communication with the patient remote external device using a proprietary network protocol.
  • the wireless communication unit comprises a Bluetooth transceiver.
  • the wireless communication unit comprises a UWB transceiver.
  • a communication range of the wireless communication unit is less than a communication range of the auxiliary wireless communication unit.
  • the patient display device is configured to authenticate the patient remote external device if a distance between the patient display device and the patient remote external device is less than a predetermined threshold value, or to be authenticated by the patient remote external device if a distance between the patient display device and the patient remote external device is less than a predetermined threshold value.
  • the patient display device is configured to allow the transfer of data between the patient display device and the patient remote external device on the basis of the authentication.
  • the patient display device is a wearable external device or a handset.
  • the system comprises a master private key device configured to allow issuance of a new private key device, wherein the HCP or HCP admin have such master private key device adapted to able to replace and pair a new patient private key device or HCP private key device into the system, through the HCP EID external device.
  • the patient remote external device and the patient EID external device are an integrated unit.
  • the HCP dedicated device and the HCP EID external device are an integrated unit.
  • the system comprises a measurement device or sensor adapted to deliver a measurement to at least one of the DDI, patent EID external device and a patient display device.
  • the system comprises a food sensor, adapted to measure at least if the patient swallows solid food or is drinking fluid, wherein said food sensor is connected to the control unit of a medical device to cause an action to stretch the stomach after a determined amount of food intake.
  • the computing unit is configured to encrypt at least one of the control interface and the control commands.
  • the patient display device is configured to encrypt the user input.
  • the server is configured to encrypt at least one of the user input received from the patient display device and the control interface received from the patient remote external device.
  • the computing unit is configured to encrypt the control interface and the patient display device is configured to decrypt the encrypted control interface.
  • the server is configured to act as a router, transferring the encrypted control interface from the patient remote external device to the patient display device without decryption.
  • the implantable medical device comprises at least one of: an external heart compression device, an
  • RECTIFIED SHEET (RULE 91) ISA/EP apparatus assisting the pump function of a heart of the patient, an apparatus assisting the pump function comprising a turbine bump placed within a patient’s blood vessel for assisting the pump function of the heart, an operable artificial heart valve, an operable artificial heart valve for increasing the blood flow to the coronary arteries, an implantable drug delivery device, an implantable drug delivery device for injecting directly into a blood vessel and change the position of the injection site, all from within the patient’s body, an implantable drug delivery device for injecting potency enhancing drugs into an erectile tissue of the patient, a hydraulic, mechanic, and/or electric constriction implant, an operable volume filling device, an operable gastric band, an operable implant for stretching the stomach wall of the patient for creating satiety, an implant configured to sense the frequency of the patient ingesting food, an operable cosmetic implant, an operable cosmetic implant for adjust the shape and/or size in the breast region of a patient, an implant controlling medical device for the empty
  • RECTIFIED SHEET (RULE 91) ISA/EP bladder neck, an implant configured for stimulating the ampulla vas deference and creating temporary constriction.
  • the communication system further comprises a server.
  • the server may comprise a wireless communication unit configured for wirelessly receiving an implant control interface received from the patient remote external device and wirelessly transmitting the implant control interface as a remote display portal to the patient display device.
  • the wireless communication unit is further configured for wirelessly receiving implant control user input from a patient EID external device and wirelessly transmitting the implant control user input to the patient display device.
  • the system comprises a master private key device configured to allow issuance of a new private key device, wherein the HCP or HCP admin have such master private key device adapted to able to replace and pair a new patient private key device or HCP private key device into the system, through the HCP EID external device.
  • the patient remote external device and the patient EID external device are an integrated unit.
  • the HCP dedicated device and the HCP EID external device are an integrated unit.
  • the system comprises a measurement device or sensor adapted to deliver a measurement to at least one of the DDI, patent EID external device and a patient display device.
  • the system comprises a food sensor, adapted to measure at least if the patient swallows solid food or is drinking fluid, wherein said food sensor is connected to the control unit of a medical device to cause an action to stretch the stomach after a determined amount of food intake.
  • the first log-in is a PIN-based log-in.
  • At least one of the first and second log-in is a log-in based on a biometric input or a hardware key.
  • the patient display device further comprises an auxiliary wireless communication unit, and wherein the auxiliary wireless communication unit is configured to be disabled to enable wireless communication with the patient external device.
  • the patient display device is configured to wirelessly receive an implant control interface as a remote display portal from the patient external device to be displayed on the display.
  • the wireless communication unit is configured for wireless communication with the patient external device using a standard network protocol.
  • the wireless communication unit is configured for wireless communication with the patient external device using a proprietary network protocol.
  • the wireless communication unit is configured for wireless communication with the patient external device using a first network protocol and with the server using a second network protocol.
  • the wireless communication unit is configured for wireless communication with the patient external device using a first frequency band and with the server using a second frequency band.
  • the wireless communication unit comprises a Bluetooth transceiver.
  • the wireless communication unit comprises a UWB transceiver.
  • the standard network protocol is one from the list of: Radio Frequency type protocol, RFID type protocol, WLAN type protocol, Bluetooth type protocol, BLE type protocol, NFC type protocol, 3G/4G/5G type protocol, and GSM type protocol.
  • a communication range of the wireless communication unit is less than a communication range of the auxiliary wireless communication unit.
  • the wireless communication unit comprises a first wireless transceiver for communication with the patient external device and a second wireless transceiver for communication with the server.
  • the second wireless transceiver is configured to be disabled to enable wireless communication using the first wireless transceiver.
  • the patient display device is configured to authenticate the patient external device if a distance between the patient display device and the patient external device is less than a predetermined threshold value, or to be authenticated by the patient external device if a distance between the patient display device and the patient external device is less than a predetermined threshold value.
  • the patient display device is configured to allow the transfer of data between the patient display device and the patient external device on the basis of the authentication.
  • the patient display device is a wearable external device or a handset.
  • the second application is configured to receive data related to a parameter of the implanted medical device.
  • the second application is configured to receive data related to a sensor value received from the implanted medical device.
  • the second application is configured to receive data related to a parameter related to at least one of: a battery status, a temperature, a time, and an error.
  • the patient display device is configured to encrypt the user input.
  • the display is configured to encrypt the user input for decryption by the implantable medical device.
  • the patient display device is configured to decrypt the control interface received from the patient external device, for displaying the control interface on the display.
  • At least one of the first and second application is configured to receive data from an auxiliary external device and present the received data to the user.
  • at least one of the first and second application is configured to receive data from an auxiliary external device comprising a scale for determining the weight of the user.
  • At least one of the first and second application is configured to receive data related to the weight of the user from an auxiliary external device comprising a scale.
  • the patient display device is configured to: wirelessly transmit the data related to the weight of the user to the patient external device, or wirelessly transmit an instruction derived from the data related to the weight of the user, or wirelessly transmit an instruction derived from a combination of the data related to the weight of the user and the implant control input received from the user.
  • the system comprises a master private key device configured to allow issuance of a new private key device, wherein the HCP or HCP admin have such master private key device adapted to able to replace and pair a new patient private key device or HCP private key device into the system, through the HCP EID external device.
  • the patient remote external device and the patient EID external device are an integrated unit.
  • the HCP dedicated device and the HCP EID external device are an integrated unit.
  • the system comprises a measurement device or sensor adapted to deliver a measurement to at least one of the DDI, patent EID external device and a patient display device.
  • the system comprises a food sensor, adapted to measure at least if the patient swallows solid food or is drinking fluid, wherein said food sensor is connected to the control unit of a medical device to cause an action to stretch the stomach after a determined amount of food intake.
  • the patient display device comprises a first log-in function and a second log-in function, and wherein the first log-in function gives the user access to the first application and wherein the first and second log-in function in combination gives the user access to the second application.
  • the second application is configured to receive data related to a parameter of the implanted medical device.
  • the second application is configured to receive data related to a sensor value received from the implanted medical device.
  • the second application is configured to receive data related to a parameter related to at least one of: a battery status, a temperature, a time, or an error.
  • the patient display device is configured to encrypt the user input.
  • the display is configured to encrypt the user input for decryption by the implantable medical device.
  • the patient remote external device is configured to act as a router, transferring the encrypted user input from the patient display device to the implantable medical device without decryption.
  • the patient remote external device is configured to encrypt at least one of the control interface and the control commands.
  • the patient remote external device is configured to encrypt the control interface and wherein the patient display device is configured to decrypt the encrypted control interface.
  • the second application is configured to receive data related to a parameter of the implanted medical device.
  • the second application is configured to receive data related to a sensor value received from the implanted medical device.
  • the second application is configured to receive data related to a parameter related to at least one of: a battery status, a temperature, a time, or an error.
  • the implantable medical device comprises at least one of: an external heart compression device, an apparatus assisting the pump function of a heart of the patient, an apparatus assisting the pump function comprising a turbine bump placed within a patient’s blood vessel for assisting the pump function of the heart, an operable artificial heart valve, an operable artificial heart valve for increasing the blood flow to the coronary arteries, an implantable drug delivery device, an implantable drug delivery device for injecting directly into a blood vessel and change the position of the injection site, all from within the patient’s body, an implantable drug delivery device for injecting potency enhancing drugs into an erectile tissue of the patient, a hydraulic, mechanic, and/or electric constriction implant, an operable volume filling device, an operable gastric band, an operable
  • RECTIFIED SHEET (RULE 91) ISA/EP of an erectile tissue, an implant with a reservoir for holding bodily fluids, an implant storing and/or emptying a bodily reservoir or a surgically created reservoir, an implant communicating with a database outside the body, an implant able to be programmed from outside the body, an implant able to be programmed from outside the body with a wireless signal, an implant treating impotence, an implant controlling the flow of eggs in the uterine tube, an implant controlling the flow of sperms in the uterine tube, an implant controlling the flow of sperms in the vas deferens, an implant for hindering the transportation of the sperm in the vas deferens, an implant treating osteoarthritis, an implant performing a test of parameters inside the body, an implant controlling specific treatment parameters from inside the body, an implant controlling bodily parameters from inside the body, an implant controlling the blood pressure, an implant controlling the blood pressure by affecting the dilatation of the renal artery, an implant controlling a drug
  • the system comprises a master private key device configured to allow issuance of a new private key device, wherein the HCP or HCP admin have such master private key device adapted to able to replace and pair a new patient private key device or HCP private key device into the system, through the HCP EID external device.
  • the patient remote external device and the patient EID external device are an integrated unit.
  • the HCP dedicated device and the HCP EID external device are an integrated unit.
  • the system comprises a measurement device or sensor adapted to deliver a measurement to at least one of the DDI, patent EID external device and a patient display device.
  • the system comprises a food sensor, adapted to measure at least if the patient swallows solid food or is drinking fluid, wherein said food sensor is
  • RECTIFIED SHEET (RULE 91) ISA/EP connected to the control unit of a medical device to cause an action to stretch the stomach after a determined amount of food intake.
  • the patient display device is configured to wirelessly receive an implant control interface from the patient external device to be displayed on the display.
  • at least two of: the wireless communication unit of the server, the wireless communication unit of the patient display device, the wireless communication unit of the patient external device, and the wireless communication unit of the implantable medical device are configured for wireless communication using a standard network protocol.
  • the wireless communication unit of the server the wireless communication unit of the patient display device, the wireless communication unit of the patient external device, and the wireless communication unit of the implantable medical device, are configured for wireless communication using a proprietary network protocol.
  • the wireless communication unit of the patient external device is configured to use a first network protocol for communication with the implantable medical device and use a second network protocol for communication with the server, or use a first network protocol for communication with the implantable medical device and use a second network protocol for communication with the patient display device.
  • the wireless communication unit of the patient external device is configured to use a first frequency band for communication with the implantable medical device and use a second frequency band for communication with the server, or use a first frequency band for communication with the implantable medical device and use a second frequency band for communication with the patient display device.
  • the wireless communication unit of the patient display device is configured to use a first network protocol for communication with the patient external device and use a second network protocol for communication with the server.
  • the wireless communication unit of the patient display device is configured to use a first frequency band for communication with the patient external device and use a second frequency band for communication with the server.
  • the wireless communication unit of the server is configured to use a first network protocol for communication with the patient external device and use a second network protocol for communication with the patient display device.
  • the wireless communication unit of the server is configured to use a first frequency band for communication with the patient external device and use a second frequency band for communication with the patient display device.
  • the wireless communication unit of at least one of the server, the patient display device, the patient external device, and the implantable medical device comprises a Bluetooth transceiver.
  • the wireless communication unit of at least one of the server, the patient display device, the patient external device, and the implantable medical device comprises a UWB transceiver.
  • the standard network protocol is one from the list of: Radio Frequency type protocol, RFID type protocol, WLAN type protocol, Bluetooth type protocol, BLE type protocol, NFC type protocol, 3G/4G/5G type protocol, and GSM type protocol.
  • the wireless communication unit of the patient external device comprises a first wireless transceiver for wireless communication with the implantable medical device, and a second wireless transceiver for wireless communication with the server, and wherein the second wireless transceiver has a longer effective range than the first wireless transceiver.
  • the wireless communication unit of the patient external device comprises a first wireless transceiver for wireless communication with the implantable medical device, and a second wireless transceiver for wireless communication with the patient display device, and wherein the second wireless transceiver has a longer effective range than the first wireless transceiver.
  • the wireless communication unit of the patient display device comprises a first wireless transceiver for wireless communication with the patient external device, and a second wireless transceiver for wireless communication with the server, and wherein the second wireless transceiver has a longer effective range than the first wireless transceiver.
  • the second wireless transceiver has an effective range being one of: 2 times, 4 times, 8 times 20 times, 50 times or 100 times longer than the first wireless transceiver.
  • the second wireless transceiver is configured to be disabled to enable wireless communication using the first wireless transceiver.
  • the patient display device is configured to authenticate the patient external device if a distance between the patient display device and the patient external device is less than a predetermined threshold value
  • the patient display device is configured to be authenticated by the patient external device if a distance between the patient display device and the patient external device is less than a predetermined threshold value
  • the patient display device is configured to authenticate the implantable medical device if a distance between the patient display device and the implantable medical device is less than a predetermined threshold value
  • the patient display device is configured to be authenticated by the implantable medical device if a distance between the patient display device and the implantable medical device is less than a predetermined threshold value
  • the patient external device is configured to authenticate the patient display device if a distance between the patient external device and the patient display device is less than a predetermined threshold value
  • the patient external device is configured to be authenticated by the patient display device if a distance between the patient external device and the patient display device is less than a predetermined threshold value
  • the patient external device is configured to be authenticated
  • RECTIFIED SHEET (RULE 91) ISA/EP less than a predetermined threshold value
  • the patient external device is configured to be authenticated by the implantable medical device if a distance between the patient external device and the implantable medical device is less than a predetermined threshold value.
  • the patient display device is configured to allow the transfer of data between the patient display device and the patient external device on the basis of the authentication.
  • the patient external device is configured to allow the transfer of data between the patient display device and the patient external device on the basis of the authentication.
  • the patient external device is configured to allow the transfer of data between the patient external device and the implantable medical device on the basis of the authentication.
  • the patient display device is a wearable patient external device or a handset.
  • the data encrypted by the implantable medical device is related to at least one of: a battery status, a temperature, a time, or an error.
  • the system comprises a master private key device configured to allow issuance of a new private key device, wherein the HCP or HCP admin have such master private key device adapted to able to replace and pair a new patient private key device or HCP private key device into the system, through the HCP EID external device.
  • the patient remote external device and the patient EID external device are an integrated unit.
  • the HCP dedicated device and the HCP EID external device are an integrated unit.
  • the system comprises a measurement device or sensor adapted to deliver a measurement to at least one of the DDI, patent EID external device and a patient display device.
  • the system comprises a food sensor, adapted to measure at least if the patient swallows solid food or is drinking fluid, wherein said food sensor is connected to the control unit of a medical device to cause an action to stretch the stomach after a determined amount of food intake.
  • HCP private key device comprises a hardware key.
  • the private key device is at least one of, a smartcard, a key-ring device, a watch an arm or wrist band a neckless or any shaped device.
  • At least two of: the HCP EID external device, the patient EID external device, the HCP private key device, the patient private key device, and the DDI are configured for wireless communication using a standard network protocol.
  • At least two of: the HCP EID external device, the patient EID external device, the HCP private key device, the patient private key device, and the DDI are configured for wireless communication using a proprietary network protocol.
  • the patient EID external device is configured to use a first network protocol for communication with the implantable medical device and use a second network protocol for communication with the DDI.
  • the patient EID external device is configured to use a first frequency band for communication with the implantable medical device and use a second frequency band for communication with the DDI.
  • the DDI is configured to use a first frequency band for communication with the patient EID external device and a second frequency band for communication with the patient private key device.
  • At least one of the HCP EID external device, the patient EID external device, the HCP private key device, the patient private key device and the DDI comprises a Bluetooth transceiver.
  • At least one of the HCP EID external device, the patient EID external device, the HCP private key device, the patient private key device and the DDI comprises a UWB transceiver.
  • the standard network protocol is one from the list of: Radio Frequency type protocol, RFID type protocol, WLAN type protocol, Bluetooth type protocol, BLE type protocol, NFC type protocol, 3G/4G/5G type protocol, and GSM type protocol.
  • the patient EID external device comprises a first wireless transceiver for wireless communication with the implantable medical device, and a second wireless transceiver for wireless communication with the DDI, and wherein the second wireless transceiver has longer effective range than the first wireless transceiver.
  • the patient private key device comprises a first wireless transceiver for wireless communication with the HCP EID external device, and a second wireless transceiver for wireless communication with the DDI, and wherein the second wireless transceiver has longer effective range than the first wireless transceiver.
  • the second wireless transceiver has an effective range being one of: 2 times, 4 times, 8 time, 20 times, 50 times or 100 times longer than the effective range of the first wireless transceiver.
  • the second wireless transceiver is configured to be disabled to enable wireless communication using the first wireless transceiver.
  • the patient EID external device is configured to allow transfer of data between the EID external device and the implantable medical device on the basis of an authentication of the patient EID external device.
  • the patient EID external device is a wearable patient external device or a handset.
  • the data encrypted by the implantable medical device is related to at least one of: a battery status, a temperature, a time, or an error.
  • the system comprises a master private key device configured to allow issuance of a new private key device, wherein the HCP or HCP admin have such master private key device adapted to able to replace and pair a new patient private key device or HCP private key device into the system, through the HCP EID external device.
  • the patient remote external device and the patient EID external device are an integrated unit.
  • the HCP dedicated device and the HCP EID external device are an integrated unit.
  • the system comprises a measurement device or sensor adapted to deliver a measurement to at least one of the DDI, patent EID external device and a patient display device.
  • the system comprises a food sensor, adapted to measure at least if the patient swallows solid food or is drinking fluid, wherein said food sensor is connected to the control unit of a medical device to cause an action to stretch the stomach after a determined amount of food intake.
  • the HCP EID external device further comprises a wireless transceiver configured for communication with the implanted medical device through a second network protocol.
  • the HCP private key device is adapted to be provided to the at least one HCP external device via at least one of: a reading slot or comparable for the HCP private key device, a RFID communication, and a close distance wireless activation communication unit, or electrical direct contact.
  • the HCP EID external device comprises at least one of reading slot or comparable for the HCP private key device, a RFID communication and a close distance wireless activation communication unit, or electrical direct contact.
  • the HCP EID external device is adapted to receive a command from a HCP dedicated device to change said pre-programmed treatment steps of the implantable medical device, when implanted, wherein the HCP dedicated device is further adapted to be activated, authenticated, and allowed to perform said command by the HCP providing their private key.
  • At least two of: the HCP EID external device, the patient EID external device, the HCP private key device, and the patient private key device are configured for wireless communication using a standard network protocol.
  • At least two of: the HCP EID external device, the patient EID external device, the HCP private key device, and the patient private key device are configured for wireless communication using a proprietary network protocol.
  • the patient EID external device is configured to use a first network protocol for communication with the implantable medical device and use a second network protocol for communication with the patient private key device.
  • the patient EID external device is configured to use a first frequency band for communication with the implantable medical device and use a second frequency band for communication with the patient private key device.
  • At least one of the HCP EID external device, the patient EID external device, the HCP private key device, and the patient private key device comprises a Bluetooth transceiver.
  • At least one of the HCP EID external device, the patient EID external device, the HCP private key device, and the patient private key device comprises a UWB transceiver.
  • the standard network protocol is one from the list of: Radio Frequency type protocol, RFID type protocol, WLAN type protocol, Bluetooth type protocol, BLE type protocol, NFC type protocol, 3G/4G/5G type protocol, and GSM type protocol.
  • the patient EID external device comprises a first wireless transceiver for wireless communication with the implantable medical device, and a second wireless transceiver for wireless communication with the patient private key device, and wherein the second wireless transceiver has longer effective range than the first wireless transceiver.
  • the second wireless transceiver has an effective range being one of: 2 times, 4 times, 8 time, 20 times, 50 times or 100 times longer than the effective range of the first wireless transceiver.
  • the second wireless transceiver is configured to be disabled to enable wireless communication using the first wireless transceiver.
  • the patient EID external device is configured to allow transfer of data between the EID external device and the implantable medical device on the basis of an authentication of the patient EID external device.
  • the patient EID external device is a wearable patient external device or a handset.
  • the data encrypted by the implantable medical device is related to at least one of: a battery status, a temperature, a time, or an error.
  • the wireless transceiver, the remote display portal, and the remote display portal are comprised in the patient remote external device.
  • the system further comprises the patient display device, which may comprise a supporting application, a display which hosts the Remote Display Portal, and a patient display device private key.
  • the patient display device which may comprise a supporting application, a display which hosts the Remote Display Portal, and a patient display device private key.
  • the remote display portal is capable of generating a command to be signed by the patient display device private key.
  • the patient remote external device is adapted to accept input from the patient via said patient display device through its remote display portal.
  • the patient remote external device comprises a graphical user interface arranged on a touch-responsive display exposing buttons to express actuation functions of the implanted medical device.
  • the system is configured to allow the patient to actuate the implant at home through the patient remote external device by means of an authorization granted by a patient private key.
  • the patient private key comprises at least one of: a smart card, a keyring device, a watch, a arm or wrist band, a necklace, and any shaped device.
  • the system is configured to allow the patient to actuate the implantable medical device, when implanted, at home through the patient remote external device, using an authorization granted by the patient private key.
  • system further comprises a patient EID external device comprising at least one of: a reading slot or comparable for the patient private key device, a RFID communication, and a close distance wireless activation communication, or electrical direct contact.
  • patient EID external device is adapted to be synchronised with the patient remote external device.
  • the patient EID external device further comprises at least one of: a wireless transceiver configured for communication with the patient, a remote external device, and a wired connector for communication with the patient remote external device.
  • the patient EID external device is adapted to generate an authorization to be signed by the patient private key to be installed into at least one of: the patient remote external device through the patient EID external device, and the implantable medical device.
  • the system comprises a patient display device comprising a supporting application capable of displaying the remote display portal with content delivered from the patient remote external device.
  • the remote display portal and patient remote external device are adapted to expose buttons to express the will to actuate the functions of the implanted medical device by the patient through the patient remote external device.
  • the patient display device comprises at least one of: a display which hosts the remote display portal, and a patient display device private key.
  • the remote display portal is capable of generating a command to be signed by the patient private key.
  • the system comprises a master private key device configured to allow issuance of a new private key device, wherein the HCP or HCP admin have such master private key device adapted to able to replace and pair a new patient private key device or HCP private key device into the system, through the HCP EID external device.
  • the patient remote external device and the patient EID external device are an integrated unit.
  • the HCP dedicated device and the HCP EID external device are an integrated unit.
  • the system comprises a measurement device or sensor adapted to deliver a measurement to at least one of the DDI, patent EID external device and a patient display device.
  • the system comprises a food sensor, adapted to measure at least if the patient swallows solid food or is drinking fluid, wherein said food sensor is connected to the control unit of a medical device to cause an action to stretch the stomach after a determined amount of food intake.
  • the at least one patient EID external device is adapted to receive information from the implant, through a second network protocol.
  • the system comprises the DDI, wherein the DDI is adapted to receive information from said patient EID external device, and wherein the DDI comprises a wireless transceiver configured for communication with said patient EID external device.
  • the patient EID external device is adapted to receive a command relayed by the DDI, to further send the command to the implanted medical device to change said pre-programmed treatment settings of the implanted medical device, and further adapted to be activated and authenticated and allowed to perform said command by the patient providing the patient private key.
  • the patient private key device is adapted to provide the patient private key to the patient EID external device by the patient via at least one of; a reading slot or comparable for the patient private key device, an RFID communication or other close distance wireless activation communication, or electrical direct contact.
  • the patient EID external device comprises at least one of: a reading slot or comparable for the HCP private key device, a RFID communication, and other close distance wireless activation communication, or direct electrical contact.
  • the patient EID external device further comprising at least one wireless transceiver configured for communication with the implanted medical device through a second network protocol.
  • the system comprises the implantable medical device, which may be adapted to, when implanted, treat the patient or perform a bodily function.
  • the patient private key comprises at least one of: a smart card, a keyring device, a watch, an arm band or wrist band, a necklace, and any shaped device.
  • at least two of: the patient EID external device, the IDD, and the patient private key device are configured for wireless communication using a standard network protocol.
  • At least two of: the patient EID external device, the IDD, and the patient private key device, are configured for wireless communication using a proprietary network protocol.
  • the patient EID external device is configured to use a first network protocol for communication with the implantable medical device and use a second network protocol for communication with the patient private key device.
  • the patient EID external device is configured to use a first frequency band for communication with the implantable medical device and use a second frequency band for communication with the patient private key device.
  • At least one of the patient EID external device, the patient private key device and the IDD comprises a Bluetooth transceiver.
  • At least one of the patient EID external device, the patient private key device and the IDD comprises a UWB transceiver.
  • the standard network protocol is one from the list of: Radio Frequency type protocol, RFID type protocol, WLAN type protocol, Bluetooth type protocol, BLE type protocol, NFC type protocol, 3G/4G/5G type protocol, and GSM type protocol.
  • the patient EID external device comprises a first wireless transceiver for wireless communication with the implantable medical device, and a second wireless transceiver for wireless communication with the patient private key device, and wherein the second wireless transceiver has longer effective range than the first wireless transceiver.
  • the second wireless transceiver has an effective range being one of: 2 times, 4 times, 8 time, 20 times, 50 times or 100 times longer than the effective range of the first wireless transceiver.
  • the second wireless transceiver is configured to be disabled to enable wireless communication using the first wireless transceiver.
  • the patient EID external device is a wearable patient external device or a handset.
  • the data encrypted by the implantable medical device is related to at least one of: a battery status, a temperature, a time, or an error.
  • the system comprises a master private key device configured to allow issuance of a new private key device, wherein the HCP or HCP admin have such master private key device adapted to able to replace and pair a new patient private key device or HCP private key device into the system, through the HCP EID external device.
  • the patient remote external device and the patient EID external device are an integrated unit.
  • the HCP dedicated device and the HCP EID external device are an integrated unit.
  • the system comprises a measurement device or sensor adapted to deliver a measurement to at least one of the DDI, patent EID external device and a patient display device.
  • the system comprises a food sensor, adapted to measure at least if the patient swallows solid food or is drinking fluid, wherein said food sensor is connected to the control unit of a medical device to cause an action to stretch the stomach after a determined amount of food intake.
  • the at least one patient remote external device comprises a patient remote external device private key, wherein the DDI via the patient EID external device is able to inactivate the authority and authenticating function of the patient remote external device, thereby inactivating the patient remote external device.
  • the patient EID external device comprises at least one wireless transceiver configured for communication with the DDI via a first network protocol.
  • the system comprises the DDI, wherein the DDI is adapted to receive command from a HCP EID external device, and to send the received command to the patient EID external device, wherein the DDI comprises a wireless transceiver configured for communication with said patient external device.
  • the patient EID external device is adapted to receive the command from the DDI, wherein the command originates from a health care provider, HCP, and wherein the patient EID is adapted to inactivate the patient private key and to send the command to the implanted medical device.
  • the patient EID external device is adapted to receive the command from the DDI, wherein the command originates from a health care provider, HCP, wherein the patient EID external device is adapted to receive the command from the HCP via the DDI to inactivate the patient remote external device comprising a patient remote external device private key, and wherein the patient EID external device is further adapted to send this command to the implanted medical device.
  • HCP health care provider
  • the patient EID external device further comprises at least one wireless transceiver configured for communication with the implanted medical device through a second network protocol.
  • At least one of the patient private key and a patient remote external device private key comprises a hardware key.
  • the private key device is at least one of, a smartcard, a key-ring device, a watch an arm or wrist band a neckless or any shaped device.
  • At least two of: the patient remote external device, the patient EID external device, the patient private key device, and the DDI are configured for wireless communication using a standard network protocol.
  • RECTIFIED SHEET (RULE 91) ISA/EP [000668] According to one embodiment, wherein at least two of: the patient remote external device, the patient EID external device, the patient private key device, and the DDI, are configured for wireless communication using a proprietary network protocol.
  • the patient EID external device is configured to use a first network protocol for communication with the implantable medical device and use a second network protocol for communication with the patient private key device.
  • the patient EID external device is configured to use a first frequency band for communication with the implantable medical device and use a second frequency band for communication with the patient private key device.
  • At least one of the patient remote external device, the patient EID external device, the patient private key device, and the DDI comprise a Bluetooth transceiver.
  • At least one of the patient remote external device, the patient EID external device, the patient private key device, and the DDI comprise an UWB transceiver.
  • the standard network protocol is one from the list of: Radio Frequency type protocol, RFID type protocol, WLAN type protocol, Bluetooth type protocol, BLE type protocol, NFC type protocol, 3G/4G/5G type protocol, and GSM type protocol.
  • the patient EID external device comprises a first wireless transceiver for wireless communication with the implantable medical device, and a second wireless transceiver for wireless communication with the patient private key device, and wherein the second wireless transceiver has longer effective range than the first wireless transceiver.
  • the second wireless transceiver has an effective range being one of: 2 times, 4 times, 8 time, 20 times, 50 times or 100 times longer than the effective range of the first wireless transceiver.
  • the second wireless transceiver is configured to be disabled to enable wireless communication using the first wireless transceiver.
  • the patient EID external device is a wearable patient external device or a handset.
  • the data encrypted by the implantable medical device is related to at least one of: a battery status, a temperature, a time, or an error.
  • the system comprises a master private key device configured to allow issuance of new private key device, wherein the HCP or HCP admin have such master private key device adapted to be able to replace and pair a new patient private key device or HCP private key device into the system, through the HCP EID external device.
  • the patient remote external device and the patient EID external device are an integrated unit.
  • the HCP dedicated device and the HCP EID external device are an integrated unit.
  • the system comprises a measurement device or sensor adapted to deliver a measurement to at least one of the DDI, patent EID external device and a patient display device.
  • the system comprises a food sensor, adapted to measure at least if the patient swallows solid food or is drinking fluid, wherein said food sensor is connected to the control unit of a medical device to cause an action to stretch the stomach after a determined amount of food intake.
  • the system comprises a master private key device that allow issuance of new private key device wherein the HCP or HCP admin have such master private key device adapted to be able to replace and pair a new patient private key device or HCP private key device into the system, through the HCP EID external device.
  • the patient remote external device and the patient EID external device are an integrated unit.
  • the HCP dedicated device and the HCP EID external device are an integrated unit.
  • the system further comprises a measurement device or sensor adapted to deliver a measurement to at least one of the DDI, patent EID external device and a patient display device.
  • the system further comprises a food sensor adapted to measure at least if the patient swallows solid food or is drinking fluid, wherein said food sensor is configured to be connected to the control unit of a medical device to cause an action to stretch the stomach after a determined amount of food intake.
  • the HCP EID external device further comprises a wireless transceiver configured for communication with the implanted medical device through a second network protocol.
  • the HCP private key device is adapted to be provided to the at least one HCP external device via at least one of: a reading slot or comparable for the HCP private key device, a RFID communication, and a close distance wireless activation communication unit, or electrical direct contact.
  • the HCP EID external device comprises at least one of: reading slot or comparable for the HCP private key device, a RFID communication, and a close distance wireless activation communication unit, or electrical direct contact.
  • the HCP EID external device is adapted to receive a command from an HCP dedicated device to change said pre-programmed treatment steps of the implantable medical device, when implanted, wherein the HCP dedicated device is further adapted to be activated, authenticated, and allowed to perform said command by the HCP providing their private key.
  • the HCP EID external device and the HCP private key device are configured for wireless communication using a standard network protocol.
  • the HCP EID external device and the HCP private key device are configured for wireless communication using a proprietary network protocol.
  • the HCP EID external device is configured to use a first network protocol for communication with the implantable medical device and use a second network protocol for communication with the HCP private key device.
  • the HPC EID external device is configured to use a first frequency band for communication with the implantable medical device and use a second frequency band for communication with the HCP private key device.
  • At least one of the HCP EID external device and the HCP private key device comprises a Bluetooth transceiver.
  • At least one of the HCP EID external device and the HCP private key device comprises a UWB transceiver.
  • the HCP private key device comprising a HCP private key, comprising at least one of: a smart card, a keyring device, a watch, an arm or wrist band, a necklace, and any shaped device.
  • the patient private key device comprises a patient private key, comprising at least one of: a smart card, a keyring device, a watch, an arm or wrist band, a necklace, and any shaped device.
  • the patient private key is adapted to activate, be authenticated, and allowed to perform said command provided by the HCP, either via the HCP EID external device or when the action is performed remotely via a patient EID external device.
  • the system further comprises a dedicated data infrastructure, DDI, the patient EID external device, and the HCP EID external device, wherein the communication between the patient EID external device and the HCP EID external device is performed via the DDI.
  • the system comprises a master private key device that allows issuance of new private key device wherein the HCP or HCP admin have such master private key device adapted to be able to replace and pair a new patient private key device or HCP private key device into the system.
  • the patient remote external device and the patient EID external device are an integrated unit.
  • the HCP dedicated device and the HCP EID external device are an integrated unit.
  • the system further comprises a measurement device or sensor adapted to deliver a measurement to at least one of the DDI, patent EID external device and patient display device.
  • the system comprises a food sensor, adapted to measure at least if the patient swallow solid food or is drinking fluid, wherein said food sensor is connected to
  • RECTIFIED SHEET (RULE 91) ISA/EP the control unit of a medical device to cause an action to stretch the stomach after a determined amount of food intake.
  • the HCP EID external device further comprises a wireless transceiver configured for communication with the implanted medical device through a second network protocol.
  • the HCP private key device is adapted to be provided to the at least one HCP external device via at least one of: a reading slot or comparable for the HCP private key device, a RFID communication, and a close distance wireless activation communication unit, or electrical direct contact.
  • the HCP EID external device comprises at least one of: reading slot or comparable for the HCP private key device, a RFID communication, and a close distance wireless activation communication unit, or electrical direct contact.
  • the HCP EID external device is adapted to receive a command from an HCP dedicated device to change said pre-programmed treatment steps of the implantable medical device, when implanted, wherein the HCP dedicated device is further adapted to be activated, authenticated, and allowed to perform said command by the HCP providing their private key.
  • the HCP EID external device and the HCP private key device are configured for wireless communication using a standard network protocol.
  • the HCP EID external device and the HCP private key device are configured for wireless communication using a proprietary network protocol.
  • the HCP EID external device is configured to use a first network protocol for communication with the implantable medical device and use a second network protocol for communication with the HCP private key device.
  • the HPC EID external device is configured to use a first frequency band for communication with the implantable medical device and use a second frequency band for communication with the HCP private key device.
  • At least one of the HCP EID external device and the HCP private key device comprises a Bluetooth transceiver.
  • At least one of the HCP EID external device and the HCP private key device comprises a UWB transceiver.
  • At least one of the patient private key device or HCP private key device comprises a hardware key.
  • the private key device is at least one of, a smartcard, a key-ring device, a watch an arm or wrist band a neckless or any shaped device.
  • the system comprises a master private key device that allow issuance of new private key device wherein the HCP or HCP admin have such master private key device adapted to be able to replace and pair a new patient private key device or HCP private key device into the system, through the HCP EID external device.
  • the patient remote external device and the patient EID external device is an integrated unit.
  • the HCP dedicated device and the HCP EID external device are an integrated unit.
  • the system comprises a measurement device or sensor adapted to deliver a measurement to at least one of the DDI, patent EID external device and a patient display device.
  • the system comprises a food sensor, adapted to measure at least if the patient swallow solid food or is drinking fluid, wherein said food sensor is connected to the control unit of a medical device to cause an action to stretch the stomach after a determined amount of food intake.
  • the HCP EID external device further comprises a wireless transceiver configured for communication with the implanted medical device through a second network protocol.
  • the HCP private key device is adapted to be provided to the at least one HCP external device via at least one of; a reading slot or comparable for the HCP private key device, a RFID communication, and a close distance wireless activation communication unit, or electrical direct contact.
  • the HCP EID external device comprises at least one of: reading slot or comparable for the HCP private key device, a RFID communication, and a close distance wireless activation communication unit, or electrical direct contact.
  • the HCP EID external device is adapted to receive a command from an HCP dedicated device to change said pre-programmed treatment steps of the implantable medical device, when implanted, wherein the HCP dedicated device is further adapted to be activated, authenticated, and allowed to perform said command by the HCP providing their private key.
  • the HCP EID external device and the HCP private key device are configured for wireless communication using a standard network protocol.
  • the HCP EID external device and the HCP private key device are configured for wireless communication using a proprietary network protocol.
  • the HCP EID external device is configured to use a first network protocol for communication with the implantable medical device and use a second network protocol for communication with the HCP private key device.
  • the HPC EID external device is configured to use a first frequency band for communication with the implantable medical device and use a second frequency band for communication with the HCP private key device.
  • At least one of the HCP EID external device and the HCP private key device comprises a Bluetooth transceiver.
  • At least one of the HCP EID external device and the HCP private key device comprises a UWB transceiver.
  • FIG. 1 shows an embodiment of an implantable pumping device for constricting a urinary bladder of a patient and for evacuating urine from the urinary bladder.
  • FIG. 2 shows an embodiment of an implantable pumping device for constricting a urinary bladder of a patient and for evacuating urine from the urinary bladder.
  • Fig. 3a-3c shows an embodiment of an implantable pumping device for constricting a urinary bladder of a patient and for evacuating urine from the urinary bladder.
  • Fig. 4a-4c shows an embodiment of an implantable pumping device for constricting a urinary bladder of a patient and for evacuating urine from the urinary bladder.
  • FIG. 5 shows an embodiment of an implantable pumping device for constricting a urinary bladder of a patient and for evacuating urine from the urinary bladder.
  • FIG. 6 shows an embodiment of an implantable pumping device for constricting a urinary bladder of a patient and for evacuating urine from the urinary bladder.
  • FIG. 7 shows an embodiment of an implantable pumping device for constricting a urinary bladder of a patient and for evacuating urine from the urinary bladder.
  • FIG. 8 shows an embodiment of an implantable pumping device for constricting a urinary bladder of a patient and for evacuating urine from the urinary bladder.
  • FIG. 9 shows an embodiment of an implantable pumping device comprising hydraulic constriction devices for constricting a urinary bladder of a patient and for evacuating urine from the urinary bladder.
  • Fig. 10 shows an embodiment of an implantable pumping device comprising hydraulic constriction devices for constricting a urinary bladder of a patient and for evacuating urine from the urinary bladder.
  • FIG. 11 shows an embodiment of an implantable pumping device comprising mechanical constriction devices for constricting a urinary bladder of a patient and for evacuating urine from the urinary bladder.
  • Fig. 12 shows an embodiment of an implantable pumping device comprising hydraulic constriction devices for constricting a urinary bladder of a patient and for evacuating urine from the urinary bladder.
  • FIG. 13 shows an embodiment of an implantable pumping device being a rotary peristaltic pump for constricting a urinary bladder of a patient and for evacuating urine from the urinary bladder.
  • Fig. 14 shows an embodiment of an implantable pumping device using electric stimulation for constricting a urinary bladder of a patient and for evacuating urine from the urinary bladder.
  • Fig. 15a shows an embodiment of an implantable constriction device for constricting the luminary organ of a patient, in an elevated view when being placed around the luminary organ.
  • Fig. 15b shows an embodiment of an implantable constriction device for constricting the luminary organ of a patient, in an elevated view when placed around the luminary organ.
  • Fig. 15c shows an embodiment of an implantable constriction device for constricting the luminary organ of a patient, in an elevated view when placed around the luminary organ, in the state when the implantable constriction device constricts the luminary organ.
  • Fig. 15d shows an embodiment of an implantable constriction device for constricting the luminary organ of a patient, in an elevated view when placed around the luminary organ, in the state when the implantable constriction device constricts the luminary organ.
  • Fig. 15e shows an embodiment of an implantable constriction device for constricting the luminary organ of a patient, in a cross-sectional view.
  • Fig. 15f shows an embodiment of an implantable pumping device for constricting the urinary bladder of a patient, in an elevated view when placed around the urinary bladder.
  • Fig. 16a shows an embodiment of an implantable constriction device for constricting the luminary organ of a patient, in an embodiment in which a portion of the surrounding structure is replaceable.
  • Fig. 16b shows an embodiment of a portion of the surrounding structure.
  • Fig. 16c shows an embodiment of a portion of the surrounding structure.
  • Fig. 16d shows an embodiment of a portion of the surrounding structure.
  • Fig. 16e shows an embodiment of a portion of the surrounding structure.
  • Fig. 16f shows an embodiment of an implantable constriction device for constricting the luminary organ of a patient, in an embodiment in which a portion of the surrounding structure is replaceable.
  • Fig. 17 shows an embodiment of an implantable pumping device for constricting the luminary organ of a patient in a sectional side view, in its constricted state.
  • Fig. 18 shows an embodiment of an implantable pumping device for constricting the luminary organ of a patient in a sectional side view, in its constricted state.
  • Fig. 19 shows an embodiment of an implantable pumping device for constricting the luminary organ of a patient in a sectional side view, in its constricted state.
  • Fig. 20 shows an embodiment of an implantable pumping device for constricting the luminary organ of a patient in a sectional side view, in its constricted state.
  • Fig. 21a shows an embodiment of an implantable constriction device for constricting the luminary organ of a patient in a sectional side view, in its un-constricted state.
  • Fig. 21b shows an embodiment of an implantable constriction device for constricting the luminary organ of a patient in a sectional side view, in its un-constricted state.
  • Fig. 21c shows an embodiment of an implantable constriction device for constricting the luminary organ of a patient in a sectional side view, in its un-constricted state..
  • Fig. 22a shows an embodiment of an implantable pumping device for constricting the luminary organ of a patient in a sectional side view, in its un-constricted state.
  • Fig. 22b shows an embodiment of an implantable pumping device for constricting the luminary organ of a patient in a sectional side view, in its constricted state.
  • Fig. 23a shows an embodiment of an implantable constriction device for constricting the luminary organ of a patient in a sectional view, in its constricted state.
  • Fig. 23b shows an embodiment of an implantable constriction device for constricting the luminary organ of a patient in a sectional view, in its un-constricted state.
  • Fig. 23c shows an embodiment of an implantable constriction device for constricting the luminary organ of a patient in a sectional view, in its constricted state.
  • Fig. 23d shows an embodiment of an implantable constriction device for constricting the luminary organ of a patient in a sectional view, in its constricted state.
  • Fig. 24a shows an embodiment of an implantable constriction device for constricting the luminary organ of a patient in a sectional view, in its constricted state.
  • Fig. 24b shows an embodiment of an implantable constriction device for constricting the luminary organ of a patient in a sectional view, in its un-constricted state.
  • Fig. 24c shows an embodiment of an implantable constriction device for constricting the luminary organ of a patient in a sectional view, in its constricted state.
  • Fig. 24d shows an embodiment of an implantable constriction device for constricting the luminary organ of a patient in a sectional view, in its constricted state.
  • Fig. 24e shows an embodiment of an implantable constriction device for constricting the luminary organ of a patient in a sectional view, in its un-constricted state.
  • Fig. 24f shows an embodiment of an implantable constriction device for constricting the luminary organ of a patient in a sectional view, in its un-constricted state.
  • Fig. 25 shows a cross-sectional view of an implantable energized medical device for powering an implantable medical device with hydraulic force.
  • Fig. 26 shows an exploded cross-sectional view of an implantable energized medical device for powering an implantable medical device with hydraulic force.
  • Fig. 27a shows a detailed cross-sectional view of a first unit of an implantable energized medical device for powering an implantable medical device with hydraulic force.
  • Fig. 27b shows a detailed cross-sectional view of a first unit of an implantable energized medical device for powering an implantable medical device with hydraulic force.
  • Fig. 27c shows a detailed cross-sectional view of a first unit of an implantable energized medical device for powering an implantable medical device with hydraulic force.
  • Fig. 27d shows a detailed cross-sectional view of a first unit of an implantable energized medical device for powering an implantable medical device with hydraulic force.
  • Figs. 28a-28b,29a-29b, 30a-30b show alternative embodiments of connecting portions for an implantable energized medical device.
  • Fig. 31 shows, schematically, a kit of components forming an implantable energized medical device.
  • FIG. 32 shows a detailed cross-sectional view of an embodiment of an implantable energized medical device for powering an implantable medical device.
  • Fig. 33 shows a perspective elevated view from the right of an embodiment of an implantable energized medical device for powering an implantable medical device.
  • Fig. 34 shows a perspective elevated view from the right of a portion of an embodiment of an implantable energized medical device for powering an implantable medical device.
  • Fig. 35 shows a perspective elevated view from the right of a portion of an embodiment of an implantable energized medical device for powering an implantable medical device.
  • Fig. 36a shows a cross-sectional plain side view of an embodiment of an implantable energized medical device for powering an implantable medical device.
  • Fig. 36b shows a cross-sectional plain side view of an embodiment of an implantable energized medical device for powering an implantable medical device.
  • Fig. 36c shows a cross-sectional plain side view of an embodiment of an implantable energized medical device for powering an implantable medical device.
  • Fig. 36d shows a cross-sectional plain side view of an embodiment of an implantable energized medical device for powering an implantable medical device.
  • Fig. 37a shows a perspective elevated view from the right of an embodiment of an implantable energized medical device for powering an implantable medical device.
  • Fig. 37b shows a perspective elevated view from the right of an embodiment of an implantable energized medical device for powering an implantable medical device.
  • Fig. 37c shows a perspective elevated view from the right of an embodiment of an implantable energized medical device for powering an implantable medical device.
  • Fig. 37d shows a perspective elevated view from the right of an embodiment of an implantable energized medical device for powering an implantable medical device.
  • Fig. 37a-k, 37m, 37n, 37p and 37q show perspective elevated views from the right of embodiments of an implantable energized medical device for powering an implantable medical device
  • Fig. 38 shows a perspective elevated view from the right of an embodiment of an implantable energized medical device for powering an implantable medical device.
  • Fig. 39 shows a plain top view of an embodiment of an implantable energized medical device for powering an implantable medical device.
  • Figs. 40 and 41 show, schematically, plain top views of two embodiments of implantable energized medical devices for powering implantable medical devices.
  • Figs. 42a - 42c illustrate three stages of insertion and fixation of an embodiment of an implantable energized medical device for powering an implantable medical device.
  • Fig. 43 shows a detailed cross-sectional view of an embodiment of an implantable energized medical device for powering an implantable medical device.
  • Fig. 44a shows, schematically, a portion of an implantable energized medical device for powering an implantable medical device.
  • Fig. 44b shows, schematically, a portion of an implantable energized medical device for powering an implantable medical device.
  • Fig. 44c shows, schematically, a portion of an implantable energized medical device for powering an implantable medical device.
  • Fig. 45a shows a frontal view of a human patient in cross section when a remotely powered medical device for actively stretching a stomach wall of a patient has been implanted.
  • Fig. 45b shows a frontal view of a human patient in cross section when a remotely powered medical device for affecting the flow of urine of a patient has been implanted.
  • Fig. 46a shows a plain view of an embodiment of a hydraulic pump for an implantable constriction device.
  • Fig. 46b shows a side view of the hydraulic pump of fig. 46a, for an implantable constriction device.
  • Fig. 47a shows a top view of a gear system for an implantable constriction device.
  • Fig. 47b shows a partially sectional side view of a gear system for an implantable constriction device.
  • Fig. 48 shows a sectional side view of an embodiment of a hydraulic pump for an implantable constriction device.
  • Fig. 49a shows a sectional side view of an embodiment of a hydraulic pump for an implantable constriction device.
  • Fig. 49b shows a partially sectional perspective view from the left of an embodiment of a hydraulic pump for an implantable constriction device.
  • Fig. 49c shows a partially sectional perspective view from the left of an embodiment of a hydraulic pump for an implantable constriction device.
  • Fig. 49d shows a partially sectional perspective view from the left of an embodiment of a hydraulic pump for an implantable constriction device.
  • Fig. 49e shows a partially sectional perspective view from the left of an embodiment of a hydraulic pump for an implantable constriction device.
  • Fig. 49f shows a partially sectional perspective view from the left of an embodiment of a hydraulic pump for an implantable constriction device.
  • Fig. 49g shows a partially sectional perspective view from the left of an embodiment of a hydraulic pump for an implantable constriction device.
  • Fig. 50 shows an elevated perspective view from the left of an embodiment of a hydraulic pump for an implantable constriction device.
  • Fig. 5 la shows an embodiment of a sensor for sensing the pressure in a hydraulic portion of the implantable constriction device.
  • Fig. 5 lb shows an embodiment of a sensor for sensing the pressure in a hydraulic portion of the implantable constriction device.
  • Fig. 52a shows an embodiment of an implantable constriction device in section, including an electrode arrangement for electrical stimulation, when placed on the luminary organ of a patient.
  • Fig. 52b shows an embodiment of an implantable constriction device for constricting the luminary organ of a patient in a sectional side view, including an electrode arrangement for electrical stimulation, in its constricted state.
  • Fig. 52c shows an embodiment of an implantable constriction device for constricting the luminary organ of a patient in a sectional side view, including an electrode arrangement for electrical stimulation, in its constricted state.
  • Fig. 52d shows an embodiment of an implantable constriction device for constricting the luminary organ of a patient in a sectional side view, including an electrode arrangement for electrical stimulation, in its constricted state.
  • Fig. 53a shows an embodiment of an electrode arrangement, for inclusion in an implantable constriction device.
  • Fig. 53b shows an embodiment of an electrode arrangement, for inclusion in an implantable constriction device.
  • Fig. 53c shows an embodiment of an electrode arrangement, for inclusion in an implantable constriction device.
  • Fig. 53d shows an embodiment of an electrode arrangement, for inclusion in an implantable constriction device.
  • Fig. 54 shows an embodiment of a stimulation cycle for electrical stimulation of a tissue wall.
  • Fig. 55 shows an embodiment of a stimulation cycle for electrical stimulation of a tissue wall.
  • Fig. 56 is a block diagram schematically describing the function of the system for electrical stimulation of a tissue wall of the patient.
  • Fig. 57a - 57n shows embodiments and describes various functions of an implantable controller for controlling the implantable medical device / implant and a system for communication between different external devices.
  • Fig. 58a-58c shows an embodiment of an implantable pumping device for constricting a urinary bladder of a patient and for evacuating urine from the urinary bladder.
  • Fig. 59a-59c shows an embodiment of an implantable pumping device for constricting a urinary bladder of a patient and for evacuating urine from the urinary bladder.
  • Fig. 60a-60c shows an embodiment of an implantable pumping device for constricting a urinary bladder of a patient and for evacuating urine from the urinary bladder.
  • Fig. 6 la-6 lb shows an embodiment of an implantable pumping device being a rotary peristaltic pump for constricting a urinary bladder of a patient and for evacuating urine from the urinary bladder.
  • Figs. 62a - 62c are flow charts describing various aspect of the surgical procedure required for implanting and testing the implantable constriction device.
  • Fig. 63a-63c shows what occurs in the body in case a blood vessel breaks.
  • Fig. 64 shows an implantable medical device with a blood clot forming.
  • Fig. 65a-65c shows the different steps of formation of a blood clot on an implantable medical device.
  • Fig. 66 discloses an implantable medical device with a coating configured to prevent fibrin formation.
  • Fig. 67 discloses an implantable medical device with a coating configured to prevent fibrin formation.
  • Fig. 68 discloses an implantable medical device with a coating configured to prevent fibrin formation.
  • Fig. 69a-69b shows examples of micropattem coatings that may be added to an implantable medical device in order to reduce fibrin formation.
  • Fig. 70a shows a perspective elevated view from the right of an embodiment of an implantable energized medical device for powering an implantable medical device.
  • Figs. 70b and 70c show lengthwise cross-sectional areas of the implantable medical device along the line A-A in Fig. 70a.
  • Figs. 71-73 show cross-sectional plain side views of embodiments of an implantable energized medical device for powering an implantable medical device.
  • Fig. 74a shows a perspective elevated view from the right of an embodiment of an implantable energized medical device for powering an implantable medical device
  • Figs. 74b and 74c show lengthwise cross-sectional areas of the implantable medical device along the line A-A in Fig. 74a.
  • Fig. 75a shows an elevated perspective view from the left of a housing unit.
  • Fig. 75b shows a plain view from the left of a housing unit.
  • Fig. 75c shows an elevated perspective view from the left of a housing unit.
  • Fig. 75d shows a plain view from the left of a housing unit.
  • Fig. 76 shows a system overview of an external device comprising a housing unit and a display device in wireless communication with an implanted medical device.
  • Restriction of the luminary organ is to be understood as any operation decreasing a cross- sectional area of the luminary organ.
  • the restriction may decrease the flow of matter in the lumen or may completely close the lumen such that no matter can pass.
  • a luminary organ is any organ in which a lumen can be formed.
  • the lumen can be formed to be fdled with a bodily fluid, another type of bodily tissue, or an implantable device or fluid.
  • luminary organs for the purpose of this application are: the urethra, the urinary bladder, the ureters, a blood vessel, an intestine (including the rectum), the bile duct, the vas deference or the oviducts.
  • the urinary bladder will be the prime example used in the text and figures, it is however clear that a similar pumping device could be manufactured for other luminary organs.
  • a controller is to be understood as any implantable unit capable of controlling the restriction device.
  • a controller could include a motor and/or pump or another operation device for operating the implantable hydraulic restriction device or could be separate from the operation device and only be adapted to control the operation thereof.
  • a control signal is to be understood as any signal capable of carrying information and/or electric power such that the restriction device can be directly or indirectly controlled.
  • Implantable operation device is to be understood as any device or system capable of operating an active implant.
  • An operation device could for example be an actuator such as a hydraulic actuator such as a hydraulic pump or a hydraulic cylinder, or a mechanical actuator, such as a mechanical element actuating an implant by pressing or pulling directly or indirectly on the implant, or an electromechanical actuator such as an electrical motor or solenoid directly or indirectly pressing or pulling on the implant.
  • a gear system is to be understood as any system capable of providing transmission such that work of a first form can be transmission into work of a second form.
  • the form of the work could for example include the velocity, the force and/or the direction of the work.
  • Inflatable is to be understood as possible to fill with a fluid, which may be a liquid, or gaseous fluid, or a plurality of solid structures suspended in a fluid, for the purpose of expanding the inner volume of a luminary device.
  • a fluid which may be a liquid, or gaseous fluid, or a plurality of solid structures suspended in a fluid, for the purpose of expanding the inner volume of a luminary device.
  • Fig. 1 shows a cross-sectional view of a female patient in which an implantable pumping device 10 for evacuating urine from the urinary bladder U has been implanted surrounding a distal portion of the urinary bladder U.
  • the implantable pumping device 10 is configured to first constrict a first portion (shown as Pl in fig. 3a) of the urinary bladder U more proximal and then constrict a second portion (shown as P2 in fig. 3a) of the urinary bladder U, more distal and downstream the first portion.
  • the implantable pumping device 10 evacuates urine by peristaltic movement of the urine in the urinary bladder U in a downstream direction towards the urethra.
  • FIG. 2 shows a cross-sectional view of a male patient in which the implantable pumping device 10 for evacuating urine from the urinary bladder U has been implanted surrounding a distal portion of the urinary bladder U.
  • the implantable pumping device 10 is configured to first constrict a first portion (shown as Pl in fig. 3a) of the urinary bladder U more proximal and then constrict a second portion (shown as P2 in fig. 3a) of the urinary bladder U, more distal and downstream the first portion.
  • the implantable pumping device 10 evacuates urine by peristaltic movement of the urine in the urinary bladder U in a downstream direction towards the urethra.
  • Figs. 3a-14 all show an implantable pumping device 10 according to different embodiment placed around a urinary bladder U of a patient.
  • the urinary bladder U is any other luminary organ where pumping may be needed to move a solid or liquid through or out from the luminary organ.
  • the urinary bladder U may be interchanged with an intestine of a patient and the pump may be configured to move and to evacuate the content of the intestine.
  • Fig. 3a shows an implantable pumping device 10 according to one embodiment when placed surrounding a first and second portion Pl, P2 of the urinary bladder U.
  • the implantable pumping device 10 is in its relaxed state and the urinary bladder U is substantially unconstricted.
  • the implantable pumping device is comprised of a support element 24, being a surrounding structure 20 surrounding the urinary bladder U.
  • the implantable pumping device 10 comprises a first constriction device configured to constrict the first portion Pl of the urinary bladder U for closing the first portion Pl of the urinary bladder U.
  • the implantable pumping device further comprises a second constriction device configured to constrict the second portion P2 of the urinary bladder U.
  • the second portion P2 is downstream the first portion Pl and the second constriction device is configured to constrict the second portion P2 for evacuating urine from the urinary bladder U when the first portion Pl of the urinary bladder is closed.
  • a first, second, third and fourth operable constriction element 101a’, 101a”, 101b’, 101b” are connected to and supported by the support element 24.
  • a first and second operable constriction element 101a’, 101a” are configured to constrict a first portion P 1 of the urinary bladder U and third and fourth operable constriction element 101b’, 101b” are configured to constrict a second portion P2 of the urinary bladder U.
  • the support element 24 comprises a curvature C adapted for the curvature of the urinary bladder U such that the implantable pumping device 10 fits snuggly around the urinary bladder U such that the distance that the operable constriction elements 101a’, 10 la”, 10 lb’, 10 lb” needs to expand to constrict the urinary bladder U is kept at a minimum.
  • the curvature C has a radius R of about 40mm.
  • the radius of the curvature C is anywhere in the range 15mm - 60mm.
  • the support element 24 is substantially rigid and has a modulus of elasticity (E), radially, in the range 0,2 GPa - 1000 GPa or in the range 1 GPa - 400 GPa.
  • E modulus of elasticity
  • the modulus of elasticity calculated as the elastic deformation of an area of the inner surface of the support element 24 causing an elongation in the radius at that area, when a force is applied to that area from the center of the support element 24.
  • the surrounding structure 20 has a major portion, i.e. a portion making up more than half of the periphery P of the surrounding structure
  • RECTIFIED SHEET (RULE 91) ISA/EP 20 having a modulus of elasticity (E), in the extension of the periphery P of the surrounding structure 20, in the range 0,2 GPa - 1000 GPa or in the range 1 GPa - 400 GPa.
  • E modulus of elasticity
  • the first and second constriction device 10a, 10b both comprise a first and a second constriction element 101a’, 101a”, 101b’, 101b”, wherein the first constriction element 101a’, 101b’ is configured to contact a first portion of the urinary bladder and the second constriction element 101a”, 101b” is configured to contact a second portion of the urinary bladder, such that the urinary bladder is constricted between the first and second constriction elements.
  • each constriction device may comprise more than two constriction elements.
  • the first and third constriction elements 101a’, 101b’ are configured to exert pressure on the urinary bladder U in a first direction to constrict the urinary bladder.
  • the second and fourth constriction elements 101a”, 101b” are configured to exert pressure on the urinary bladder U in a second direction to constrict the urinary bladder.
  • the second distance is substantially opposite to the first direction.
  • Fig. 3b shows the implantable pumping device 10 according to the embodiment described with reference to fig. 3a in a state in which the first and second operable constriction elements 10 la’, 10 la” of the first constriction device is constricting and closing the first portion Pl of the urinary bladder U for restricting the passage of urine through the portion Pl, both in an upstream and downstream direction.
  • the first and second constriction element 101a’, 101a” of the first constriction device expands towards the center of the surrounding structure 20 formed by the support element 24, withholding force from the support element 24.
  • the first and second operable constriction element 10 la’, 10 la” of the first constriction device has rounded surfaces in both an upward and downward direction which reduces the risk that the constriction elements 10 la’, 10 la” damages the tissue of the urinary bladder U.
  • Fig. 3c shows the implantable pumping device 10 according to the embodiment described with reference to figs. 3a and 3b in a state in which the third and fourth operable constriction elements 101b’, 101b” of the second constriction device is constricting the second portion P2 of the urinary bladder U for pumping urine downstream by evacuating the urine present in the second portion P2 of the urinary bladder U.
  • the second and third operable constriction element 101b’, 101b” of the second constriction device has rounded surfaces in both an upward and downward direction which reduces the risk that the constriction elements 101b’, 101b” damages the tissue of the urinary bladder U.
  • a major portion of the support element 24 is made from a rigid material, and a major portion of the operable constriction elements 101a’, 101a”, 101b’, 101b” are made from a resilient material, and the resilient material is more than 2 times as elastic as the rigid material.
  • the embodiments shown in figs. 3a-3c may also comprise a controller configured to control the first and second constriction device in order to evacuate urine from the urinary bladder U of a patient.
  • Fig. 4a shows an implantable pumping device 10 according to one embodiment when placed surrounding a first Pl, a second P2, a third P3 and a fourth portion P4 of the urinary bladder U.
  • the implantable pumping device 10 is in its relaxed state and the urinary bladder U is substantially un-constricted.
  • the implantable pumping device is comprised of support element 24, being a surrounding structure 20 surrounding the urinary bladder U.
  • the implantable pumping device 10 comprises a first constriction device configured to constrict the first portion Pl of the urinary bladder U for closing the first portion Pl of the urinary bladder U.
  • the implantable pumping device further comprises a second constriction device configured to constrict the second portion P2 of the urinary bladder U.
  • the second portion P2 is downstream the first portion Pl and the second constriction device is configured to constrict the second portion P2 for evacuating urine from the urinary bladder U when the first portion Pl of the urinary bladder is closed.
  • the second constriction device comprises a plurality of constrictions elements configured to sequentially constrict the urinary bladder U for evacuating urine from the urinary bladder U.
  • a first, second, third, fourth, fifth, seventh and eighth operable constriction element 101a’, 101a”, 101b’, 101b”, 101c’, 101c”, 101d’,101d” are connected to and supported by the support element 24.
  • a first and second operable constriction element 101a’, 101a” are configured to constrict a first portion Pl of the urinary bladder U and third and fourth operable constriction element 101b’, 101b” are configured to constrict a second portion P2 of the urinary bladder U.
  • a fifth and sixth operable constriction element 101c’, 101c” are configured to constrict a third portion P3 of the urinary bladder U and a seventh and eighth operable constriction element 10 Id’, 10 Id” are configured to constrict a fourth portion P4 of the urinary bladder U.
  • the support element 24 comprises a curvature C adapted for the curvature of the urinary bladder U such that the implantable pumping device 10 fits snuggly around the urinary bladder U such that the distance that the operable constriction elements 101a’, 101a”, 101b’, 101b” needs to expand to constrict the urinary bladder U is kept at a minimum.
  • the curvature C has a radius R of about 40mm.
  • the radius of the curvature C is anywhere in the range 15mm - 60mm.
  • the support element 24 is substantially rigid and has a modulus of elasticity (E), radially, in the range 0,2 GPa - 1000 GPa or in the range 1 GPa - 400 GPa. I.e. the modulus of elasticity calculated as the elastic deformation of an area of the inner surface of the support element 24 causing an elongation in the radius at that area, when a force is applied to that area from the center of the support element 24.
  • the surrounding structure 20 has a major portion, i.e.
  • Fig. 4b shows the implantable pumping device 10 according to the embodiment described with reference to fig. 4a in a state in which the first and second operable constriction
  • ISA/EP elements 10 la’, 10 la” of the first constriction device is constricting and closing the first portion Pl of the urinary bladder U for restricting the passage of urine through the portion Pl, both in an upstream and downstream direction.
  • the first and second constriction element 101a’, 101a” of the first constriction device expands towards the center of the surrounding structure 20 formed by the support element 24, withholding force from the support element 24.
  • the first and second operable constriction element 10 la’, 10 la” of the first constriction device has rounded surfaces in both an upward and downward direction which reduces the risk that the constriction elements 10 la’, 10 la” damages the tissue of the urinary bladder U.
  • Fig. 4c shows the implantable pumping device 10 according to the embodiment described with reference to figs. 4a and 4b in a state in which the third, fourth, fifth, sixth, seventh and eighth operable constriction elements 101b’, 101b”, 101c’, 101c”, 10 Id’, 10 Id” are at least partially constricting the urinary bladder U.
  • the third and fourth operable constriction elements 101b’, 101b” may be configured to constrict the second portion P2 after the first and second operable constriction elements 101a’, 101a” constricts the first portion Pl but before the fifth and sixth operable constriction elements 101c’, 101c” constricts the third portion P3.
  • the seventh and eighth operable constriction elements 10 Id’ , 10 Id” may be configured to constrict the fourth portion P4 of the urinary bladder U after the fifth and sixth operable constriction elements 101c’, 101c” have constricted the third portion P3 of the urinary bladder U. Allowing the implantable pumping device 10 to sequentially constrict the urinary bladder U may ensure that no urine is trapped in any of the portions P1,P2,P3,P4 and thusly ensure a smooth and safe pumping of the urine out of the urinary bladder U.
  • Fig. 5 shows an implantable pumping device 10 according to one embodiment when placed surrounding a first Pl and second portion P2 of the urinary bladder U.
  • the embodiment in fig. 5 resembles the embodiment in fig. 3a and may comprise any feature that is brought up with reference to fig. 3a.
  • the implantable pumping device 10 is in a partially relaxed state and the urinary bladder U is substantially un-constricted.
  • the implantable pumping device is comprised of a support element 24, being a surrounding structure 20 surrounding the urinary bladder U.
  • the implantable pumping device 10 comprises a first constriction device configured to constrict the first portion P 1 of the urinary bladder U for closing the first portion P 1 of the urinary bladder U.
  • the implantable pumping device further comprises a second constriction device configured to constrict the second portion P2 of the urinary bladder U.
  • the second portion P2 is downstream the first portion P 1 and the second constriction device is configured to constrict the second portion P2 for evacuating urine from the urinary bladder U when the first portion Pl of the urinary bladder is closed.
  • a first and second operable constriction element 101a and 101b are connected to and supported by the support element 24.
  • the first operable constriction element 101a is configured to constrict the first portion Pl of the urinary bladder U together with at least one abutment configured to contact at least a portion of the first portion P 1 and for withholding the force from the first operable constriction element 101a.
  • the second operable constriction element 101b is configured to constrict the second portion P2 of the urinary bladder U together with at least one abutment configured to contact at least a portion of the second portion P2 and for withholding the force from the second operable constriction element 101b.
  • RECTIFIED SHEET (RULE 91) ISA/EP
  • the abutments configured to withhold the force from the operable constriction elements 10 la, 10 lb may be part of the support element 24.
  • the embodiment shown in fig. 5 may comprise a urethra contacting element in the form of a cushioning element 30 which is more resilient than the support element 24b and thereby provides a less damaging contacting surface against the urethra U, such that damage to the urethra U is minimized.
  • Fig. 6 shows an implantable pumping device 10 according to one embodiment when placed surrounding a first Pl, a second P2, a third P3 and a fourth portion P4 of the urinary bladder U.
  • the embodiment shown in fig. 6 resembles the embodiment of fig. 5.
  • the second constriction device comprises a plurality of operable constriction elements 10 lb, 101c, 10 Id configured to sequentially constrict the urinary bladder for evacuating urine from the urinary bladder.
  • the first operable constriction element 101a is configured to constrict the first portion Pl of the urinary bladder U together with at least one abutment configured to contact at least a portion of the first portion P 1 and for withholding the force from the first operable constriction element 101a.
  • the second, third and fourth operable constriction element 101b, 101c, 10 Id are configured to constrict the urinary bladder U together with at least one abutment configured to contact at least a portion of the urinary bladder U and for withholding the force from the second, third and fourth operable constriction elements 101b, 101c, 10 Id for evacuating urine from the urinary bladder.
  • the operable constriction elements 10 la, 10 lb, 101c, 10 Id may be configured to constrict the urinary bladder U in sequence so that no urine is trapped between the operable constriction elements 101a, 101b, 101c, 10 Id.
  • Fig. 7 shows an implantable pumping device 10 according to one embodiment when placed surrounding a first and a second portion Pl, P2 of the urinary bladder U.
  • the embodiment shown in fig.7 resembles the embodiment of fig. 3a-3c and may comprise any features presented in relation to these features.
  • the first, second, third and fourth operable constriction elements 101 a’, 101 a”, 101b’, 101b” of the first and second constriction device are constricting the first and second portion Pl, P2 of the urinary bladder U.
  • the first constriction device comprises a first curvature Cl having a first radius R1 adapted for a curvature of the urinary bladder U.
  • the second constriction device comprises a second curvature C2 having a second radius R2 adapted for a curvature of the urinary bladder U.
  • the first radius R1 is smaller than the second radius R2. This may be beneficial since the implantable pumping device 10 is tilted an angle a.
  • the urinary bladder U may not be straight but may instead have a tapered shape, an implantable pumping device 10 comprising a tapered shape may then provide a snugger fit.
  • the first and second constriction device may then be closer to the wall of the urinary bladder U and may therefore not have to be moved an unnecessary distance in order to constrict the urinary bladder U in order to evacuate urine.
  • Fig. 8 shows an implantable pumping device 10 according to one embodiment when placed surrounding a first Pl, a second P2, a third P3 and a fourth portion P4 of the urinary bladder U.
  • the embodiment in fig. 8 resembles the embodiment of fig. 7 but the second constriction device comprises a plurality of operable constriction elements 101b’, 101b”, 101c’, 101c”, 101d’,101d” configured to sequentially constrict the urinary bladder for evacuating urine from the urinary bladder U.
  • the embodiment of fig. 8 may have a tapered shape and the implantable pumping device 10 may be tilted an angle a.
  • Fig. 9 shows an implantable pumping device 10 according to one embodiment where at least one of the first and second constriction device is a hydraulic constriction device.
  • the first and second constriction devices comprises operable hydraulic constriction elements 101 a’, 101 a”, 101b’, 101b” for constricting the urinary bladder U.
  • the implantable pumping device 10 may comprise at least one fluid conduit at least partially integrated in the support element.
  • the fluid conduit may allow the first and second constriction device to constrict the urinary bladder U in order to evacuate urine from the urinary bladder U.
  • the embodiment of fig. 9 comprises a first, second, third and fourth fluid conduit 109a’, 109a”, 109b ’,109b” at least partially integrated in the support element 24.
  • the first, second, third and fourth fluid conduits 109a’, 109a”, 109b ’,109b” may be configured such that a fluid can flow through the at least partially integrated fluid conduit 109a’, 109a”, 109b ’,109b” into the operable hydraulic constriction elements 101a’, 101a”, 101b’, 101b” for constricting the urinary bladder U.
  • Fig. 10 shows an implantable pumping device 10 according to an embodiment and similar to the embodiment in fig. 9.
  • the first and second constriction devices are hydraulic constriction devices.
  • the first and second constriction devices comprises operable hydraulic constriction elements 101a’, 101a”, 101b’, 101b”, 101c’, 101c”, 10 Id’, 10 Id” for constricting the urinary bladder U.
  • the second constriction device comprises a plurality of operable hydraulic constriction elements 101b’, 101b”, 101c’, 101c”, 101d’, lOld” to sequentially constrict the urinary bladder for evacuating urine from the urinary bladder U.
  • 10 comprises a first, second, third, fourth, fifth, sixth, seventh and eighth fluid conduit 109a’, 109a”, 109b’, 109b”, 109c’, 109c”, 109d’, 109d” at least partially integrated in the support element 24.
  • the first, second, third and fourth fluid conduits 109a’, 109a”, 109b’, 109b”, 109c’, 109c”, 109d’, 109d” may be configured such that a fluid can flow through the at least partially integrated fluid conduit 109a’, 109a”, 109b’, 109b”, 109c’, 109c”, 109d’, 109d” into the operable hydraulic constriction elements 101a’, 101a”, 101b’, 101b”, 101c’, 101c”, 101d’, lOld” for constricting the urinary bladder U.
  • Fig. 11 shows an implantable pumping device 10 according to an embodiment where the first and second constriction device are mechanical constriction devices. It is however possible that in some embodiment only one of first and second constriction device is a mechanical constriction device, and the remaining constriction device is a hydraulic constriction device, or any other type of constriction device discussed throughout this application.
  • the embodiment of the implantable pumping device 10 disclosed in fig. 11 comprises a first mechanical constriction device 10a comprising a first operable mechanical constriction element 101a’ and a second operable mechanical constriction element 101a” configured to constrict a first portion Pl of the urinary bladder U.
  • the first and second operable mechanical constriction elements 101a’ and 101a” each comprises an electric motor Ma’. Ma”, a screw 701a’, 701a” and a plate 702a’, 702a”.
  • the electric motor M is configured to turn the screw 701 in order to push the plate 702 toward the urinary bladder U in order to constrict the urinary bladder U. Downstream the first
  • a second mechanical constriction device 10b is located configured to constrict a second portion of the urinary bladder U and to evacuate urine from the urinary bladder U. Similar to the first mechanical constriction device 10a, the second mechanical constriction device 10b comprises two operable mechanical constriction elements 101b’, 101b”. The two operable mechanical constriction elements 101b’, 101b” each comprises an electrical motor Mb’, Mb”, a screw 701b’, 701b” and a plate 702b’, 702b”. The second constriction device 10b is configured to constrict the urinary bladder U after the first constriction device 10a has constricted the urinary bladder U.
  • the second mechanical constriction device 10b may be larger than the first mechanical constriction device 10a. It is also conceivable that at least one of the first and the second mechanical constriction devices 10a, 10b comprises more or fewer mechanical constriction elements than discloses in fig. 11. As an example, fig. 12 is provided.
  • Fig. 12 shows an implantable pumping device 10 according to an embodiment similar to the embodiment shown in fig. 11. However, in fig. 12 the implantable pumping device 10 comprises a second mechanical constriction device 10b comprising more than two mechanical constriction elements.
  • the second mechanical constriction device 10b comprises a third, fourth, fifth, sixth, seventh and eight mechanical constriction element 101b’, 101b”, 101c’, 101c”, 101d’, 10 Id”.
  • the mechanical constriction elements 101a’, 101a”, 101b’, 101b”, 101c’, 101c”, 101c”, 101d’, lOld” ofboth the first and second mechanical constriction device 10a, 10b each comprise an electrical motor Ma’, Ma”, Mb’, Mb”, Me’, Me”, Md, Md”, a screw 701a’, 701a”, 701b’, 701b”, 701c’, 701c”,701d’,701d” and a plate 702a’, 702a”, 702b’, 702b”, 702c’, 702c”, 702d’, 702d”.
  • the plate 702 is configured to be moved the screw 701 in order to constrict the urinary bladder U. In this way the implantable pumping device can move the urine from the urinary bladder U and forward through the urethra.
  • Fig. 13 shows an implantable pumping device 10 according to an embodiment of the present invention.
  • the implantable pumping device 10 is a rotary peristaltic pump 10 that is applied to the urinary bladder U of a patient.
  • the rotary peristaltic pump 10 includes a rotor 200 carrying a constriction device 10a in the form of three cylindrical constriction elements 101a, 101b and 101c positioned equidistantly from the axis 23 of the rotor 200.
  • the constriction elements 101 a- 101c may be designed as rollers.
  • a stationary elongate support element 24 is positioned spaced from but close to the rotor 200 and has a part cylindrical surface 25 concentric with the axis 23 of the rotor 200.
  • the pump 10 is applied on the urinary bladder U, so that the urinary bladder U extends between the support element 24 and the rotor 200.
  • the implantable pumping device 10 may also comprise a control device that controls the rotor 200 to rotate so that the constriction elements 101 a- 101c successively constricts portions of a series of selected portions of the urinary bladder U against the elongate support element 24.
  • the constriction element 22A constricts the urinary bladder U at a first portion P 1.
  • the third constriction element 101c will engage the urinary bladder U and force urine from the bladder to be pushed down and to be evacuated.
  • a control device can therefore control the rotor 20 to cyclically move the constriction elements 101 a- 101c one after the other
  • RECTIFIED SHEET (RULE 91) ISA/EP along the elongate support element 24 while constricting the selected portions of urinary bladder U, so that urine in the urinary bladder U is displaced in a peristaltic manner.
  • the same constriction principle may also be practiced by other mechanical constriction devices that do not include a rotor. Further features of an implantable pumping device 10 of the sort disclosed with regards to Fig. 13 can be found in relation to Figs. 61a and 61b.
  • the implantable pumping device 10 may be used in combination with any other pumping device or constriction device described within this application.
  • a constriction device may be placed upstream an implantable pumping device 10 according to Fig. 13.
  • the constriction device may be configured to constrict a part of the luminary organ, for example a urinary bladder, and then the implantable pumping device 10 may be configured to evacuate the urine from the urinary bladder that is located downstream the constriction device.
  • Fig. 14 shows an implantable pumping device 10 according to an embodiment of the present invention.
  • the implantable pumping device 10 is configured to constrict and evacuate urine from the urinary bladder U but here the first constriction device 10a and the second constriction device 10b are constriction devices configured to constrict by electrically stimulating at least one tissue wall of the urinary bladder U.
  • the first constriction device 10a may be configured to stimulate a first portion of the urinary bladder U in order to constrict the urinary bladder U so that urine cannot pass.
  • the second constriction device 10b may be configured to stimulate a second portion of the urinary bladder U after the first constriction device has stimulated the first portion of the urinary bladder in order to constrict the urinary bladder U and thusly force the urine to be evacuated from the urinary bladder U.
  • Further features of an implantable pump of this sort can be found in relation to other figures, for example figure 59.
  • the implantable pumping device 10 of Fig. 14 may also comprise a cancellation unit configured to be placed downstream the second portion.
  • the cancellation unit may be configured to cancel the electrical stimulation such that the urinary sphincter remains substantially unaffected by the electrical stimulation.
  • the electrodes or electrode arrangement of the constriction devices 10a, 10b in Fig. 14 may also be configured to engage and electrically stimulate the muscle tissue of the urinary bladder U to exercise the muscle tissue to improve the conditions for long term implantation of the implantable pumping device 10.
  • Such an electrode arrangements may also be present in any one of the embodiments described in relation to Figs. 1-13.
  • the first constriction device 10a may be configured to constrict a first portion of the urinary bladder U extending a first distance axially in the direction of the flow of urine.
  • the second constriction device may be configured to constrict a second portion of the urinary bladder U extending a second distance axially in the direction of the flow of urine.
  • the second distance may be at least two times as long as the first distance.
  • the first constriction device 10a may constrict the urinary bladder U in order to restrict the flow of urine.
  • the second constriction device may then be used in order to constrict the second portion of the urinary bladder U for evacuating urine from the urinary bladder U.
  • ISA/EP second constriction device 10b are also plausible. However, it is advantageous that the second portion P2 being constricted by the second constriction device 10b is larger than the first portion Pl in order to evacuate more urine from the urinary bladder.
  • the second portion P2 may also be constricted by many constriction elements as described for example in relation to figure 4,6,8,10, 12.
  • Figs 15a-15e discloses an embodiment of a first constriction device 10a placed around a luminary organ U.
  • the luminary organ U is a generic luminary organ, however for the following text it will be referred to as a urinary bladder U for clarity.
  • the embodiment disclosed in Figs. 15a-15e may be part of an implantable pumping device 10 configured to evacuate urine from a urinary bladder U.
  • the first constriction device 10a is arranged around another luminary organ for constricting the luminary organ.
  • An implantable pumping device for evacuating urine from the urinary bladder U of a patient may comprise at least two constriction devices as disclosed in figs. 15a-15e.
  • Such an implantable pumping device may comprise a first constriction device 10a configured to constrict a portion of the urinary bladder U for closing a first portion p 1 of the urinary bladder.
  • Such an implantable pumping device may further comprise a second constriction device 10b similar to the first constriction device but not necessarily identical.
  • the second constriction device may be configured to constrict a second portion p2 of the urinary bladder U, downstream the first portion pl, for evacuating urine from the urinary bladder U when the first portion of the urinary bladder U is closed.
  • the first constriction device 10a may be configured to constrict a first portion of the urinary bladder U extending a first distance axially in the direction of the flow of urine.
  • the second constriction device may be configured to constrict a second portion of the urinary bladder U extending a second distance axially in the direction of the flow of urine.
  • the second distance may be at least two times as long as the first distance.
  • the first constriction device 10a may constrict the urinary bladder U in order to restrict the flow of urine.
  • the second constriction device may then be used in order to constrict the second portion of the urinary bladder U for evacuating urine from the urinary bladder U.
  • the implantable pumping device may also comprise a controller configured to control the first and second constriction devices. It is also conceivable that the first and second constriction devices share a surrounding structure. As an example, the embodiment in fig. 15f is provided.
  • Fig. 15a shows an embodiment of a first constriction device 10a configured to constrict a portion of the urinary bladder U for closing a first portion of the urinary bladder U of a patient.
  • the first constriction device 10a may be part of an implantable pumping device, for example as disclosed in relation to fig. 3a-3c or 9, and comprises a surrounding structure having a periphery surrounding the urinary bladder U when implanted.
  • the surrounding structure comprises two support elements 24a, 24b connected to each other for forming the surrounding structure.
  • the first support element 24a is configured to support a first operable hydraulic constriction element 101a’ and a third operable hydraulic constriction element 101a’”.
  • the second support element 24b is configured to support a second operable hydraulic constriction element 101a” and a fourth operable hydraulic constriction element 101a””.
  • RECTIFIED SHEET (RULE 91) ISA/EP 101a”, 101a’” and 101a” are configured to constrict the urinary bladder U for restricting the flow of fluid therethrough and configured to release the constriction of the urinary bladder U.
  • the first and second support elements 24a, 24b each comprises a curvature C adapted for the curvature of the urinary bladder U such that the implantable pumping device 10 fits snuggly around the urinary bladder U such that the distance that the operable hydraulic constriction elements 101a’, 101a” needs to expand to constrict the urinary bladder U is kept at a minimum .
  • the curvature C has a radius R of about 40mm.
  • the radius R of the curvature C is anywhere in the range 15mm - 60mm.
  • the first and second support elements 24a, 24b are hingedly connected to each other such that a periphery of the surrounding structure is possible to open, such that the surrounding structure can be placed around the urinary bladder U.
  • a first end of the first and second support elements 24a, 24b comprises a hinge 26, whereas the other ends of the first and second support elements 24a, 24b comprises portions of a locking member 27’, 27” which are configured to be interconnected to lock the surrounding structure around the urinary bladder U.
  • a locking member 27’, 27 which are configured to be interconnected to lock the surrounding structure around the urinary bladder U.
  • the locking ends of the first and second support elements 24a, 24b comprises portions of locking members 27’, 27” each comprising protruding snap-lock locking members 27’, 27” materially integrated in the first second support elements 24a, 24b and configured to be snapped together for closing the periphery of the surrounding structure, such that the surrounding structure completely encircles the urinary bladder U.
  • each of the first and second support elements 24a, 24b comprises fluid conduits 109a’, 109a”, 109a’”, 109a”” partially integrated in the support elements 24a, 24b.
  • a first conduit 109a’ comprises a first portion in the form of a first tubing which enters a tubing fixation portion 25a fixated to, or materially integrated with, the first support element 24a.
  • the fluid conduit 109a’ is transferred into a first integrated channel 23a in the first support element 24a.
  • the first integrated channel 23a is drilled, milled or casted into the material of the first support element 24a.
  • the first support element 24a comprises an inner surface 28a which is directed towards the urinary bladder U, when the implantable pumping device 10 is implanted.
  • the inner surface 28a of the first support element 24a comprises a fixation surface for fixating the first and third operable hydraulic constriction elements 101a’, 101a’”.
  • the fixation surface also comprises an outlet from the first integrated channel 23a into the first operable hydraulic constriction element 101a’, such that fluid can be transferred from the first tubing to the first integrated channel 23a and into the first operable hydraulic constriction element 101a’ for expanding the first operable hydraulic constriction element 101a’.
  • a second tubing of the third fluid conduit 109a’” also enters the tubing fixation portion 25a fixated to, or materially integrated with, the first support element 24a.
  • the third fluid conduit 109a’” is transferred into a second integrated channel 23b in the first support element 24a.
  • the second integrated channel 23b is also drilled, milled or casted into the material of the first support element 24a.
  • the fixation surface also comprises an outlet from the second integrated channel 23b into the third operable hydraulic constriction element 101a’”, such that fluid can be transferred from the second
  • a second conduit 109a” comprises a first portion in the form of a third tubing which enters a tubing fixation portion 25b fixated to, or materially integrated with, the second support element 24b.
  • the fluid conduit 109a” is transferred into a third integrated channel 23c in the second support element 24b.
  • the third integrated channel 23c is drilled, milled or casted into the material of the second support element 24b.
  • the second support element 24b comprises an inner surface 28b which is directed towards the urinary bladder U, when the implantable pumping device 10 is implanted.
  • the inner surface 28b of the second support element 24b comprises a fixation surface for fixating the second and fourth operable hydraulic constriction elements 101a”, 101a””.
  • the fixation surface also comprises an outlet from the third integrated channel 23c into the second operable hydraulic constriction element 101a”, such that fluid can be transferred from the first tubing to the third integrated channel 23c and into the second operable hydraulic constriction element 101a” for expanding the second operable hydraulic constriction element 101a”.
  • a tubing portion of the fourth fluid conduit 109a”” also enters the tubing fixation portion 25b fixated to, or materially integrated with, the second support element 24b. In the tubing fixation portion 25b the fourth fluid conduit 109a”” is transferred into a fourth integrated channel 23d in the second support element 24b.
  • the fourth integrated channel 23d is also drilled, milled or casted into the material of the second support element 24b.
  • the fixation surface also comprises an outlet from the fourth integrated channel 23d into the fourth operable hydraulic constriction element 101a””, such that fluid can be transferred from the fourth tubing to the fourth integrated channel 23d and into the fourth operable hydraulic constriction element 101a”” for expanding the fourth operable hydraulic constriction element 101a””.
  • the tubing portion of the fluid conduits 109a’, 109a”, 109a’”, 109a”” is preferably made from a biocompatible material such as silicone and/or polyurethane.
  • Integrating the fluid conduit(s) in the support element(s) enables the fluid entry to the operable hydraulic constriction elements 101a’, 101a”, 101a’”, 101a”” to be protected and encapsulated by the support element(s) which reduces the space occupied by the operable hydraulic constriction element 10 and reduces the amount of protruding portions thus reducing the risk of damaging the urinary bladder U.
  • the first constriction device 10a shown in fig. 15a may correspond to part of an implantable pumping device 10 for evacuating urine from the urinary bladder as disclosed throughout this application.
  • the implantable pumping device may also include a second constriction device similar to the one disclosed in fig. 15a-15e.
  • the second constriction device may be arranged downstream the first portion, i.e. downstream the first constriction device 10a, and be configured for evacuating urine from the urinary bladder when the first portion of the urinary bladder is closed.
  • a second constriction device similar to the first constriction device 10a may be incorporated into the same support structure 24 or an individual support structure placed adjacent the support structure 24 shown in fig. 15a-15e.
  • Fig. 15b shows the first constriction device 10a of the embodiment shown in fig. 15a when the first and second support elements have been connected and closed such that a periphery P of the surrounding structure 20 surrounds a cross section of the urinary bladder U perpendicularly in relation to the axial direction of the urinary bladder U.
  • the locking member 27 has been closed and locked.
  • the implantable pumping device 10 is illustrated in its open, unrestricted state, i.e. the state in which the implantable pumping device 10 is placed when allowing a flow from the urinary bladder U.
  • the first operable hydraulic constriction element 101a’ and the second operable hydraulic constriction element 101a” is deflated for providing room for the urinary bladder U, while the third and fourth operable hydraulic constriction elements 101a’”, 101a”” are inflated for assisting the urinary bladder U assuming its normal substantially circular cross section.
  • hydraulic fluid is pumped from the first and second operable hydraulic constriction element 101a’, 101a” via the fluid conduits 109a’, 109a” and hydraulic fluid is pumped into the second and fourth operable hydraulic constriction elements I01b, 10 Id.
  • the first and third operable hydraulic constriction element 10 la’, 10 la’” may be connected to a shared first hydraulic system, such that the hydraulic fluid can be pumped from the first operable hydraulic constriction element 101a’ to the third operable hydraulic constriction element 101a’” for releasing the constriction of the urinary bladder U for restoring the flow of fluid therethrough, and pumped from the third operable hydraulic constriction element 101a’” to the first operable hydraulic constriction element 101a’ for constricting the urinary bladder U and restricting the flow of fluid therethrough.
  • the second and fourth operable hydraulic constriction element 101a”, 101a”” may be connected to a shared second hydraulic system, such that the hydraulic fluid can be pumped from the second operable hydraulic constriction element 101a” to the fourth operable hydraulic constriction element 101a”” for releasing the constriction of the urinary bladder U for restoring the flow of fluid therethrough, and pumped from the fourth operable hydraulic constriction element 101a”” to the second operable hydraulic constriction element 101a” for constricting the urinary bladder U and restricting the flow of fluid therethrough.
  • the shared first and second hydraulic systems may be separate from each other and thus without fluid communication.
  • the advantage of having the first and second operable hydraulic constriction element 101a’, 101a” connected to separate hydraulic systems is that the first and second operable hydraulic constriction element 101a’, 101a” may be filled the same amount of hydraulic fluid irrespective of the amount of resistance from the urinary bladder U that the respective first and second operable hydraulic constriction element 101a’, 101a” encounters. This means that the urinary bladder U will always be centered in the first construction device, and thus in the implantable pumping device 10, which reduced the risk of tissue damage to the urinary bladder U.
  • the first, second, third and fourth operable hydraulic constriction element 101a’, 101a”, 101a’”, 101a”” may be connected to a shared hydraulic system, such that the hydraulic fluid can be
  • RECTIFIED SHEET (RULE 91) ISA/EP pumped from the first and second operable hydraulic constriction element 101a’, 101a” to the third and fourth operable hydraulic constriction element 101a’”, 101a”” for releasing the constriction of the urinary bladder U for restoring the flow of fluid therethrough, and pumped from the third and fourth operable hydraulic constriction element 101a’”, 101a”” to the first and second operable hydraulic constriction element 101a’, 101a” for constricting the urinary bladder U and restricting the flow of fluid therethrough.
  • the first and second operable hydraulic constriction element 101a’, 101a” have smaller volumes than the third and fourth operable hydraulic constriction element 101a’”, 101a””.
  • the first and second operable hydraulic constriction element 101a’, 101a” have a volume which is more than 1.5 times as large as the volume of the third and fourth operable hydraulic constriction element 101a’”, 101a””, however it is also conceivable that the first and second operable hydraulic constriction element 101a’, 101a” have a volume which is more than 2 times as large as the volume of the third and fourth operable hydraulic constriction element 101a’”, 101a””.
  • An implantable pumping device may include a first constriction device 10a according to the embodiment shown in fig. 15a-15e.
  • the implantable pumping device may further comprise a second constriction device according to the embodiment shown in fig. 15a-15e placed adjacent the first constriction device 10a.
  • the first constriction device 10a may be configured to constrict a first portion of the urinary bladder U extending a first distance axially in the direction of the flow of urine.
  • the second constriction device may be configured to constrict a second portion of the urinary bladder U extending a second distance axially in the direction of the flow of urine.
  • the second distance may be at least two times as long as the first distance.
  • the first constriction device 10a may constrict the urinary bladder U in order to restrict the flow of urine.
  • the second constriction device may then be used in order to constrict the second portion of the urinary bladder U for evacuating urine from the urinary bladder U.
  • the surrounding structure 20 When closed, the surrounding structure 20 is substantially rigid and has a modulus of elasticity (E), radially, in the range 0,2 GPa - 1000 GPa or in the range 1 GPa - 400 GPa. I.e. the modulus of elasticity calculated as the elastic deformation of an area of the inner surface 22 of the surrounding structure 20 causing an elongation in the radius R at that area when a force is applied to that area from the center of the surrounding structure 20.
  • E modulus of elasticity
  • Fig. 15c shows the implantable constriction device 10a of the embodiment shown in figs, 15a - 15c when the first and second operable hydraulic constriction elements 10 la’, 10 la” have been inflated with hydraulic fluid for compressing and restricting the urinary bladder U and the third and fourth operable hydraulic constriction element 101a’”, 101a”” have been deflated to make room for the expansion of the width W of the urinary bladder U that follows from the compression of the urinary
  • Fig. 15d shows an embodiment of the first constriction device 10a when in its constricted state.
  • the embodiment shown in fig. 15d is identical to the embodiment shown in figs 15a - 15c, the only difference being that the tubing fixation portions 25a, 25b enters the first and second support elements 24a, 24b perpendicularly into the first and second support elements 24a, 24b such that the fluid conduits 109a’, 109a”, 109a” ’,109a””” enters the support elements 24a, 24b perpendicularly, after which the fluid conduits is transferred over to the integrated channels in the support elements 24a, 24b.
  • Fig. 15d shows an embodiment of the first constriction device 10a when in its constricted state.
  • the embodiment shown in fig. 15d is identical to the embodiment shown in figs 15a - 15c, the only difference being that the tubing fixation portions 25a, 25b enters the first and second support elements 24a, 24b perpendicularly
  • FIG. 15e shows the embodiment of the first constricting device described with reference to figures 15a - 15c in a cross sectional view when implanted and placed surrounding the urinary bladder U, such that the flow F of fluid can be restricted by a constriction substantially perpendicular to the axial direction AD of the urinary bladder U.
  • the support elements 24a, 24b making up the surrounding structure 20 has a length 11 in the direction of the axial direction AD of the urinary bladder U.
  • the first 101a’ and second 101a” operable hydraulic constriction elements have a length 12 in the axial direction AD of the urinary bladder U.
  • the length 12 of the first and second operable hydraulic constriction elements 101a’, 101a” is longer than the length of the support elements 24a, 24b and thereby than the length of the surrounding structure 20.
  • the first and second operable hydraulic constriction elements 101a’, 101a” are 1.2 times as long as the surrounding structure 20 but in alternative embodiments, the constriction elements may be as little as 1.1 times as long as the surrounding structure 20 or as much as 1.5 or 2 times as long as the surrounding structure 20.
  • the constriction elements may also be shorter than the surrounding structure.
  • the surrounding structure is to house more than the constriction elements disclosed in figures 15a-15e.
  • the constriction elements may be arranged as in fig.
  • first and second operable hydraulic constriction elements 101a’, 101a” extending beyond the surrounding structure 20 both upstream and downstream in the axial direction AD of the urinary bladder U.
  • the first and second operable hydraulic constriction elements 101a’, 101a” can deform by flexing upwards and downwards to cover the rigid edges of the surrounding structure 20, such that the urinary bladder U does not come in contact with the surrounding structure 20, which reduces the risk of damages to the urinary bladder U.
  • a major portion of the surrounding structure 20 is made from a rigid material, and a major portion of the first and second operable hydraulic constriction elements 101a’, 101a” are made from a resilient material, and the resilient material is more than 2 times as elastic as the rigid material.
  • Fig. 15f shows a similar structure as the one shown in fig. 15a.
  • an implantable pumping device 10 for evacuating urine from the urinary bladder U of a patient is shown.
  • the implantable pumping device 10 has the same structure as the first constriction device 10a shown in fig. 15a expect here the surrounding structure 20 also houses a second constriction device configured to
  • the first constriction device 10a comprises a first operable hydraulic constriction element 101a’ and a second operable hydraulic constriction device 101a” for constricting a first portion of the urinary bladder U.
  • the implantable pumping device 10 further comprises a third and a fourth constriction element 101b’, 101b” for constricting a second portion of the urinary bladder U in order to evacuate urine from the urinary bladder U.
  • Any features as discussed in relation to fig. 9 can also be applied to the embodiment of figure 15f Further, the features discussed in relation to fig. 15a-15e can be applied here to the connection of the different hydraulic conduits or the different constriction elements.
  • the third and fourth operable hydraulic constriction elements 101b’, 101b” are of similar size as the first and second operable hydraulic constriction elements 10 la’, 10 la”.
  • the second constriction device 10b may comprise operable hydraulic constriction elements 10 lb’, 10 lb” that are longer than the operable hydraulic constriction elements 101a’, 101a” of the first constriction device 10a. For example, as described in relation to figure 3a-3c or 9.
  • Fig. 16a shows an overview of an implantable pumping device 10 when the implantable pumping device 10 is assembled from a kit for forming the surrounding structure 20.
  • the surrounding structure 20 having a periphery P surrounding the luminary organ, for example urinary bladder, U when implanted.
  • the kit comprising a first, second, third and fourth support element 24a, 24b, 24c, 24d.
  • the second, third and fourth support elements 24b, 24c, 24d are all configured to be connected to the first support element 24a for forming the surrounding structure 20.
  • the surrounding structure can be made to match the urinary bladder of the particular patient. In the embodiment shown in fig.
  • the second support 24b element has a curvature C having the same radius R1 as a curvature C of the first support element 24a.
  • the third support element 24c is adapted for a larger urinary bladder and has a more U-shaped cross section perpendicular to the axial direction of the urinary bladder U and thus has a curvature C having a smaller radius R3.
  • the fourth support element 24d is adapted for a smaller urinary bladder and has a shallower cross-section perpendicular to the axial direction of the urinary bladder U and thus has a curvature C having a larger radius R3 than the radii R1 and R2.
  • the first support element 24a comprises a first operable hydraulic constriction element 101a’ configured to be inflated with a hydraulic fluid entering the first operable hydraulic constriction element 101a’ through a first hydraulic fluid conduit 109a’ via a tubing fixation portion 25a for constricting a portion of the tissue wall of the urinary bladder and thereby restrict the flow of fluid therethrough.
  • the second, third and fourth support elements 24b, 24c, 24d all comprise a second operable hydraulic constriction element 101a” configured to be inflated with a hydraulic fluid entering the second operable hydraulic constriction element 101a” through a second hydraulic fluid conduit 109b via a tubing fixation portion 25b for constricting a portion of the tissue wall of the urinary bladder and thereby restrict the flow of fluid therethrough.
  • the first, second, third and fourth support elements 24a, 24b, 24c, 24d all comprises connecting portions 24a’, 24b’, 24c’, 24d’, 24a”, 24b”,24c”,24d” for connecting the first support element 24a to the second, third and fourth support
  • the first support element 24a may further comprises a third operable hydraulic constriction element (not shown in this perspective) according to the invention and described in relation to the previous figures, for example fig. 15f or figs. 3a-3c or figs. 9 or 10.
  • the second, third and fourth support elements 24b, 24c, 25d further comprises a fourth operable hydraulic constriction element (not shown in this perspective) according to the invention and described in relation to the previous figures.
  • Fig. 16a may also show a first constriction device 10a similar to the one discussed with relation to figs. 15a-15e.
  • An implantable pumping device for evacuating urine from the urinary bladder of a patient may then comprise a plurality of constriction devices according to fig. 16a arranged sequentially.
  • the first operable hydraulic constriction element 101a’ is connected to a first hydraulic system and the second operable hydraulic constriction element 101a” is connected to a second hydraulic system separate from the first hydraulic system.
  • the advantage of having the first and second operable hydraulic constriction element 10 la’, 10 la” connected to separate hydraulic systems is that the first and second operable hydraulic constriction element 10 la’, 10 la” may be filled the same amount of hydraulic fluid irrespective of the amount of resistance from the urinary bladder U that the respective first and second operable hydraulic constriction element 101a’, 101a” encounters. This means that the urinary bladder U will always be centered in the implantable pumping device 10 which reduced the risk of tissue damage to the urinary bladder U.
  • the third and fourth operable hydraulic constrict elements may be connected to separate hydraulic systems.
  • Fig. 16b shows an alternative embodiment of the supporting element 24c.
  • the supporting element 24c has an identical curvature and connecting portions 24c’, 24c”, the difference is that the supporting element 24c of the embodiment shown in fig. 16b does not comprise an operable hydraulic constriction element, instead the supporting element 24c comprises a cushioning element 30 configured to contact the urinary bladder.
  • the cushioning element 30 is fixated to the inner surface of the support element 24c by means of an adhesive and is more resilient than the support element 24c.
  • the cushioning element 30 is made from a solid medical grade silicone or polyurethane material.
  • Fig. 16c shows an alternative embodiment of the supporting element 24d.
  • the supporting element 24d has an identical curvature and connecting portions 24d’,24d”, the difference is that the supporting element 24d of the embodiment shown in fig. 16c does not comprise an operable hydraulic constriction element, instead the supporting element 24d comprises a cushioning element 30 configured to contact the urinary bladder.
  • the cushioning element 30 is fixated to the inner surface of the support element 24d by means of an adhesive and is more resilient than the support element 24d.
  • the cushioning element 30 is made from a solid medical grade silicone or polyurethane material.
  • Fig. 16d shows an alternative embodiment of the supporting element 24c.
  • the supporting element of fig. 16d has an identical curvature but is in turn divided into a second and third support elements 24b, 24c such that the surrounding structure will be comprised of three support elements 24a (of fig. 16a), 24b, 24c together having a periphery encircling the urinary bladder.
  • the second and third support elements 24b, 24c each comprises connecting portions 24b’, 24b”, 24c’, 24c” such that a first
  • ISA/EP connecting portion 24b’ of the second support element 24b can be connected to the first support element and a second connecting portion 24b” of the second support element 24b can be connected to the first connecting portion 24c’ of the third support element 24c and a second connecting portion 24c” of the third support element 24c can be connected to the first support element.
  • the second and third support elements 24b, 24c each comprises cushioning elements 30a, 30b configured to contact the urinary bladder.
  • the cushioning elements 30a, 30b are fixated to the inner surface of the support elements 24b, 24c by means of an adhesive and is more resilient than the support elements 24b, 24c.
  • the cushioning elements 30a, 30b are made from a solid medical grade silicone or polyurethane material.
  • Fig. 16e shows an alternative embodiment of the supporting element 24d.
  • the supporting element of fig. 16e has an identical curvature but is in turn divided into a second and third support elements 24b, 24c such that the surrounding structure will be comprised of three support elements 24a (of fig. 16a), 24b, 24c together having a periphery encircling the urinary bladder.
  • the second and third support elements 24b, 24c each comprises connecting portions 24b’, 24b”, 24c’, 24c” such that a first connecting portion 24b’ of the second support element 24b can be connected to the first support element and a second connecting portion 24b” of the second support element 24b can be connected to the first connecting portion 24c’ of the third support element 24c and a second connecting portion 24c” of the third support element 24c can be connected to the first support element.
  • the second and third support elements 24b, 24c each comprises cushioning elements 30a, 30b configured to contact the urinary bladder.
  • the cushioning elements 30a, 30b are fixated to the inner surface of the support elements 24b, 24c by means of an adhesive and is more resilient than the support elements 24b, 24c.
  • the cushioning elements 30a, 30b are made from a solid medical grade silicone or polyurethane material.
  • Fig. 16f shows an embodiment similar to the combination of the first and second support element 24a, 24b of fig. 16a. The difference being that the lower portion, equivalent to the second support element 24b of fig. 16a, is divided into a second and third support element 24b, 24c, such that the surrounding structure will be comprised of three support elements 24a, 24b, 24c together having a circular periphery P encircling the urinary bladder.
  • the first, second and third support elements 24a, 24b, 24c each comprises connecting portions 24a’, 24a”, 24b’, 24b”, 24c’, 24c” such that a first connecting portion 24b’ of the second support element 24b can be connected to a second connecting portion 24a” of the first support element 24a and a second connecting portion 24b” of the second support element 24b can be connected to the first connecting portion 24c’ of the third support element 24c and a second connecting portion 24c” of the third support element 24c can be connected to a first connecting portion 24a’ of the first support element 24a.
  • the first, second and third support elements 24a, 24b, 24c all comprise operable hydraulic constriction elements 101a’, 101a”, 101a’” configured to be inflated with a hydraulic fluid entering the operable hydraulic constriction elements 101a’, 101a”, 101a’” through a first, second and third hydraulic fluid conduit 109a’, 109a”, 109a’” via a tubing fixation portions 25a, 25b, 25c for constricting a portion of the tissue wall of the urinary bladder and thereby restrict the flow of fluid therethrough.
  • ISA/EP 24a has a first length la extending along a portion of the periphery P of the surrounding structure 20.
  • the second and third support element 24b, 24c have a second and third length lb, 1c, respectively, extending along a portion of the periphery P of the surrounding structure 20.
  • the second and third lengths lb, 1c are equally long and the first length la is more than 1.2 times as long as the second and third lengths.
  • a major portion of the all the support elements of the embodiments of figs. 3a - 16f can be made of a substantially rigid material, such that the resulting surrounding structure becomes substantially rigid.
  • the material of the major portion may comprise a material having a modulus of elasticity (E), in the range 0,2 GPa - 1000 GPa or in the range 1 GPa - 400 GPa.
  • the material could for example be a biocompatible metallic material, such as titanium or a medical grade metal alloy, such as medical grade stainless steel.
  • material could be a ceramic material such as zirconium carbide, or a stiff medical grade polymer material such as Ultra-high-molecular-weight polyethylene (UHMWPE) or Polytetrafluoroethylene (PTFE) or a thermoplastic polyester such as polylactide (PLA).
  • the support elements could also comprise at least one composite material, such as any combination of metallic/ceramic and polymer materials or a polymer material reinforced with organic or inorganic fibers, such as carbon or mineral fibers.
  • the hydraulic fluid conduits, and thereby the operable hydraulic constriction elements are configured to be connected to a hydraulic pump and control system, such as any the hydraulic pump and control systems disclosed with reference to figs. 18 - 22.
  • kits for a surrounding structure 20 for an implantable constriction device 10a for constricting a urinary bladder U of a patient may be configured to have a periphery P surrounding the urinary bladder U when implanted.
  • the kit comprises at least a first and second support element 24a, 24b, 24c, 24d.
  • the kit may also comprise at least three support elements.
  • the second support element 24b may be configured to be connected to the first support element 24a for forming at least a portion of the surrounding structure 20.
  • the third support element 24c may be configured to be connected to the first support element 24a for forming at least a portion of the surrounding structure 20. And at least one of the second and third support elements 24b, 24c may be connected to the first support element 24a for forming at least a portion of the surrounding structure 20 when the surrounding structure is implanted.
  • an implantable pumping device may be formed comprising at least a first kit configured to be placed around a first portion p 1 of a urinary bladder U in order to constrict the urinary bladder.
  • the implantable pumping device may also comprise a second kit similar to the first kit configured to be placed around a second portion p2 of the urinary bladder U in order to constrict the urinary bladder and to evacuate urine from the urinary bladder U.
  • the second kit may then be arranged downstream the first kit and be configured to constrict the second portion of the urinary bladder U for evacuating urine from the urinary bladder after the first kit has constricted the first portion.
  • a pumping device is made from a single kit, where a kit may be for at least two constriction devices 10a, 10b.
  • the second constriction device may be similar to the first
  • RECTIFIED SHEET (RULE 91) ISA/EP 10a
  • the kit may be held within the same support elements and when the kit is assembled configured to constrict the urinary bladder U downstream the first constriction device 10a.
  • the second constriction device 10b constricts the urinary bladder U, or any luminary organ, the content will be pumped forward and evacuated from the organ.
  • Figs 17-24f discloses an embodiment of a first constriction device 10a or of an implantable pumping device 10 placed around a luminary organ U.
  • the luminary organ U is a generic luminary organ U, however for the following text it will be referred to as a urinary bladder U for clarity.
  • the embodiment disclosed in Figs. 17-24f may be or may be a part of an implantable pumping device 10 configured to evacuate urine from a urinary bladder U.
  • the first constriction device 10a and/or the implantable pumping device 10 is arranged around another luminary organ for constricting the luminary organ and for evacuating a substance from the luminary organ.
  • Fig. 17 shows a schematic view of an embodiment of an implantable pumping device 10 for evacuating urine from the urinary bladder U of a patient by constricting the urinary bladder U of the patient.
  • the implantable pumping device 10 comprises a first operable hydraulic constriction element 101a configured to be inflated to constrict the urinary bladder U for restricting the flow of fluid therethrough, and a second operable hydraulic constriction element 101b configured to be inflated to constrict the urinary bladder U for restricting the flow of fluid therethrough and for evacuating urine from the urinary bladder U.
  • the first and second operable hydraulic constriction elements 101a, 101b are configured to be connected to a hydraulic pump and control system, such as any of the hydraulic pump and control systems disclosed with reference to figs. 18 - 22.
  • the first operable hydraulic constriction element 101a is configured to be placed at a first portion p 1 of the urinary bladder U for constricting the first portion p 1 of the urinary bladder U for restricting the flow of fluid therethrough
  • the second operable hydraulic constriction element 101b is configured to be placed at a second portion p2 of the urinary bladder U, downstream the first portion pl, for constricting the second portion p2 of the urinary bladder U for restricting the flow of fluid therethrough.
  • the lumen 103a of the first operable hydraulic constriction element 101a is connected to the lumen 103b of the second operable hydraulic constriction element 101b by means of an interconnecting fluid conduit 116, and as such, the first operable hydraulic constriction element 101a is in fluid connection with the second operable hydraulic constriction element 101b.
  • the fluid connection is configured to conduct fluid from the first operable hydraulic constriction element 10 la to the second operable hydraulic constriction element 101b when the pressure increases in the first operable hydraulic constriction element 101a, such that second operable hydraulic constriction element constricts 101b the second portion p2 of the urinary bladder U further.
  • first and second operable hydraulic constriction elements 10 la, 10 lb are of the same size. It is however equally conceivable that the first and second operable hydraulic constriction elements 101a,101b have different sizes, such as for example described
  • RECTIFIED SHEET (RULE 91) ISA/EP with reference to fig. 5 or 22. There may also be more than two operable hydraulic constriction elements, for example as described with reference to fig. 10.
  • the implantable pumping device 10 comprises a second interconnecting fluid conduit 117 fluidly connecting the first operable hydraulic constriction element 101a to the second operable hydraulic constriction element 101b.
  • a cross section of a tubular lumen of the second interconnecting fluid conduit 117 has an area which is less than 0,5 times a cross section area of a tubular lumen of the first interconnecting fluid conduit 116.
  • the second interconnecting fluid conduit 117 could comprise a hydraulic restrictor valve restricting the flow over the valve allowing a small leakage over the valve, which means that the pressures in the first operable hydraulic constriction element 101a and the second operable hydraulic constriction element 101b will reach an equilibrium over time. That time may be in the interval 1 - 10 minutes, or may be more than 10 seconds, or may be between 10 seconds and 1 hour or may be less than one hour.
  • the second operable hydraulic constriction element 101b may be configured to hold a higher pressure than the first operable hydraulic constriction element 101a.
  • a wall of the second operable hydraulic constriction element 101b may be thicker than a wall of the first operable hydraulic constriction element 101a, e.g the wall of the second operable hydraulic constriction element may be more than 1,5 times as thick as the wall of the first operable hydraulic constriction element.
  • the material of the wall of the second operable hydraulic constriction element 101b may be more durable than the material of the wall of the first operable hydraulic constriction element 101a.
  • the material of the wall of the second operable hydraulic constriction element 101b may be made from a material which is less elastic than the material of the wall of the first operable hydraulic constriction element 101a, e.g. the material of the wall of the first operable hydraulic constriction element 101a may be more than 1.2 times as elastic as the material of the wall of the second operable hydraulic constriction element 101b.
  • the lumens 103a, 103b of the first and second operable hydraulic constriction elements 101a, 101b are divided by a resilient division wall 115, which in the embodiment of fig. 17 is a wall made from the same medical grade silicone as the other walls 102 of the first and second operable hydraulic constriction elements 101a, 101b and concurrently made in the same molding process, which means that the resilient division wall 115 is materially integrated with the other walls 102 of the first and second operable hydraulic constriction elements 101a, 101b.
  • the division wall 115 is pleated such that the division wall 115 can accordion fold when the first and second operable hydraulic constriction elements 101a, 101b are compressed.
  • the implantable pumping device 10 further comprises a surrounding structure 20 having a periphery surrounding the urinary bladder U when implanted.
  • the surrounding structure 20 is substantially rigid and a major portion of the surrounding structure 20 could for example comprise a biocompatible metallic material, such as titanium or a medical grade metal alloy, such as medical grade stainless steel.
  • the surrounding structure 20 could be
  • RECTIFIED SHEET (RULE 91) ISA/EP comprise a ceramic material such as zirconium carbide, or a stiff medical grade polymer material such as Ultra-high-molecular-weight polyethylene (UHMWPE) or Polytetrafluoroethylene (PTFE) or a thermoplastic polyester such as polylactide (PLA).
  • the surrounding structure 20 could also comprise at least one composite material, such as any combination of metallic/ceramic and polymer materials or a polymer material reinforced with organic or inorganic fibers, such as carbon or mineral fibers. In the embodiment shown in fig.
  • the material of the major portion of the surrounding structure 20 has a modulus of elasticity (E) in the range 0,2 GPa - 1000 GPa or more specifically in the range 1 GPa - 400 GPa.
  • the major portion of the surrounding structure 20 being made from a stiff material results in that the surrounding structure 20 has a modulus of elasticity (E), radially, in the range 0,2 GPa - 1000 GPa or more specifically in the range 1 GPa - 400 GPa, which means that the supporting structure 20 only expands an insignificant distance when the operable hydraulic constriction devices are expanded to close the urinary bladder U, which means that it can be established with high precision that the fluid pumped into the operable hydraulic constriction devices are used for exerting a closing force on the urinary bladder U.
  • E modulus of elasticity
  • the surrounding structure 20 comprises an inner surface 22 configured to face the urinary bladder U, when implanted.
  • the portion of the wall of the first and second operable hydraulic constriction elements 101a, 101b facing the inner surface 22 of the surrounding structure 20 is configured to be fixated to the inner surface 22 of the surrounding structure 20 e.g. by means of an adhesive.
  • the implantable pumping device 10 further comprises at least one cushioning element 30 configured to contact the urinary bladder U.
  • the cushioning element is fixated to the inner surface 22 of the surrounding structure 20 by means of an adhesive and is more resilient than the surrounding structure 20.
  • the cushioning element 30 is made from a solid medical grade silicone or polyurethane material.
  • Fig. 18 shows an overview of an embodiment of an implantable pumping device 10 for evacuating urine from the urinary bladder U of a patient by constricting the urinary bladder U of the patient.
  • the implantable pumping device 10 comprises a first operable hydraulic constriction element 101a configured to be inflated to constrict the urinary bladder U for restricting the flow of fluid therethrough, and a second operable hydraulic constriction element 10b’ configured to be inflated to constrict the urinary bladder U for restricting the flow F of fluid therethrough and for evacuating urine from the urinary bladder U.
  • the first operable hydraulic constriction element 101a is configured to be placed at a first portion p 1 of the urinary bladder U for constricting the first portion p 1 of the urinary bladder U for restricting the flow F of fluid therethrough
  • the second operable hydraulic constriction element 101b is configured to be placed at a second portion p2 of the urinary bladder U, downstream the first
  • a first portion 109’ of a first reservoir conduit 109 is connected to the lumen 103a of the first operable hydraulic constriction element 101a and a second portion 109” of the first reservoir conduit 109 is connected to the lumen 103b of the second operable hydraulic constriction element 101b.
  • the lumen 103a of the first operable hydraulic constriction element 101a is connected to the lumen 103b of the second operable hydraulic constriction element 101b by means of an interconnecting fluid conduit 116, and as such, the first operable hydraulic constriction element 101a is in fluid connection with the second operable hydraulic constriction element 101b.
  • the fluid connection is configured to conduct fluid from the first operable hydraulic constriction element 10 la to the second operable hydraulic constriction element 101b when the pressure increases in the first operable hydraulic constriction element 101a, such that second operable hydraulic constriction element constricts 101b the second portion p2 of the urinary bladder U further in order to pump the urine out of the urinary bladder U.
  • the lumen 103a of the first operable hydraulic constriction element 101a has the same volume as the lumen 103b of the second operable hydraulic constriction element 101b.
  • the lumens 103a, 103b of the first and second operable hydraulic constriction elements 10 la, 10 lb are divided by a resilient division wall 115, which in the embodiment of fig. 18 is a wall made from the same medical grade silicone as the other walls 102 of the first and second operable hydraulic constriction elements 101a, 101b and concurrently made in the same molding process, which means that the resilient division wall 115 is materially integrated with the other walls 102 of the first and second operable hydraulic constriction elements 101a, 101b.
  • the division wall 115 is pleated such that the division wall 115 can accordion-fold when the first and second operable hydraulic constriction elements 101a,101bare compressed.
  • a pump 104 is placed on the first portion of the reservoir conduit 109’, such that the pump 104 can pump a hydraulic fluid from the reservoir 107 to the first operable hydraulic constriction element 101a.
  • the pump 104 may be of any of the types of hydraulic pumps disclosed herein.
  • an electrically operable valve 105 is placed on the second portion of the reservoir conduit 109”, to open a fluid communication between the second operable hydraulic constriction element 101b and the reservoir 107.
  • the electrically operable valve 105 may in any of the embodiments herein be an electrically operable ball valve, butterfly valve, swing valve, diaphragm valve, pinch valve, needle valve or gate valve, and the valve may be electrically operable by means of a solenoid.

Landscapes

  • Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)

Abstract

La présente divulgation concerne des techniques servant à restreindre une vessie urinaire et à évacuer l'urine d'une vessie urinaire. Plus particulièrement, l'invention concerne un dispositif de pompage implantable, comprenant un ou plusieurs dispositifs de constriction configurés pour comprimer la vessie urinaire afin d'évacuer l'urine.
PCT/EP2022/073763 2021-08-30 2022-08-26 Appareil et procédé permettant d'obtenir un contrôle urinaire WO2023031032A1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
EP22772432.5A EP4395704A1 (fr) 2021-08-30 2022-08-26 Appareil et procédé permettant d'obtenir un contrôle urinaire
JP2024513471A JP2024536982A (ja) 2021-08-30 2022-08-26 排尿コントロールを得るための装置および方法
CA3230660A CA3230660A1 (fr) 2021-08-30 2022-08-26 Appareil et procede permettant d'obtenir un controle urinaire
AU2022336957A AU2022336957A1 (en) 2021-08-30 2022-08-26 Apparatus and method for obtaining urinary control
AU2023221544A AU2023221544A1 (en) 2022-02-18 2023-02-16 Apparatus and method for obtaining urinary control
PCT/EP2023/053988 WO2023156574A1 (fr) 2022-02-18 2023-02-16 Appareil et procédé pour obtenir un contrôle urinaire
PCT/EP2024/054071 WO2024170775A1 (fr) 2022-02-18 2024-02-16 Appareil et procédé pour obtenir un contrôle urinaire

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
PCT/EP2021/073893 WO2022043555A1 (fr) 2020-08-31 2021-08-30 Fourniture d'énergie à distance à un implant comprenant un condensateur pour fournir les rafales d'énergie nécessaire aux parties de l'implant consommant de l'énergie
EPPCT/EP2021/073893 2021-08-30
SE2250204-1 2022-02-18
SE2250217 2022-02-18
SE2250204 2022-02-18
SE2250217-3 2022-02-18

Publications (1)

Publication Number Publication Date
WO2023031032A1 true WO2023031032A1 (fr) 2023-03-09

Family

ID=83355651

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2022/073763 WO2023031032A1 (fr) 2021-08-30 2022-08-26 Appareil et procédé permettant d'obtenir un contrôle urinaire

Country Status (1)

Country Link
WO (1) WO2023031032A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024170775A1 (fr) * 2022-02-18 2024-08-22 Implantica Patent Ltd Appareil et procédé pour obtenir un contrôle urinaire

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3810259A (en) * 1971-01-25 1974-05-14 Fairchild Industries Implantable urinary control apparatus
WO2009048394A2 (fr) * 2007-10-11 2009-04-16 Milux Holding Sa Appareil de régulation du flux de spermatozoïdes dans une trompe de fallope
US20160015392A1 (en) * 2013-03-15 2016-01-21 Mayo Foundation For Medical Education And Research Luminal compression device
EP3586794A1 (fr) * 2007-10-11 2020-01-01 Implantica Patent Ltd. Dispositif de traitement de l'anévrisme
AU2019283984A1 (en) * 2007-10-11 2020-01-23 Implantica Patent Ltd System and method for embryo control
EP2967954B1 (fr) * 2013-03-15 2021-07-07 Implantica Patent Ltd. Dispositif de restriction

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3810259A (en) * 1971-01-25 1974-05-14 Fairchild Industries Implantable urinary control apparatus
WO2009048394A2 (fr) * 2007-10-11 2009-04-16 Milux Holding Sa Appareil de régulation du flux de spermatozoïdes dans une trompe de fallope
EP3586794A1 (fr) * 2007-10-11 2020-01-01 Implantica Patent Ltd. Dispositif de traitement de l'anévrisme
AU2019283984A1 (en) * 2007-10-11 2020-01-23 Implantica Patent Ltd System and method for embryo control
US20160015392A1 (en) * 2013-03-15 2016-01-21 Mayo Foundation For Medical Education And Research Luminal compression device
EP2967954B1 (fr) * 2013-03-15 2021-07-07 Implantica Patent Ltd. Dispositif de restriction

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024170775A1 (fr) * 2022-02-18 2024-08-22 Implantica Patent Ltd Appareil et procédé pour obtenir un contrôle urinaire

Similar Documents

Publication Publication Date Title
WO2023031038A1 (fr) Dispositif d'étirage
WO2024170775A1 (fr) Appareil et procédé pour obtenir un contrôle urinaire
WO2023031032A1 (fr) Appareil et procédé permettant d'obtenir un contrôle urinaire
WO2023156529A1 (fr) Dispositif d'étirage
WO2023031046A1 (fr) Dispositif de restriction d'urètre implantable
WO2023031045A1 (fr) Dispositif de restriction
WO2023031036A1 (fr) Dispositif pour traiter un anévrisme d'un vaisseau sanguin
WO2023280859A1 (fr) Traitement d'une maladie de reflux gastro-oesophagien
AU2022336957A1 (en) Apparatus and method for obtaining urinary control
US20240269456A1 (en) Restriction device
US20230067834A1 (en) Implantable urethra restriction device
US20230065828A1 (en) Restriction device
WO2024041758A1 (fr) Pompe hydraulique ou pneumatique implantable
US20240268980A1 (en) Stretching device
AU2022338025A1 (en) Stretching device
AU2023221535A1 (en) Stretching device
US20240307202A1 (en) Treatment of gerd
WO2024170769A1 (fr) Dispositif de restriction
WO2024170779A1 (fr) Dispositif d'étirement
WO2023031049A1 (fr) Dispositif médical alimenté implantable, méthodes et kit associés
WO2023156563A1 (fr) Dispositif médical alimenté implantable, méthodes et kit associés

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22772432

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2024513471

Country of ref document: JP

Ref document number: 3230660

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2022336957

Country of ref document: AU

Ref document number: AU2022336957

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2022772432

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2022772432

Country of ref document: EP

Effective date: 20240402

ENP Entry into the national phase

Ref document number: 2022336957

Country of ref document: AU

Date of ref document: 20220826

Kind code of ref document: A